WO2016105054A2 - Organic light emitting compound and organic electroluminescent element using same - Google Patents

Organic light emitting compound and organic electroluminescent element using same Download PDF

Info

Publication number
WO2016105054A2
WO2016105054A2 PCT/KR2015/014035 KR2015014035W WO2016105054A2 WO 2016105054 A2 WO2016105054 A2 WO 2016105054A2 KR 2015014035 W KR2015014035 W KR 2015014035W WO 2016105054 A2 WO2016105054 A2 WO 2016105054A2
Authority
WO
WIPO (PCT)
Prior art keywords
group
aryl
mmol
alkyl
formula
Prior art date
Application number
PCT/KR2015/014035
Other languages
French (fr)
Korean (ko)
Other versions
WO2016105054A3 (en
Inventor
한송이
김영배
김회문
Original Assignee
주식회사 두산
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 두산 filed Critical 주식회사 두산
Publication of WO2016105054A2 publication Critical patent/WO2016105054A2/en
Publication of WO2016105054A3 publication Critical patent/WO2016105054A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Definitions

  • the present invention relates to a novel organic light emitting compound and an organic electroluminescent device using the same, and more particularly, to include a novel azepine compound having excellent hole injection and transport ability, light emitting ability, and the like in one or more organic material layers,
  • the present invention relates to an organic EL device having improved characteristics such as driving voltage and lifetime.
  • the material used as the organic material layer may be classified into a light emitting material, a hole injection material, a hole transport material, an electron transport material, an electron injection material and the like according to its function.
  • the light emitting layer forming material of the organic EL device may be classified into blue, green, and red light emitting materials according to light emission colors. In addition, yellow and orange light emitting materials are also used as light emitting materials to realize better natural colors.
  • a host / dopant system may be used as the light emitting material in order to increase the light emission efficiency through increase in color purity and energy transfer.
  • the dopant material may be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. The development of such phosphorescent materials can theoretically improve the luminous efficiency up to 4 times compared to fluorescence, and thus, attention has been focused on phosphorescent dopants as well as phosphorescent host materials.
  • NPB hole blocking layer
  • BCP hole blocking layer
  • Alq 3 hole blocking layer
  • anthracene derivatives have been reported as fluorescent dopant / host materials in the light emitting material.
  • phosphorescent materials having a great advantage in terms of efficiency improvement among light emitting materials include metal complex compounds containing Ir such as Firpic, Ir (ppy) 3 , and (acac) Ir (btp) 2 as blue, green, and red dopant materials. It is used.
  • CBP has shown excellent properties as a phosphorescent host material.
  • the present invention can be applied to an organic electroluminescent device, and an object of the present invention is to provide a novel organic compound having excellent hole injection, transporting ability, light emitting ability, and the like.
  • Another object of the present invention is to provide an organic electroluminescent device including the novel organic compound, which exhibits low driving voltage and high luminous efficiency and has an improved lifetime.
  • the present invention to achieve the above object provides a compound represented by the following formula (1).
  • R 1 and R 2 are bonded to each other to form a condensed ring with the formula (2),
  • the dotted line is the part where condensation takes place
  • X 1 and X 2 are each independently selected from the group consisting of O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 );
  • Y 1 to Y 12 are each independently selected from N or C (R 3 );
  • R 3 is plural, they are the same or different from each other, and the R 3 are each independently hydrogen, deuterium, a halogen, a cyano group, a nitro group, C 1 ⁇ alkenyl group of the C 40 alkyl group, C 2 ⁇ C 40 of, C Alkynyl group of 2 to C 40 , a cycloalkyl group of C 3 to C 40 , a heterocycloalkyl group of 3 to 40 nuclear atoms, an aryl group of C 6 to C 60 , a heteroaryl group of 5 to 60 nuclear atoms, C 1 C 6 -C 40 alkyloxy group, C 6 -C 60 aryloxy group, C 3 -C 40 alkylsilyl group, C 6 -C 60 arylsilyl group, C 1 -C 40 alkyl boron group, C 6 - of C 60 aryl boron group, C 6 ⁇ C 60 aryl phosphine group, each selected from C
  • Ar 1 to Ar 5 is C 1 ⁇ C 40 Alkyl group, C 2 ⁇ C 40 Alkenyl group, C 2 ⁇ C 40 Alkynyl group, C 3 ⁇ C 40 Cycloalkyl group, 3 to 40 heterocycloheteronuclear Alkyl group, C 6 ⁇ C 60 aryl group, 5 to 60 heteroaryl group, C 1 ⁇ C 40 alkyloxy group, C 6 ⁇ C 60 aryloxy group, C 3 ⁇ C 40 alkylsilyl Group, C 6 ⁇ C 60 arylsilyl group, C 1 ⁇ C 40 alkyl boron group, C 6 ⁇ C 60 aryl boron group, C 6 ⁇ C 60 aryl phosphine group, C 6 ⁇ C 60 mono or A diaryl phosphinyl group and a C 6 -C 60 arylamine group;
  • R 3 Ar 1 to Ar 5 alkyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group, arylsilyl group, alkyl boron group, aryl boron group, aryl
  • a phosphine group, a mono or diaryl phosphinyl group and an arylamine group are each independently a C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 A cycloalkyl group, a nuclear atom having 3 to 40 heterocycloalkyl groups, a C 6 to C 60 aryl group, a nuclear atom having 5 to 60 heteroaryl groups, a C 1 to C 40 alkyloxy group, a C 6 to C 60 group Aryloxy group, C 3 ⁇ C 40 alkylsilyl group, C 6 ⁇
  • the present invention also provides an organic electroluminescent device comprising (i) an anode, (ii) a cathode, and (iii) at least one organic layer interposed between the anode and the cathode, wherein at least one of the at least one organic layer
  • an organic electroluminescent device comprising a compound represented by the formula (1).
  • Alkyl as used herein means a monovalent substituent derived from a straight or branched chain saturated hydrocarbon of 1 to 40 carbon atoms. Examples thereof include, but are not limited to, methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amyl, hexyl and the like.
  • alkenyl refers to a monovalent substituent derived from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms having at least one carbon-carbon double bond. Examples thereof include, but are not limited to, vinyl, allyl, isopropenyl, 2-butenyl, and the like.
  • alkynyl refers to a monovalent substituent derived from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms having at least one carbon-carbon triple bond. Examples thereof include, but are not limited to, ethynyl, 2-propynyl, and the like.
  • Aryl in the present invention means a monovalent substituent derived from a C6-C40 aromatic hydrocarbon in which a single ring or two or more rings are combined.
  • a form in which two or more rings are attached to each other (pendant) or condensed may also be included.
  • Examples of such aryl include, but are not limited to, phenyl, naphthyl, phenanthryl, anthryl, and the like.
  • Heteroaryl as used herein means a monovalent substituent derived from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 40 nuclear atoms. At least one carbon in the ring, preferably 1 to 3 carbons, is substituted with a heteroatom such as N, O, S or Se.
  • a form in which two or more rings are pendant or condensed with each other may be included, and may also include a form in which the two or more rings are condensed with an aryl group.
  • heteroaryl examples include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, phenoxathienyl, indolinzinyl, indolyl ( polycyclic rings such as indolyl, purinyl, quinolyl, benzothiazole, carbazolyl and 2-furanyl, N-imidazolyl, 2-isoxazolyl , 2-pyridinyl, 2-pyrimidinyl, and the like, but are not limited thereto.
  • 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, phenoxathienyl, indolinzinyl, indolyl ( polycyclic rings such as indolyl, purinyl, quinolyl, benzothiazole, carb
  • aryloxy is a monovalent substituent represented by RO-, wherein R means aryl having 5 to 40 carbon atoms.
  • R means aryl having 5 to 40 carbon atoms. Examples of such aryloxy include, but are not limited to, phenyloxy, naphthyloxy, diphenyloxy, and the like.
  • alkyloxy is a monovalent substituent represented by R'O-, wherein R 'means an alkyl having 1 to 40 carbon atoms, and linear, branched or cyclic structure It may include.
  • alkyloxy include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.
  • Arylamine in the present invention means an amine substituted with aryl having 6 to 40 carbon atoms.
  • cycloalkyl is meant herein monovalent substituents derived from monocyclic or polycyclic non-aromatic hydrocarbons having 3 to 40 carbon atoms.
  • examples of such cycloalkyl include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.
  • Heterocycloalkyl as used herein means a monovalent substituent derived from 3 to 40 non-aromatic hydrocarbons of nuclear atoms, wherein at least one carbon in the ring, preferably 1 to 3 carbons, is N, O, S Or a hetero atom such as Se.
  • heterocycloalkyl include, but are not limited to, morpholine, piperazine, and the like.
  • alkylsilyl means silyl substituted with alkyl having 1 to 40 carbon atoms
  • arylsilyl means silyl substituted with aryl having 5 to 40 carbon atoms
  • condensed ring means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring, or a combination thereof.
  • the compound represented by Formula 1 of the present invention may be used as a material of the organic material layer of the organic electroluminescent device because of its excellent thermal stability and luminescence properties.
  • an organic electroluminescent device having excellent light emission performance, low driving voltage, high efficiency, and long life compared to a conventional host material can be manufactured. Full color display panels with improved performance and lifetime can also be manufactured.
  • Compounds of the present invention are dibenzoazine (5H-dibenzo [b, d] azepine), dibenzooxepine (dibenzo [b, d] oxepine), dibenzothiepine (dibenzo [b, d] thiepine), 5-membered heteroaromatic ring moiety, indene moiety, in which benzene is condensed to dibenzosilene (5H-dibenzo [b, d] silepine) or dibenzocycloheptene (5H-dibenzo [a, d] cycloheptene) moiety, or indole moiety is condensed to form a basic skeleton, characterized in that represented by the following formula (1):
  • R 1 and R 2 are bonded to each other to form a condensed ring with the formula (2),
  • the dotted line is the part where condensation takes place
  • X 1 and X 2 are each independently selected from the group consisting of O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 );
  • Y 1 to Y 12 are each independently selected from N or C (R 3 );
  • R 3 if multiple individuals which are the same or different from each other, and the R 3 are each independently hydrogen, deuterium, a halogen, a cyano group, a nitro group, C 1 ⁇ alkenyl group of the C 40 alkyl group, C 2 ⁇ C 40 of, C Alkynyl group of 2 to C 40 , a cycloalkyl group of C 3 to C 40 , a heterocycloalkyl group of 3 to 40 nuclear atoms, an aryl group of C 6 to C 60 , a heteroaryl group of 5 to 60 nuclear atoms, C 1 C 6 -C 40 alkyloxy group, C 6 -C 60 aryloxy group, C 3 -C 40 alkylsilyl group, C 6 -C 60 arylsilyl group, C 1 -C 40 alkyl boron group, C 6 - of C 60 aryl boron group, C 6 ⁇ C 60 aryl phosphine group, each selected from C
  • Ar 1 to Ar 5 is C 1 ⁇ C 40 Alkyl group, C 2 ⁇ C 40 Alkenyl group, C 2 ⁇ C 40 Alkynyl group, C 3 ⁇ C 40 Cycloalkyl group, 3 to 40 heterocycloheteronuclear Alkyl group, C 6 ⁇ C 60 aryl group, 5 to 60 heteroaryl group, C 1 ⁇ C 40 alkyloxy group, C 6 ⁇ C 60 aryloxy group, C 3 ⁇ C 40 alkylsilyl Group, C 6 ⁇ C 60 arylsilyl group, C 1 ⁇ C 40 alkyl boron group, C 6 ⁇ C 60 aryl boron group, C 6 ⁇ C 60 aryl phosphine group, C 6 ⁇ C 60 mono or A diaryl phosphinyl group and a C 6 -C 60 arylamine group;
  • R 3 Ar 1 to Ar 5 alkyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group, arylsilyl group, alkyl boron group, aryl boron group, aryl
  • a phosphine group, a mono or diaryl phosphinyl group and an arylamine group are each independently a C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 A cycloalkyl group, a nuclear atom having 3 to 40 heterocycloalkyl groups, a C 6 to C 60 aryl group, a nuclear atom having 5 to 60 heteroaryl groups, a C 1 to C 40 alkyloxy group, a C 6 to C 60 group Aryloxy group, C 3 ⁇ C 40 alkylsilyl group, C 6 ⁇
  • the compound represented by Chemical Formula 1 has a higher molecular weight than the conventional organic EL device material [for example, 4,4-dicarbazolybiphenyl (hereinafter referred to as 'CBP')], the glass transition temperature is high, and thus the thermal stability is excellent. In addition, the carrier transporting ability, the light emitting ability and the like are excellent. Therefore, when the organic electroluminescent device includes the compound of Formula 1, the driving voltage, efficiency, lifespan, etc. of the device may be improved.
  • the conventional organic EL device material for example, 4,4-dicarbazolybiphenyl (hereinafter referred to as 'CBP')
  • 'CBP' 4,4-dicarbazolybiphenyl
  • the host material should have a triplet energy gap of which is higher than the triplet energy gap of the dopant. That is, when the lowest excited state of the host is higher in energy than the lowest emitted state of the dopant, phosphorescence efficiency may be improved.
  • the compound of Formula 1 has a high triplet energy, by introducing a specific substituent in the basic skeleton condensed with a broad singlet energy level and a high triplet energy level, the energy level can be controlled higher than the dopant It can be used as a host material.
  • the compound of the present invention since the compound of the present invention has a high triplet energy as described above, it is possible to prevent the excitons generated in the light emitting layer from diffusing into the electron transport layer or the hole transport layer adjacent to the light emitting layer. Therefore, when the organic material layer (hereinafter, referred to as a 'light emitting auxiliary layer') is formed between the hole transport layer and the light emitting layer by using the compound of Formula 1, the exciton is prevented from being diffused by the compound, and thus the first exciton is diffused. Unlike conventional organic electroluminescent devices that do not include a barrier layer, the number of excitons that substantially contribute to light emission in the light emitting layer may be increased, thereby improving the luminous efficiency of the device.
  • the compound represented by Chemical Formula 1 may be used as a light emitting auxiliary layer material or a life improvement layer material other than the host of the light emitting layer.
  • the compound of Formula 1 may adjust HOMO and LUMO energy levels according to the type of substituents introduced into the basic skeleton, may have a wide bandgap, it may have a high carrier transport.
  • EWG electron-withdrawing electron
  • the compound is bonded to an electron-withdrawing electron (EWG) having a high electron absorption such as a nitrogen-containing heterocycle (eg, pyridine group, pyrimidine group, triazine group, etc.) to the basic skeleton, Since it has a bipolar characteristic, it is possible to increase the bonding force between the hole and the electron.
  • EWG electron-withdrawing electron
  • the compound of Formula 1 having EWG introduced into the basic skeleton has excellent carrier transport properties and luminescent properties, and thus, as an electron injection / transport layer material or a life improvement layer material, in addition to the light emitting layer material of the organic EL device. Can be used.
  • an electron donor group EWG
  • the hole injection and transport is smooth.
  • it can be usefully used as a hole injection / transport layer or a light emitting auxiliary layer material.
  • the compound represented by Chemical Formula 1 may improve the light emission characteristics of the organic EL device, and may also improve the hole injection / transport ability, the electron injection / transport capability, the luminous efficiency, the driving voltage, and the lifespan characteristics.
  • the compound of formula 1 according to the present invention is an organic material layer material of an organic electroluminescent device, preferably a light emitting layer material (blue, green and / or red phosphorescent host material), an electron transport / injection layer material and a hole transport / injection layer Material, light emitting auxiliary layer material, life improving layer material, more preferably light emitting layer material, electron injection layer material, light emitting auxiliary layer material, and life improving layer material.
  • the compound of Formula 1 has a variety of substituents, particularly aryl groups and / or heteroaryl groups introduced into the basic skeleton significantly increases the molecular weight of the compound, thereby improving the glass transition temperature, thereby conventional light emission It may have a higher thermal stability than the material (eg CBP).
  • the compound represented by the formula (1) is effective in suppressing the crystallization of the organic material layer. Therefore, the organic electroluminescent device including the compound of Formula 1 according to the present invention can greatly improve performance and lifespan characteristics, and the full-color organic light emitting panel to which the organic electroluminescent device is applied can also maximize its performance.
  • the compound of the present invention may combine R 1 and R 2 to form a condensed heteroaromatic ring or a condensed aromatic ring represented by the formula (2).
  • R 1 and R 2 may be bonded to form condensed indene, condensed indole, condensed benzothiophene, condensed benzofuran, condensed benzosilol and the like including one or more of N, O, S, and Si.
  • the compound of the present invention may be represented by the following formula (3) or (4).
  • X 1 , X 2 and Y 1 to Y 12 are as defined in Chemical Formulas 1 and 2.
  • X 1 and X 2 are each independently O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4) (Ar 5 ), and at least one of them is preferably N (Ar 1 ).
  • Y 1 to Y 12 are each independently selected from N or C (R 3 ), and all of them are C (R 3 ) or one of them is N. desirable.
  • the compound of the present invention may be specifically selected from the group consisting of compounds represented by Formulas 1-1 to 1-18 below, but is not limited thereto.
  • Each of Y 1 to Y 12 and Ar 1 to Ar 5 is the same or different, in particular, a plurality of Ar 1 in Formulas 1-1 and 1-6 are the same as or different from each other, as defined in Formulas 1 and 2.
  • At least one of R 3 , Ar 1 to Ar 5 is an alkyl group of C 1 ⁇ C 40 , an aryl group of C 6 ⁇ C 60 , It is selected from the group consisting of 5 to 60 heteroaryl groups and C 6 ⁇ C 60 arylamine group, the alkyl group, aryl group, heteroaryl group, arylamine group, each independently, deuterium, halogen, cyano group, It may be substituted with at least one member selected from the group consisting of C 1 ⁇ C 40 alkyl group, C 6 ⁇ C 60 aryl group, 5 to 60 heteroaryl group, C 6 ⁇ C 60 arylamine group. When substituted with a plurality of substituents, they may be the same or different from each other.
  • At least one of R 3 to Ar 1 to Ar 5 except for forming a condensation in the formula (1) and 2 may be a substituent represented by the formula (5) or a phenyl group.
  • L 1 is a single bond or is selected from the group consisting of C 6 to C 18 arylene groups and heteroarylene groups having 5 to 18 nuclear atoms, preferably single bond, phenylene group, biphenylene group, carbazolyl group Can;
  • Z 1 to Z 5 are each independently N or C (R 11 ), provided that at least one of Z 1 to Z 5 is N and when there are a plurality of R 11 , they are the same or different from each other;
  • R 11 is hydrogen, deuterium, halogen, cyano group, nitro group, C 1 -C 40 alkyl group, C 2 -C 40 alkenyl group, C 2 -C 40 alkynyl group, C 6 -C 40 aryl group, 5 to 40 heteroaryl groups, C 6 to C 40 aryloxy groups, C 1 to C 40 alkyloxy groups, C 3 to C 40 cycloalkyl groups, 3 to 40 heterocycloalkyl groups, C 6 ⁇ C 40 arylamine group, C 1 ⁇ C 40 alkylsilyl group, C 1 ⁇ C 40 alkyl boron group, C 6 ⁇ C 40 aryl boron group, C 6 ⁇ C 40 aryl phosphine group, C 6 ⁇ C 40 mono or diaryl phosphinyl group and C 6 ⁇ C 40 arylsilyl group selected from the group consisting of, or in combination with adjacent groups (e.g., L, other adjacent R 11 ) conden
  • the arylphosphine group, mono or diarylphosphinyl group and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ⁇ C 40 alkyl group, C 2 ⁇ C 40 alkenyl group, C 2 ⁇ C 40 Alkynyl group, C 6 ⁇ C 40 aryl group, 5 to 40 heteroaryl groups, C 6 ⁇ C 40 aryloxy group, C 1 ⁇ C 40 alkyloxy group, C 6 ⁇ C 40 An arylamine group, a C 3 to C 40
  • Examples of the substituent represented by Formula 5 include a substituent represented by the following A-1 to A-15, but is not limited thereto.
  • L 1 and R 11 are each as defined in Formula 5,
  • n is an integer of 0 to 4, and when n is 0, it means that hydrogen is not substituted with a substituent R 12 , and when n is an integer of 1 to 4, R 12 is deuterium, halogen, cyano group, nitro C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 cycloalkyl group, nuclear atom of 3 to 40 heterocycloalkyl group, C 6 Aryl group of ⁇ C 40 , heteroaryl group of 5 to 40 nuclear atoms, aryloxy group of C 6 ⁇ C 40 60 C 1 ⁇ C 40 alkyloxy group, C 6 ⁇ C 40 arylamine group, C 1 ⁇ C 40 alkylsilyl group, C 1 ⁇ C 40 group of an alkyl boron, C 6 ⁇ C 40 group of the arylboronic, C 6 ⁇ mono or diaryl phosphine of C 40 aryl phosphine
  • the arylphosphine group, mono or diarylphosphinyl group and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ⁇ C 40 alkyl group, C 2 ⁇ C 40 alkenyl group, C 2 ⁇ C 40 Alkynyl group, C 6 ⁇ C 40 aryl group, 5 to 40 heteroaryl groups, C 6 ⁇ C 40 aryloxy group, C 1 ⁇ C 40 alkyloxy group, C 6 ⁇ C 40 An arylamine group, a C 3 to C 40 cycl
  • At least one of R 3 to Ar 1 to Ar 5 except for forming a condensation in the formula (1) and 2 may be a substituent represented by the following formula (6).
  • L 2 is a single bond or is selected from the group consisting of a C 6 to C 18 arylene group and a heteroarylene group having 5 to 18 nuclear atoms, preferably a single bond, or a phenylene group, a biphenylene group, or a carbazolyl group.
  • R 13 and R 14 are each independently a C 1 ⁇ C 40 alkyl group, C 6 ⁇ C 40 aryl group, the number of nuclear atoms of 5 to 40 heteroaryl group, and a C 6 ⁇ selected from the group consisting of an aryl amine of the C 60 Or R 13 and R 14 may combine to form a condensed ring;
  • the alkyl group, aryl group, heteroaryl group and arylamine group of R 13 and R 14 are each independently deuterium, halogen, cyano group, nitro group, C 1 ⁇ C 40 alkyl group, C 2 ⁇ C 40 alkenyl group, C 2 ⁇ C 40 alkynyl group, C 6 ⁇ C 40 aryl group, the number of nuclear atoms of 5 to 40 heteroaryl group, C 6 ⁇ C 40 aryloxy group, alkyloxy group of C 1 ⁇ C 40 of the, C 6 ⁇ C 40 aryl amine group, C 3 ⁇ C 40 cycloalkyl group, a number of nuclear atoms of 3 to 40 heterocycloalkyl group, C 1 ⁇ alkyl silyl group of C 40, C 1 ⁇ C 40 group of an alkyl boron, C 6 ⁇ C 40 aryl boron group, C 6 ⁇ C 40 aryl phosphine group, C 6 ⁇ C 40 mono or diary
  • the compounds of the present invention may be specifically represented as compounds of the structures exemplified below, but are not limited thereto.
  • organic electroluminescent device comprising the compound represented by the formula (1) according to the present invention.
  • the organic electroluminescent device includes an anode, a cathode, and one or more organic material layers interposed between the anode and the cathode, and at least one of the one or more organic material layers.
  • a compound represented by the formula (1) includes a compound represented by the formula (1).
  • the compound may be used alone, or two or more kinds thereof may be mixed and used.
  • the one or more organic material layers may be any one or more of a hole injection layer, a hole transport layer, a light emitting auxiliary layer, a light emitting layer, an electron transport layer and an electron injection layer, wherein at least one organic material layer may include a compound represented by Formula 1 have.
  • the organic material layer including the compound represented by Formula 1 is preferably a light emitting layer, an electron transport layer, a hole transport layer.
  • the light emitting layer of the organic electroluminescent device of the present invention may include a host material, and may include the compound of Formula 1 as the host material.
  • the light emitting layer of the organic electroluminescent device of the present invention may include a compound other than the compound of Formula 1 as a host.
  • the structure of the organic EL device of the present invention is not particularly limited, but may be a structure in which a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting auxiliary layer, a light emitting layer, an electron transport layer, and a cathode are sequentially stacked.
  • the hole injection layer, the hole transport layer, the light emitting auxiliary layer, the light emitting layer, the electron transport layer and the electron injection layer may include a compound represented by the formula (1), preferably a hole transport layer, electron blocking layer, light emission
  • the auxiliary layer may include a compound represented by Chemical Formula 1. Meanwhile, an electron injection layer may be further stacked on the electron transport layer.
  • the organic electroluminescent device of the present invention may have a structure in which an insulating layer or an adhesive layer is inserted between an electrode and an organic material layer interface.
  • the organic electroluminescent device of the present invention can be manufactured by forming an organic material layer and an electrode by materials and methods known in the art, except that at least one layer of the organic material layer includes the compound represented by Chemical Formula 1.
  • the organic material layer may be formed by a vacuum deposition method or a solution coating method.
  • the solution coating method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.
  • the substrate used in the manufacture of the organic EL device of the present invention is not particularly limited, but silicon wafers, quartz, glass plates, metal plates, plastic films, sheets, and the like may be used.
  • examples of the anode material include metals such as vanadium, chromium, copper, zinc and gold or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO); Combinations of oxides with metals such as ZnO: Al or SnO 2: Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole or polyaniline; And carbon black, but are not limited thereto.
  • metals such as vanadium, chromium, copper, zinc and gold or alloys thereof.
  • Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO); Combinations of oxides with metals such as ZnO: Al or SnO 2: Sb
  • Conductive polymers such as polythiophene, poly (3-methylthiophene), poly
  • the negative electrode material may be a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, or lead or an alloy thereof; And multilayer structure materials such as LiF / Al or LiO 2 / Al, and the like, but are not limited thereto.
  • the hole injection layer, the hole transport layer, the electron injection layer and the electron transport layer is not particularly limited, it is possible to use conventional materials known in the art.
  • a target compound A-26 (5.65 g, yield 75%) was obtained by the same method as Synthesis Example 1, except that 1, -biphenyl] -4-amine (4.76 g, 10.00 mmol) was used.
  • a target compound B-26 (5.80 g, yield 77%) was obtained by the same method as Synthesis Example 10, except using, 1'-biphenyl] -4-amine (4.76 g, 10.00 mmol).
  • a glass substrate coated with ITO Indium tin oxide having a thickness of 1500 ⁇ was washed with distilled water ultrasonic waves. After washing the distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, etc. is dried and transferred to a UV OZONE cleaner (Power sonic 405, Hwasin Tech). The substrate was transferred to.
  • ITO Indium tin oxide
  • UV OZONE cleaner Power sonic 405, Hwasin Tech
  • a green organic EL device was manufactured in the same manner as in Example 1, except that CBP was used instead of Compound A-14 as a light emitting host material when forming the emission layer.
  • the compound synthesized in the synthesis example was subjected to high purity sublimation purification by a conventionally known method, and then a red organic EL device was manufactured according to the following procedure.
  • a glass substrate coated with ITO Indium tin oxide having a thickness of 1500 ⁇ was washed with distilled water ultrasonic waves. After washing the distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, etc. is dried and transferred to a UV OZONE cleaner (Power sonic 405, Hwasin Tech). The substrate was transferred to.
  • ITO Indium tin oxide
  • UV OZONE cleaner Power sonic 405, Hwasin Tech
  • M-MTDATA 60 nm) / TCTA (80 nm) / A-41 to L-53 + 10% (piq) 2 Ir (acac) (30nm) / BCP (10 nm) /
  • An organic electroluminescent device was manufactured by laminating in order of Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm).
  • a red organic electroluminescent device was manufactured in the same manner as in Example 33, except that CBP was used instead of the compound of Synthesis Example 6 as a light emitting host material when forming the emission layer.
  • a glass substrate coated with ITO (Indium tin oxide) to a thickness of 1500 ⁇ was washed with distilled water ultrasonically. After washing with distilled water, ultrasonic washing with a solvent such as isopropyl alcohol, acetone, methanol, and drying was carried out, and then transferred to a UV OZONE cleaner (Power sonic 405, Hwasin Tech), and the substrate was cleaned for 5 minutes using UV. The substrate was then transferred to a vacuum depositor.
  • ITO Indium tin oxide
  • M-MTDATA 60nm) / Compound A-26 (80nm) / DS-H522 + 5% DS-501 (30nm) / BCP (10nm) / Alq3 (30) synthesized in Example 5 on the prepared ITO transparent electrode
  • An organic EL device was manufactured in the order of nm) / LiF (1 nm) / Al (200 nm).
  • DS-H522 and DS-501 used in device fabrication are products of Doosan Electronics BG, and the structures of m-MTDATA, TCTA, CBP, Ir (ppy) 3 , and BCP are as follows.
  • An organic EL device was manufactured in the same manner as in Example 61, except that A-64 to L-64 were used instead of the compound A-26 used as the hole transport layer material in forming the hole transport layer in Example 61.
  • An organic EL device was manufactured in the same manner as in Example 61, except that NPB was used as the hole transport layer material instead of Compound A-26 used as the hole transport layer material when forming the hole transport layer in Example 61.
  • the structure of the NPB used is as follows.
  • Example 61 A-26 4.8 20.8
  • Example 62 A-64 4.9 20.3
  • Example 64 B-64 4.8 20.4
  • Example 65 C-26 4.8 20.4
  • Example 66 C-64 4.7 20.2
  • Example 67 D-26 4.7 21.3
  • Example 68 D-64 4.6 21.5
  • Example 69 E-26 4.8 21.2
  • Example 70 E-64 4.9 22.3
  • Example 71 F-26 4.9 21.1
  • Example 72 F-64 4.8 20.4
  • Example 73 G-26 4.8 20.9
  • Example 74 G-64 4.7 22.1
  • Example 75 H-26 5.0 20.8
  • Example 76 H-64 5.1 21.4
  • Example 77 I-26 4.8 21.6
  • Example 78 I-64 4.9 21.7
  • Example 80 J-64 4.7 20.7
  • Example 81 K-26 5.1 20.9
  • Example 82 K-64 5.0 20.4
  • the organic EL device (the organic EL device manufactured in each of Examples 61 to 84) using the compounds (A-26 to L-64) according to the present invention as the hole transport layer was conventionally used NPB. Compared with the organic EL device (organic EL device of Comparative Example 3), it was found that the device exhibited better performance in terms of current efficiency and driving voltage.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Electroluminescent Light Sources (AREA)
  • Indole Compounds (AREA)

Abstract

The present invention relates to a novel compound having excellent light emitting ability, and to an organic electroluminescent element having improved characteristics, such as luminous efficiency, driving voltage, and lifespan, by containing the novel compound in one or more organic material layers.

Description

유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자 Organic light emitting compound and organic electroluminescent device using same
본 발명은 신규한 유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자에 관한 것으로, 보다 상세하게는 정공 주입 및 수송능, 발광능 등이 우수한 신규한 아제핀계 화합물 및 이를 하나 이상의 유기물층에 포함함으로써 발광효율, 구동 전압, 수명 등의 특성이 향상된 유기 전계 발광 소자에 관한 것이다.The present invention relates to a novel organic light emitting compound and an organic electroluminescent device using the same, and more particularly, to include a novel azepine compound having excellent hole injection and transport ability, light emitting ability, and the like in one or more organic material layers, The present invention relates to an organic EL device having improved characteristics such as driving voltage and lifetime.
1950년대 베르나노스(Bernanose)의 유기 박막 발광 관측을 시점으로 1965년 안트라센 단결정을 이용한 청색 전기발광으로 이어진 유기 전계 발광 (electroluminescent, EL) 소자(이하, 간단히 '유기 EL 소자'로 칭함)에 대한 연구는 1987년 탕(Tang)에 의하여 정공층과 발광층의 기능층으로 나눈 적층구조의 유기 EL 소자가 제시되었다. 이후 고효율, 고수명의 유기 EL 소자를 만들기 위하여, 소자 내 각각의 특징적인 유기물 층을 도입하는 형태로 발전하여 왔으며, 이에 사용되는 특화된 물질의 개발로 이어졌다. The study of organic electroluminescent (EL) devices (hereinafter referred to simply as 'organic EL devices') that led to blue electroluminescence using anthracene monocrystals in 1965 from the observation of Bernanose organic thin film emission from the 1950s In 1987, Tang presented an organic EL device having a laminated structure divided into a functional layer of a hole layer and a light emitting layer. Since then, in order to make high-efficiency, high-life organic EL devices, the development has been made in the form of introducing each characteristic organic material layer in the device, leading to the development of specialized materials used therein.
유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서는 정공이 주입되고, 음극에서는 전자가 유기물층으로 주입된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 이때 유기물층으로 사용되는 물질은 그 기능에 따라, 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다. In the organic electroluminescent device, when a voltage is applied between two electrodes, holes are injected from the anode, and electrons are injected into the organic material layer from the cathode. When the injected holes and electrons meet, excitons are formed, and when the excitons fall to the ground, they shine. In this case, the material used as the organic material layer may be classified into a light emitting material, a hole injection material, a hole transport material, an electron transport material, an electron injection material and the like according to its function.
유기 EL 소자의 발광층 형성재료는 발광색에 따라 청색, 녹색, 적색 발광 재료로 구분될 수 있다. 그밖에, 보다 나은 천연색을 구현하기 위한 발광재료로 노란색 및 주황색 발광재료도 사용된다. 또한, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여, 발광 재료로서 호스트/도펀트 계를 사용할 수 있다. 도펀트 물질은 유기 물질을 사용하는 형광 도펀트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도펀트로 나눌 수 있다. 이러한 인광 재료의 개발은 이론적으로 형광에 비해 4배까지의 발광 효율을 향상시킬 수 있어 인광 도펀트 뿐만 아니라 인광 호스트 재료들에 대해 관심이 집중되고 있다. The light emitting layer forming material of the organic EL device may be classified into blue, green, and red light emitting materials according to light emission colors. In addition, yellow and orange light emitting materials are also used as light emitting materials to realize better natural colors. In addition, a host / dopant system may be used as the light emitting material in order to increase the light emission efficiency through increase in color purity and energy transfer. The dopant material may be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. The development of such phosphorescent materials can theoretically improve the luminous efficiency up to 4 times compared to fluorescence, and thus, attention has been focused on phosphorescent dopants as well as phosphorescent host materials.
현재까지 정공 주입층, 정공 수송층. 정공 차단층, 전자 수송층으로는, 하기 화학식으로 표현된 NPB, BCP, Alq3 등이 널리 알려져 있고, 발광 재료는 안트라센 유도체들이 형광 도펀트/호스트 재료로서 보고되고 있다. 특히 발광재료 중 효율 향상 측면에서 큰 장점을 가지고 있는 인광 재료로서는 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등과 같은 Ir을 포함하는 금속 착체 화합물이 청색, 녹색, 적색 도펀트 재료로 사용되고 있다. 현재까지는 CBP가 인광 호스트 재료로 우수한 특성을 나타내고 있다.Hole injection layer, hole transport layer to date. As the hole blocking layer and the electron transporting layer, NPB, BCP, Alq 3 and the like represented by the following formulas are widely known, and anthracene derivatives have been reported as fluorescent dopant / host materials in the light emitting material. Particularly, phosphorescent materials having a great advantage in terms of efficiency improvement among light emitting materials include metal complex compounds containing Ir such as Firpic, Ir (ppy) 3 , and (acac) Ir (btp) 2 as blue, green, and red dopant materials. It is used. To date, CBP has shown excellent properties as a phosphorescent host material.
Figure PCTKR2015014035-appb-I000001
Figure PCTKR2015014035-appb-I000001
그러나 기존의 재료들은 발광 특성 측면에서는 유리한 면이 있으나, 유리전이온도가 낮고 열적 안정성이 매우 좋지 않아 유기 EL 소자에서의 수명 측면에서 만족할만한 수준이 되지 못하고 있다.However, existing materials have advantages in terms of luminescence properties, but the glass transition temperature is low and the thermal stability is very poor, and thus the materials are not satisfactory in terms of lifespan in organic EL devices.
[선행기술문헌][Preceding technical literature]
[특허문헌][Patent Documents]
대한민국 공개특허 2011-0066763Republic of Korea Patent Publication 2011-0066763
본 발명은 유기 전계 발광 소자에 적용할 수 있으며, 정공 주입 및 수송능, 발광능 등이 모두 우수한 신규 유기 화합물을 제공하는 것을 목적으로 한다. The present invention can be applied to an organic electroluminescent device, and an object of the present invention is to provide a novel organic compound having excellent hole injection, transporting ability, light emitting ability, and the like.
또한, 본 발명은 상기 신규 유기 화합물을 포함하여 낮은 구동전압과 높은 발광효율을 나타내며 수명이 향상되는 유기 전계 발광 소자를 제공하는 것을 또 다른 목적으로 한다.Another object of the present invention is to provide an organic electroluminescent device including the novel organic compound, which exhibits low driving voltage and high luminous efficiency and has an improved lifetime.
상기 목적을 달성하기 위하여 본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다.The present invention to achieve the above object provides a compound represented by the following formula (1).
[화학식 1][Formula 1]
Figure PCTKR2015014035-appb-I000002
Figure PCTKR2015014035-appb-I000002
상기 화학식 1에서,In Chemical Formula 1,
R1과 R2은 서로 결합하여 하기 화학식 2와 축합 환을 형성하고,R 1 and R 2 are bonded to each other to form a condensed ring with the formula (2),
[화학식 2][Formula 2]
Figure PCTKR2015014035-appb-I000003
Figure PCTKR2015014035-appb-I000003
상기 화학식 2에서,In Chemical Formula 2,
점선은 축합이 이루어지는 부분이고,The dotted line is the part where condensation takes place
X1 및 X2는 각각 독립적으로 O, S, Se, N(Ar1), C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로 구성된 군으로부터 선택되고;X 1 and X 2 are each independently selected from the group consisting of O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 );
Y1 내지 Y12은 각각 독립적으로 N 또는 C(R3)에서 선택되고;Y 1 to Y 12 are each independently selected from N or C (R 3 );
R3이 복수 개인 경우 이들은 서로 동일하거나 상이하며, 상기 R3은 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 각각의 R3는 서로 결합하여 축합 방향족환 또는 축합 헤테로방향족환을 형성할 수 있으며;If individual R 3 is plural, they are the same or different from each other, and the R 3 are each independently hydrogen, deuterium, a halogen, a cyano group, a nitro group, C 1 ~ alkenyl group of the C 40 alkyl group, C 2 ~ C 40 of, C Alkynyl group of 2 to C 40 , a cycloalkyl group of C 3 to C 40 , a heterocycloalkyl group of 3 to 40 nuclear atoms, an aryl group of C 6 to C 60 , a heteroaryl group of 5 to 60 nuclear atoms, C 1 C 6 -C 40 alkyloxy group, C 6 -C 60 aryloxy group, C 3 -C 40 alkylsilyl group, C 6 -C 60 arylsilyl group, C 1 -C 40 alkyl boron group, C 6 - of C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, each selected from C 6 ~ C 60 mono or diaryl phosphine blood group, and the group consisting of C 6 - aryl amine of the C 60 of and adjacent R 3 may be bonded to each other to form a condensed aromatic ring or a condensed heteroaromatic ring;
Ar1 내지 Ar5는 C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고;Ar 1 to Ar 5 is C 1 ~ C 40 Alkyl group, C 2 ~ C 40 Alkenyl group, C 2 ~ C 40 Alkynyl group, C 3 ~ C 40 Cycloalkyl group, 3 to 40 heterocycloheteronuclear Alkyl group, C 6 ~ C 60 aryl group, 5 to 60 heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 3 ~ C 40 alkylsilyl Group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 mono or A diaryl phosphinyl group and a C 6 -C 60 arylamine group;
R3, Ar1 내지 Ar5의 알킬기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴아민기는 각각 독립적으로, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상으로 치환될 수 있으며, 복수개의 치환기로 치환될 경우 이들은 서로 동일하거나 상이할 수 있다.R 3 , Ar 1 to Ar 5 alkyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group, arylsilyl group, alkyl boron group, aryl boron group, aryl A phosphine group, a mono or diaryl phosphinyl group and an arylamine group are each independently a C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 A cycloalkyl group, a nuclear atom having 3 to 40 heterocycloalkyl groups, a C 6 to C 60 aryl group, a nuclear atom having 5 to 60 heteroaryl groups, a C 1 to C 40 alkyloxy group, a C 6 to C 60 group Aryloxy group, C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 an aryl phosphine group, C 6 ~ C 60 mono or diaryl phosphine blood group and a C 6 ~ C 60 aryl group, and the amine may be substituted with at least one member selected from the group consisting of, optionally substituted with a plurality of substituents Wu they may be the same or different from each other.
또한, 본 발명은 (i) 양극, (ii) 음극, 및 (iii) 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함하는 것을 특징으로 하는 유기 전계 발광 소자를 제공한다.The present invention also provides an organic electroluminescent device comprising (i) an anode, (ii) a cathode, and (iii) at least one organic layer interposed between the anode and the cathode, wherein at least one of the at least one organic layer One provides an organic electroluminescent device comprising a compound represented by the formula (1).
본 발명에서 "알킬"은 탄소수 1 내지 40개의 직쇄 또는 측쇄의 포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등을 들 수 있으나, 이에 한정되지는 않는다."Alkyl" as used herein means a monovalent substituent derived from a straight or branched chain saturated hydrocarbon of 1 to 40 carbon atoms. Examples thereof include, but are not limited to, methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amyl, hexyl and the like.
본 발명에서 "알케닐(alkenyl)"은 탄소-탄소 이중 결합을 1개 이상 가진 탄소수 2 내지 40개의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "alkenyl" refers to a monovalent substituent derived from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms having at least one carbon-carbon double bond. Examples thereof include, but are not limited to, vinyl, allyl, isopropenyl, 2-butenyl, and the like.
본 발명에서 "알키닐(alkynyl)"은 탄소-탄소 삼중 결합을 1개 이상 가진탄소수 2 내지 40개의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 에티닐(ethynyl), 2-프로파닐(2-propynyl) 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "alkynyl" refers to a monovalent substituent derived from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms having at least one carbon-carbon triple bond. Examples thereof include, but are not limited to, ethynyl, 2-propynyl, and the like.
본 발명에서 "아릴"은 단독 고리 또는 2 이상의 고리가 조합된 탄소수 6 내지 40개의 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 또한, 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있다. 이러한 아릴의 예로는 페닐, 나프틸, 페난트릴, 안트릴 등을 들 수 있으나, 이에 한정되지는 않는다."Aryl" in the present invention means a monovalent substituent derived from a C6-C40 aromatic hydrocarbon in which a single ring or two or more rings are combined. In addition, a form in which two or more rings are attached to each other (pendant) or condensed may also be included. Examples of such aryl include, but are not limited to, phenyl, naphthyl, phenanthryl, anthryl, and the like.
본 발명에서 "헤테로아릴"은 핵원자수 5 내지 40개의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이때, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로원자로 치환된다. 또한, 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있고, 나아가 아릴기와의 축합된 형태도 포함될 수 있다. 이러한 헤테로아릴의 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6-원 모노사이클릭 고리, 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리 및 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등을 들 수 있으나, 이에 한정되지는 않는다."Heteroaryl" as used herein means a monovalent substituent derived from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 40 nuclear atoms. At least one carbon in the ring, preferably 1 to 3 carbons, is substituted with a heteroatom such as N, O, S or Se. In addition, a form in which two or more rings are pendant or condensed with each other may be included, and may also include a form in which the two or more rings are condensed with an aryl group. Examples of such heteroaryl include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, phenoxathienyl, indolinzinyl, indolyl ( polycyclic rings such as indolyl, purinyl, quinolyl, benzothiazole, carbazolyl and 2-furanyl, N-imidazolyl, 2-isoxazolyl , 2-pyridinyl, 2-pyrimidinyl, and the like, but are not limited thereto.
본 발명에서 "아릴옥시"는 RO-로 표시되는 1가의 치환기로, 상기 R은 탄소수 5 내지 40개의 아릴을 의미한다. 이러한 아릴옥시의 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "aryloxy" is a monovalent substituent represented by RO-, wherein R means aryl having 5 to 40 carbon atoms. Examples of such aryloxy include, but are not limited to, phenyloxy, naphthyloxy, diphenyloxy, and the like.
본 발명에서 "알킬옥시"는 R'O-로 표시되는 1가의 치환기로, 상기 R'는 탄소수 1 내지 40개의 알킬을 의미하며, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함할 수 있다. 알킬옥시의 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "alkyloxy" is a monovalent substituent represented by R'O-, wherein R 'means an alkyl having 1 to 40 carbon atoms, and linear, branched or cyclic structure It may include. Examples of alkyloxy include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.
본 발명에서 "아릴아민"은 탄소수 6 내지 40개의 아릴로 치환된 아민을 의미한다."Arylamine" in the present invention means an amine substituted with aryl having 6 to 40 carbon atoms.
본 발명에서 "시클로알킬"은 탄소수 3 내지 40개의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이러한 사이클로알킬의 예로는 사이클로프로필, 사이클로펜틸, 사이클로헥실, 노르보닐(norbornyl), 아다만틴(adamantine) 등을 들 수 있으나, 이에 한정되지는 않는다.By "cycloalkyl" is meant herein monovalent substituents derived from monocyclic or polycyclic non-aromatic hydrocarbons having 3 to 40 carbon atoms. Examples of such cycloalkyl include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.
본 발명에서 "헤테로시클로알킬"은 핵원자수 3 내지 40개의 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로 원자로 치환된다. 이러한 헤테로시클로알킬의 예로는 모르폴린, 피페라진 등을 들 수 있으나, 이에 한정되지는 않는다."Heterocycloalkyl" as used herein means a monovalent substituent derived from 3 to 40 non-aromatic hydrocarbons of nuclear atoms, wherein at least one carbon in the ring, preferably 1 to 3 carbons, is N, O, S Or a hetero atom such as Se. Examples of such heterocycloalkyl include, but are not limited to, morpholine, piperazine, and the like.
본 발명에서 "알킬실릴"은 탄소수 1 내지 40개의 알킬로 치환된 실릴이고, "아릴실릴"은 탄소수 5 내지 40개의 아릴로 치환된 실릴을 의미한다.In the present invention, "alkylsilyl" means silyl substituted with alkyl having 1 to 40 carbon atoms, and "arylsilyl" means silyl substituted with aryl having 5 to 40 carbon atoms.
본 발명에서 "축합고리"는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다.As used herein, the term “condensed ring” means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring, or a combination thereof.
본 발명의 화학식 1로 표시되는 화합물은 열적 안정성 및 발광 특성이 우수하기 때문에 유기 전계 발광 소자의 유기물층의 재료로 사용될 수 있다. 특히, 본 발명의 화학식 1로 표시되는 화합물을 인광 호스트 재료로 사용할 경우, 종래의 호스트 재료에 비해 우수한 발광 성능, 낮은 구동전압, 높은 효율 및 장수명을 갖는 유기 전계 발광 소자를 제조할 수 있고, 나아가 성능 및 수명이 향상된 풀 칼라 디스플레이 패널도 제조할 수 있다.The compound represented by Formula 1 of the present invention may be used as a material of the organic material layer of the organic electroluminescent device because of its excellent thermal stability and luminescence properties. In particular, when the compound represented by Formula 1 of the present invention is used as a phosphorescent host material, an organic electroluminescent device having excellent light emission performance, low driving voltage, high efficiency, and long life compared to a conventional host material can be manufactured. Full color display panels with improved performance and lifetime can also be manufactured.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
1. 신규 유기 화합물1. New Organic Compounds
본 발명의 화합물은 디벤조아제핀(5H-dibenzo[b,d]azepine), 디벤조옥세핀(dibenzo[b,d]oxepine), 디벤조싸이에핀(dibenzo[b,d]thiepine), 디벤조실레핀(5H-dibenzo[b,d]silepine), 또는 디벤조싸이클로헵텐(5H-dibenzo[a,d]cycloheptene)에 벤젠이 축합된 5원 헤테로방향족환 모이어티, 인덴 모이어티(indene moiety), 또는 인돌 모이어티(indole moiety)가 축합되어 기본 골격을 이루며, 아래 화학식 1로 표시되는 것을 특징으로 한다: Compounds of the present invention are dibenzoazine (5H-dibenzo [b, d] azepine), dibenzooxepine (dibenzo [b, d] oxepine), dibenzothiepine (dibenzo [b, d] thiepine), 5-membered heteroaromatic ring moiety, indene moiety, in which benzene is condensed to dibenzosilene (5H-dibenzo [b, d] silepine) or dibenzocycloheptene (5H-dibenzo [a, d] cycloheptene) moiety, or indole moiety is condensed to form a basic skeleton, characterized in that represented by the following formula (1):
[화학식 1][Formula 1]
Figure PCTKR2015014035-appb-I000004
Figure PCTKR2015014035-appb-I000004
상기 화학식 1에서,In Chemical Formula 1,
R1과 R2은 서로 결합하여 하기 화학식 2와 축합 환을 형성하고,R 1 and R 2 are bonded to each other to form a condensed ring with the formula (2),
[화학식 2][Formula 2]
Figure PCTKR2015014035-appb-I000005
Figure PCTKR2015014035-appb-I000005
상기 화학식 2에서,In Chemical Formula 2,
점선은 축합이 이루어지는 부분이고,The dotted line is the part where condensation takes place
X1 및 X2는 각각 독립적으로 O, S, Se, N(Ar1), C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로 구성된 군으로부터 선택되고;X 1 and X 2 are each independently selected from the group consisting of O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 );
Y1 내지 Y12은 각각 독립적으로 N 또는 C(R3)에서 선택되고;Y 1 to Y 12 are each independently selected from N or C (R 3 );
R3은 복수 개인 경우 이들은 서로 동일하거나 상이하며, 상기 R3은 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 각각의 R3는 서로 결합하여 축합 방향족환 또는 축합 헤테로방향족환을 형성할 수 있으며;R 3, if multiple individuals which are the same or different from each other, and the R 3 are each independently hydrogen, deuterium, a halogen, a cyano group, a nitro group, C 1 ~ alkenyl group of the C 40 alkyl group, C 2 ~ C 40 of, C Alkynyl group of 2 to C 40 , a cycloalkyl group of C 3 to C 40 , a heterocycloalkyl group of 3 to 40 nuclear atoms, an aryl group of C 6 to C 60 , a heteroaryl group of 5 to 60 nuclear atoms, C 1 C 6 -C 40 alkyloxy group, C 6 -C 60 aryloxy group, C 3 -C 40 alkylsilyl group, C 6 -C 60 arylsilyl group, C 1 -C 40 alkyl boron group, C 6 - of C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, each selected from C 6 ~ C 60 mono or diaryl phosphine blood group, and the group consisting of C 6 - aryl amine of the C 60 of and adjacent R 3 may be bonded to each other to form a condensed aromatic ring or a condensed heteroaromatic ring;
Ar1 내지 Ar5는 C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고;Ar 1 to Ar 5 is C 1 ~ C 40 Alkyl group, C 2 ~ C 40 Alkenyl group, C 2 ~ C 40 Alkynyl group, C 3 ~ C 40 Cycloalkyl group, 3 to 40 heterocycloheteronuclear Alkyl group, C 6 ~ C 60 aryl group, 5 to 60 heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 3 ~ C 40 alkylsilyl Group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 mono or A diaryl phosphinyl group and a C 6 -C 60 arylamine group;
R3, Ar1 내지 Ar5의 알킬기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴아민기는 각각 독립적으로, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상으로 치환될 수 있으며, 복수개의 치환기로 치환될 경우 이들은 서로 동일하거나 상이할 수 있다.R 3 , Ar 1 to Ar 5 alkyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group, arylsilyl group, alkyl boron group, aryl boron group, aryl A phosphine group, a mono or diaryl phosphinyl group and an arylamine group are each independently a C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 A cycloalkyl group, a nuclear atom having 3 to 40 heterocycloalkyl groups, a C 6 to C 60 aryl group, a nuclear atom having 5 to 60 heteroaryl groups, a C 1 to C 40 alkyloxy group, a C 6 to C 60 group Aryloxy group, C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 an aryl phosphine group, C 6 ~ C 60 mono or diaryl phosphine blood group and a C 6 ~ C 60 aryl group, and the amine may be substituted with at least one member selected from the group consisting of, optionally substituted with a plurality of substituents Wu they may be the same or different from each other.
이러한 화학식 1로 표시되는 화합물은 종래 유기 EL 소자용 재료[예: 4,4-dicarbazolybiphenyl (이하, 'CBP'라 함)]보다 높은 분자량을 갖기 때문에, 유리전이온도가 높아 열적 안정성이 우수할 뿐만 아니라, 캐리어 수송능, 발광능 등이 우수하다. 따라서, 상기 화학식 1의 화합물을 유기 전계 발광 소자가 포함할 경우, 소자의 구동전압, 효율, 수명 등이 향상될 수 있다.Since the compound represented by Chemical Formula 1 has a higher molecular weight than the conventional organic EL device material [for example, 4,4-dicarbazolybiphenyl (hereinafter referred to as 'CBP')], the glass transition temperature is high, and thus the thermal stability is excellent. In addition, the carrier transporting ability, the light emitting ability and the like are excellent. Therefore, when the organic electroluminescent device includes the compound of Formula 1, the driving voltage, efficiency, lifespan, etc. of the device may be improved.
일반적으로 유기 전계 발광 소자의 인광 발광층에서, 호스트 물질은 이의 삼중항 에너지 갭이 도펀트의 삼중항 에너지 갭보다 높아야 한다. 즉, 호스트의 가장 낮은 여기 상태가 도펀트의 가장 낮은 방출 상태보다 에너지가 더 높은 경우, 인광 발광 효율이 향상될 수 있다. 상기 화학식 1의 화합물은 삼중항 에너지가 높고, 넓은 일중항 에너지 준위와 높은 삼중항 에너지 준위를 가지는 인돌 유도체가 축합되어 있는 기본 골격에 특정의 치환기가 도입됨으로써, 에너지 준위가 도펀트보다 높게 조절될 수 있어 호스트 물질로 사용될 수 있다.In general, in the phosphorescent layer of an organic electroluminescent device, the host material should have a triplet energy gap of which is higher than the triplet energy gap of the dopant. That is, when the lowest excited state of the host is higher in energy than the lowest emitted state of the dopant, phosphorescence efficiency may be improved. The compound of Formula 1 has a high triplet energy, by introducing a specific substituent in the basic skeleton condensed with a broad singlet energy level and a high triplet energy level, the energy level can be controlled higher than the dopant It can be used as a host material.
또한, 본 발명의 화합물은 전술한 바와 같이 높은 삼중항 에너지를 갖기 때문에, 발광층에서 생성된 엑시톤이 발광층에 인접하는 전자수송층 또는 정공수송층으로 확산되는 것을 방지할 수 있다. 따라서, 상기 화학식 1의 화합물을 이용하여 정공 수송층과 발광층 사이에 유기물층(이하, '발광 보조층'이라 함)을 형성할 경우, 상기 화합물에 의해서 엑시톤의 확산이 방지되기 때문에, 상기 제1 엑시톤 확산 방지층을 포함하지 않은 종래의 유기 전계 발광 소자와 달리, 실질적으로 발광층 내에서 발광에 기여하는 엑시톤의 수가 증가되어 소자의 발광 효율이 개선될 수 있다. 또한, 상기 화학식 1의 화합물을 이용하여 발광층과 전자 수송층 사이에 유기물층(이하, '수명 개선층'이라 함)을 형성할 경우에도, 상기 화학식 1의 화합물에 의해 엑시톤의 확산이 방지됨으로써, 유기 전계 발광 소자의 내구성 및 안정성이 향상될 수 있고, 이로 인해 소자의 반감 수명이 효율적으로 증가될 수 있다. 이와 같이, 상기 화학식 1로 표시되는 화합물은 발광층의 호스트 이외, 발광 보조층 재료 또는 수명 개선층 재료로 사용될 수 있다. In addition, since the compound of the present invention has a high triplet energy as described above, it is possible to prevent the excitons generated in the light emitting layer from diffusing into the electron transport layer or the hole transport layer adjacent to the light emitting layer. Therefore, when the organic material layer (hereinafter, referred to as a 'light emitting auxiliary layer') is formed between the hole transport layer and the light emitting layer by using the compound of Formula 1, the exciton is prevented from being diffused by the compound, and thus the first exciton is diffused. Unlike conventional organic electroluminescent devices that do not include a barrier layer, the number of excitons that substantially contribute to light emission in the light emitting layer may be increased, thereby improving the luminous efficiency of the device. In addition, even when an organic material layer (hereinafter, referred to as a "life improvement layer") is formed between the light emitting layer and the electron transport layer by using the compound of Formula 1, the diffusion of excitons by the compound of Formula 1 prevents the organic electric field Durability and stability of the light emitting device can be improved, thereby effectively increasing the half life of the device. As such, the compound represented by Chemical Formula 1 may be used as a light emitting auxiliary layer material or a life improvement layer material other than the host of the light emitting layer.
또한, 상기 화학식 1의 화합물은 상기 기본 골격에 도입되는 치환기의 종류에 따라 HOMO 및 LUMO 에너지 레벨을 조절할 수 있어, 넓은 밴드갭을 가질 수 있고, 높은 캐리어 수송성을 가질 수 있다. 예를 들어, 상기 화합물은 상기 기본 골격에 질소-함유 헤테로환(예컨대, 피리딘기, 피리미딘기, 트리아진기등)과 같이 전자 흡수성이 큰 전자 끌개기(EWG)가 결합될 경우, 분자 전체가 바이폴라(bipolar) 특성을 갖기 때문에, 정공과 전자의 결합력을 높일 수 있다. 이와 같이, 상기 기본 골격에 EWG가 도입된 상기 화학식 1의 화합물은 우수한 캐리어 수송성 및 발광 특성이 우수하기 때문에, 유기 전계 발광 소자의 발광층 재료 이외, 전자주입/수송층 재료, 또는 수명 개선층 재료로도 사용될 수 있다. 한편, 상기 화학식 1의 화합물이 상기 기본 골격에 아릴아민기, 카바졸기, 터페닐기, 트리페닐렌기 등과 같이 전자 공여성이 큰 전자 주게기(EDG)가 결합될 경우, 정공의 주입 및 수송이 원활하게 이루어지기 때문에, 발광층 재료 이외, 정공주입/수송층 또는 발광 보조층 재료로도 유용하게 사용될 수 있다.In addition, the compound of Formula 1 may adjust HOMO and LUMO energy levels according to the type of substituents introduced into the basic skeleton, may have a wide bandgap, it may have a high carrier transport. For example, when the compound is bonded to an electron-withdrawing electron (EWG) having a high electron absorption such as a nitrogen-containing heterocycle (eg, pyridine group, pyrimidine group, triazine group, etc.) to the basic skeleton, Since it has a bipolar characteristic, it is possible to increase the bonding force between the hole and the electron. As such, the compound of Formula 1 having EWG introduced into the basic skeleton has excellent carrier transport properties and luminescent properties, and thus, as an electron injection / transport layer material or a life improvement layer material, in addition to the light emitting layer material of the organic EL device. Can be used. On the other hand, when the compound of Formula 1 is combined with an electron donor group (EDG) having a large electron donor such as an arylamine group, carbazole group, terphenyl group, triphenylene group, etc., the hole injection and transport is smooth. In addition to the light emitting layer material, it can be usefully used as a hole injection / transport layer or a light emitting auxiliary layer material.
이와 같이, 상기 화학식 1로 표시되는 화합물은 유기 전계 발광 소자의 발광 특성을 향상시킴과 동시에, 정공 주입/수송 능력, 전자 주입/수송 능력, 발광 효율, 구동 전압, 수명 특성 등을 향상시킬 수 있다. 따라서, 본 발명에 따른 화학식 1의 화합물은 유기 전계 발광 소자의 유기물층 재료, 바람직하게는 발광층 재료(청색, 녹색 및/또는 적색의 인광 호스트 재료), 전자 수송/주입층 재료 및 정공 수송/주입층 재료, 발광보조층 재료, 수명개선층 재료, 더 바람직하게는 발광층 재료, 전자 주입층 재료, 발광보조층 재료, 수명 개선층 재료로 사용될 수 있다.As described above, the compound represented by Chemical Formula 1 may improve the light emission characteristics of the organic EL device, and may also improve the hole injection / transport ability, the electron injection / transport capability, the luminous efficiency, the driving voltage, and the lifespan characteristics. . Accordingly, the compound of formula 1 according to the present invention is an organic material layer material of an organic electroluminescent device, preferably a light emitting layer material (blue, green and / or red phosphorescent host material), an electron transport / injection layer material and a hole transport / injection layer Material, light emitting auxiliary layer material, life improving layer material, more preferably light emitting layer material, electron injection layer material, light emitting auxiliary layer material, and life improving layer material.
또한, 상기 화학식 1의 화합물은 상기 기본 골격에 다양한 치환체, 특히 아릴기 및/또는 헤테로아릴기가 도입되어 화합물의 분자량이 유의적으로 증대됨으로써, 유리 전이온도가 향상될 수 있고, 이로 인해 종래의 발광 재료(예를 들어, CBP)보다 높은 열적 안정성을 가질 수 있다. 또한, 상기 화학식 1로 표시되는 화합물은 유기물층의 결정화 억제에도 효과가 있다. 따라서, 본 발명에 따른 화학식 1의 화합물을 포함하는 유기 전계 발광 소자는 성능 및 수명 특성이 크게 향상될 수 있고, 이러한 유기 전계 발광 소자가 적용된 풀 칼라 유기 발광 패널도 성능이 극대화될 수 있다.In addition, the compound of Formula 1 has a variety of substituents, particularly aryl groups and / or heteroaryl groups introduced into the basic skeleton significantly increases the molecular weight of the compound, thereby improving the glass transition temperature, thereby conventional light emission It may have a higher thermal stability than the material (eg CBP). In addition, the compound represented by the formula (1) is effective in suppressing the crystallization of the organic material layer. Therefore, the organic electroluminescent device including the compound of Formula 1 according to the present invention can greatly improve performance and lifespan characteristics, and the full-color organic light emitting panel to which the organic electroluminescent device is applied can also maximize its performance.
본 발명의 한 구체예에 따르면, 본 발명의 화합물은 R1과 R2가 결합하여 화학식 2로 표시되는 축합 헤테로방향족환 또는 축합 방향족환을 형성할 수 있다. 구체적으로 R1과 R2가 결합하여 N, O, S, Si 중 하나 이상을 포함하는 축합 인덴, 축합 인돌, 축합 벤조싸이오펜, 축합 벤조퓨란, 축합 벤조실롤 등을 형성할 수 있다.According to one embodiment of the present invention, the compound of the present invention may combine R 1 and R 2 to form a condensed heteroaromatic ring or a condensed aromatic ring represented by the formula (2). Specifically, R 1 and R 2 may be bonded to form condensed indene, condensed indole, condensed benzothiophene, condensed benzofuran, condensed benzosilol and the like including one or more of N, O, S, and Si.
보다 구체적으로 본 발명의 화합물은 하기 화학식 3 또는 화학식 4로 나타낼 수 있다.More specifically, the compound of the present invention may be represented by the following formula (3) or (4).
[화학식 3][Formula 3]
Figure PCTKR2015014035-appb-I000006
Figure PCTKR2015014035-appb-I000006
[화학식 4][Formula 4]
Figure PCTKR2015014035-appb-I000007
Figure PCTKR2015014035-appb-I000007
상기 화학식 3 또는 화학식 4에 있어서, X1, X2 및 Y1 내지 Y12는 화학식 1 및 2에 정의된 바와 같다.In Chemical Formula 3 or Chemical Formula 4, X 1 , X 2 and Y 1 to Y 12 are as defined in Chemical Formulas 1 and 2.
본 발명의 한 구체예에 따르면, 상기 화학식 3 및 4에서 X1 및 X2는 각각 독립적으로 O, S, Se, N(Ar1), C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로 구성된 군으로부터 선택되고, 이들 중 적어도 하나는 N(Ar1)인 것이 바람직하다.According to an embodiment of the present invention, in Formulas 3 and 4 X 1 and X 2 are each independently O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4) (Ar 5 ), and at least one of them is preferably N (Ar 1 ).
본 발명의 한 구체예에 따르면, 상기 화학식 3 및 4에서 Y1 내지 Y12은 각각 독립적으로 N 또는 C(R3)에서 선택되고, 이들 모두 C(R3)이거나 이들 중 하나가 N인 것이 바람직하다.According to an embodiment of the present invention, in Formulas 3 and 4, Y 1 to Y 12 are each independently selected from N or C (R 3 ), and all of them are C (R 3 ) or one of them is N. desirable.
본 발명의 화합물은 구체적으로 아래 화학식 1-1 내지 1-18로 나타내어지는 화합물로 이루어진 군으로부터 선택될 수 있으나 이에 한정되는 것은 아니다.The compound of the present invention may be specifically selected from the group consisting of compounds represented by Formulas 1-1 to 1-18 below, but is not limited thereto.
Figure PCTKR2015014035-appb-I000008
Figure PCTKR2015014035-appb-I000008
상기 화학식 1-1 내지 1-18 에서, In Chemical Formulas 1-1 to 1-18,
각각의 Y1 내지 Y12 및 Ar1 내지 Ar5는 동일하거나 상이하고, 특히 상기 화학식 1-1 및 1-6에서 복수 개의 Ar1은 서로 동일하거나 상이하며, 화학식 1 및 2에 정의된 바와 같다.Each of Y 1 to Y 12 and Ar 1 to Ar 5 is the same or different, in particular, a plurality of Ar 1 in Formulas 1-1 and 1-6 are the same as or different from each other, as defined in Formulas 1 and 2.
본 발명의 바람직한 구체예에 따르면 상기 화학식 1 및 2에서, 축합을 형성하는 것을 제외한 R3, Ar1 내지 Ar5 중 적어도 하나는 C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 상기 알킬기, 아릴기, 헤테로아릴기, 아릴아민기는 각각 독립적으로, 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상으로 치환될 수 있다. 복수개의 치환기로 치환될 경우 이들은 서로 동일하거나 상이할 수 있다.According to a preferred embodiment of the present invention, in Formulas 1 and 2, except that forming condensation, at least one of R 3 , Ar 1 to Ar 5 is an alkyl group of C 1 ~ C 40 , an aryl group of C 6 ~ C 60 , It is selected from the group consisting of 5 to 60 heteroaryl groups and C 6 ~ C 60 arylamine group, the alkyl group, aryl group, heteroaryl group, arylamine group, each independently, deuterium, halogen, cyano group, It may be substituted with at least one member selected from the group consisting of C 1 ~ C 40 alkyl group, C 6 ~ C 60 aryl group, 5 to 60 heteroaryl group, C 6 ~ C 60 arylamine group. When substituted with a plurality of substituents, they may be the same or different from each other.
본 발명의 바람직한 구체예에 따르면 상기 화학식 1및 2에서 축합을 형성하는 것을 제외한 R3 내지 Ar1 내지 Ar5 중 적어도 하나는 하기 화학식 5로 표시되는 치환체이거나 페닐기일 수 있다.According to a preferred embodiment of the present invention, at least one of R 3 to Ar 1 to Ar 5 except for forming a condensation in the formula (1) and 2 may be a substituent represented by the formula (5) or a phenyl group.
[화학식 5][Formula 5]
Figure PCTKR2015014035-appb-I000009
Figure PCTKR2015014035-appb-I000009
상기 화학식 5에서,In Chemical Formula 5,
*는 상기 화학식 1에 결합되는 부분을 의미하고;* Means a moiety bonded to Formula 1;
L1은 단일결합이거나, 또는 C6~C18의 아릴렌기 및 핵원자수 5 내지 18개의 헤테로아릴렌기로 이루어진 군에서 선택되고, 바람직하게 단일결합이거나, 페닐렌기, 비페닐렌기, 카바졸릴기일 수 있고; L 1 is a single bond or is selected from the group consisting of C 6 to C 18 arylene groups and heteroarylene groups having 5 to 18 nuclear atoms, preferably single bond, phenylene group, biphenylene group, carbazolyl group Can;
Z1 내지 Z5는 각각 독립적으로 N 또는 C(R11)이며, 다만 Z1 내지 Z5중 적어도 하나는 N이고, R11이 복수 개인 경우, 이들은 서로 동일하거나 상이하며;Z 1 to Z 5 are each independently N or C (R 11 ), provided that at least one of Z 1 to Z 5 is N and when there are a plurality of R 11 , they are the same or different from each other;
R11은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40개의 헤테로아릴기, C6~C 40의 아릴옥시기 C1~C40의 알킬옥시기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C40의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 모노 또는 디아릴포스피닐기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택되거나, 또는 인접하는 기(예컨대, L, 인접하는 다른 R11)와 결합하여 축합 고리를 형성할 수 있으며;R 11 is hydrogen, deuterium, halogen, cyano group, nitro group, C 1 -C 40 alkyl group, C 2 -C 40 alkenyl group, C 2 -C 40 alkynyl group, C 6 -C 40 aryl group, 5 to 40 heteroaryl groups, C 6 to C 40 aryloxy groups, C 1 to C 40 alkyloxy groups, C 3 to C 40 cycloalkyl groups, 3 to 40 heterocycloalkyl groups, C 6 ~ C 40 arylamine group, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 40 aryl boron group, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 mono or diaryl phosphinyl group and C 6 ~ C 40 arylsilyl group selected from the group consisting of, or in combination with adjacent groups (e.g., L, other adjacent R 11 ) condensed ring Can form;
상기 R11의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40개의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 모노 또는 디아릴포스피닐기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 상기 치환기가 복수 개인 경우, 이들은 서로 동일하거나 상이할 수 있다.An alkyl group, an alkenyl group, an alkynyl group, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, a cycloalkyl group of R 11 , a heterocycloalkyl group, an arylamine group, an alkylsilyl group, an alkyl boron group, an aryl boron group, The arylphosphine group, mono or diarylphosphinyl group and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 Alkynyl group, C 6 ~ C 40 aryl group, 5 to 40 heteroaryl groups, C 6 ~ C 40 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 40 An arylamine group, a C 3 to C 40 cycloalkyl group, a C 3 to C 40 heterocycloalkyl group, a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 40 group aryl boron group, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 mono or diaryl phosphine blood group and a C 6 ~ C 40 aryl silyl groups at least one member selected from the group consisting of When substituted or unsubstituted with a substituent and there are a plurality of the substituents, they may be the same or different from each other.
상기 화학식 5로 표시되는 치환체의 예로는 하기 A-1 내지 A-15로 표시되는 치환체 등이 있는데, 이에 한정되지 않는다.Examples of the substituent represented by Formula 5 include a substituent represented by the following A-1 to A-15, but is not limited thereto.
Figure PCTKR2015014035-appb-I000010
Figure PCTKR2015014035-appb-I000010
상기 A-1 내지 A-15에서,In the above A-1 to A-15,
L1 및 R11은 각각 상기 화학식 5에서 정의한 바와 같고,L 1 and R 11 are each as defined in Formula 5,
n은 0 내지 4의 정수로서, 상기 n이 0인 경우, 수소가 치환기 R12로 치환되지 않는 것을 의미하고, 상기 n이 1 내지 4의 정수인 경우, R12는 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40개의 헤테로아릴기, C6~C40 60의 아릴옥시기 C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 모노 또는 디아릴포스피닐기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택되거나, 또는 인접하는 기(예컨대, L1, R11 또는 다른 R12 등)와 결합하여 축합 고리를 형성할 수 있고, 상기 R12가 복수 개인 경우 이들은 서로 동일하거나 상이하며,n is an integer of 0 to 4, and when n is 0, it means that hydrogen is not substituted with a substituent R 12 , and when n is an integer of 1 to 4, R 12 is deuterium, halogen, cyano group, nitro C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 cycloalkyl group, nuclear atom of 3 to 40 heterocycloalkyl group, C 6 Aryl group of ~ C 40 , heteroaryl group of 5 to 40 nuclear atoms, aryloxy group of C 6 ~ C 40 60 C 1 ~ C 40 alkyloxy group, C 6 ~ C 40 arylamine group, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C 40 group of the arylboronic, C 6 ~ mono or diaryl phosphine of C 40 aryl phosphine group, C 6 ~ C 40 P Nyl group and C 6 ~ C 40 It is selected from the group consisting of an arylsilyl group, or it may be combined with adjacent groups (eg, L 1 , R 11 or other R 12, etc.) to form a condensed ring, wherein R 12 is If more than one They are the same or different from each other,
상기 R12의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40개의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 모노 또는 디아릴포스피닐기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 상기 치환기가 복수 개인 경우, 이들은 서로 동일하거나 상이할 수 있다.Alkyl group of the R 12, an alkenyl group, an alkynyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, an arylamine group, an alkylsilyl group, an alkyl boron group, an aryl boron group, The arylphosphine group, mono or diarylphosphinyl group and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 Alkynyl group, C 6 ~ C 40 aryl group, 5 to 40 heteroaryl groups, C 6 ~ C 40 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 40 An arylamine group, a C 3 to C 40 cycloalkyl group, a C 3 to C 40 heterocycloalkyl group, a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 40 group aryl boron group, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 mono or diaryl phosphine blood group and a C 6 ~ C 40 aryl silyl groups at least one member selected from the group consisting of When substituted or unsubstituted with a substituent and there are a plurality of the substituents, they may be the same or different from each other.
본 발명의 바람직한 구체예에 따르면 상기 화학식 1 및 2에서 축합을 형성하는 것을 제외한 R3 내지 Ar1 내지 Ar5 중 적어도 하나는 하기 화학식 6으로 표시되는 치환체일 수 있다.According to a preferred embodiment of the present invention at least one of R 3 to Ar 1 to Ar 5 except for forming a condensation in the formula (1) and 2 may be a substituent represented by the following formula (6).
[화학식 6][Formula 6]
Figure PCTKR2015014035-appb-I000011
Figure PCTKR2015014035-appb-I000011
상기 화학식 6에서,In Chemical Formula 6,
*는 상기 화학식 1에 결합되는 부분을 의미하고;* Means a moiety bonded to Formula 1;
L2은 단일결합이거나, 또는 C6~C18의 아릴렌기 및 핵원자수 5 내지 18개의 헤테로아릴렌기로 이루어진 군에서 선택되고, 바람직하게 단일결합이거나, 페닐렌기, 비페닐렌기, 카바졸릴기일 수 있고; L 2 is a single bond or is selected from the group consisting of a C 6 to C 18 arylene group and a heteroarylene group having 5 to 18 nuclear atoms, preferably a single bond, or a phenylene group, a biphenylene group, or a carbazolyl group. Can;
R13 및 R14는 각각 독립적으로 C1~C40의 알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40개의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 또는 R13 및 R14가 결합하여 축합 고리를 형성할 수 있으며;R 13 and R 14 are each independently a C 1 ~ C 40 alkyl group, C 6 ~ C 40 aryl group, the number of nuclear atoms of 5 to 40 heteroaryl group, and a C 6 ~ selected from the group consisting of an aryl amine of the C 60 Or R 13 and R 14 may combine to form a condensed ring;
상기 R13 및 R14의 알킬기, 아릴기, 헤테로아릴기 및 아릴아민기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40개의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 모노 또는 디아릴포스피닐기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 상기 치환기가 복수 개인 경우, 이들은 서로 동일하거나 상이할 수 있다.The alkyl group, aryl group, heteroaryl group and arylamine group of R 13 and R 14 are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 40 aryl group, the number of nuclear atoms of 5 to 40 heteroaryl group, C 6 ~ C 40 aryloxy group, alkyloxy group of C 1 ~ C 40 of the, C 6 ~ C 40 aryl amine group, C 3 ~ C 40 cycloalkyl group, a number of nuclear atoms of 3 to 40 heterocycloalkyl group, C 1 ~ alkyl silyl group of C 40, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C 40 aryl boron group, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 mono or diaryl phosphine blood group and one substituent at least one selected from the group consisting of C 6 ~ with an aryl silyl group of C 40 of the When substituted or unsubstituted, and when there are a plurality of said substituents, they may be the same or different from each other.
본 발명의 화합물은 구체적으로 하기 예시된 구조의 화합물들로서 나타낼 수 있으나 이에 한정되는 것은 아니다.The compounds of the present invention may be specifically represented as compounds of the structures exemplified below, but are not limited thereto.
Figure PCTKR2015014035-appb-I000012
Figure PCTKR2015014035-appb-I000012
Figure PCTKR2015014035-appb-I000013
Figure PCTKR2015014035-appb-I000013
Figure PCTKR2015014035-appb-I000014
Figure PCTKR2015014035-appb-I000014
Figure PCTKR2015014035-appb-I000015
Figure PCTKR2015014035-appb-I000015
Figure PCTKR2015014035-appb-I000016
Figure PCTKR2015014035-appb-I000016
Figure PCTKR2015014035-appb-I000017
Figure PCTKR2015014035-appb-I000017
Figure PCTKR2015014035-appb-I000018
Figure PCTKR2015014035-appb-I000018
Figure PCTKR2015014035-appb-I000019
Figure PCTKR2015014035-appb-I000019
Figure PCTKR2015014035-appb-I000020
Figure PCTKR2015014035-appb-I000020
Figure PCTKR2015014035-appb-I000021
Figure PCTKR2015014035-appb-I000021
Figure PCTKR2015014035-appb-I000022
Figure PCTKR2015014035-appb-I000022
Figure PCTKR2015014035-appb-I000023
Figure PCTKR2015014035-appb-I000023
Figure PCTKR2015014035-appb-I000024
Figure PCTKR2015014035-appb-I000024
Figure PCTKR2015014035-appb-I000025
Figure PCTKR2015014035-appb-I000025
Figure PCTKR2015014035-appb-I000026
Figure PCTKR2015014035-appb-I000026
Figure PCTKR2015014035-appb-I000027
Figure PCTKR2015014035-appb-I000027
Figure PCTKR2015014035-appb-I000028
Figure PCTKR2015014035-appb-I000028
Figure PCTKR2015014035-appb-I000029
Figure PCTKR2015014035-appb-I000029
Figure PCTKR2015014035-appb-I000030
Figure PCTKR2015014035-appb-I000030
Figure PCTKR2015014035-appb-I000031
Figure PCTKR2015014035-appb-I000031
Figure PCTKR2015014035-appb-I000032
Figure PCTKR2015014035-appb-I000032
Figure PCTKR2015014035-appb-I000033
Figure PCTKR2015014035-appb-I000033
Figure PCTKR2015014035-appb-I000034
Figure PCTKR2015014035-appb-I000034
Figure PCTKR2015014035-appb-I000035
Figure PCTKR2015014035-appb-I000035
Figure PCTKR2015014035-appb-I000036
Figure PCTKR2015014035-appb-I000036
Figure PCTKR2015014035-appb-I000037
Figure PCTKR2015014035-appb-I000037
Figure PCTKR2015014035-appb-I000038
Figure PCTKR2015014035-appb-I000038
Figure PCTKR2015014035-appb-I000039
Figure PCTKR2015014035-appb-I000039
Figure PCTKR2015014035-appb-I000040
Figure PCTKR2015014035-appb-I000040
Figure PCTKR2015014035-appb-I000041
Figure PCTKR2015014035-appb-I000041
Figure PCTKR2015014035-appb-I000042
Figure PCTKR2015014035-appb-I000042
Figure PCTKR2015014035-appb-I000043
Figure PCTKR2015014035-appb-I000043
Figure PCTKR2015014035-appb-I000044
Figure PCTKR2015014035-appb-I000044
Figure PCTKR2015014035-appb-I000045
Figure PCTKR2015014035-appb-I000045
Figure PCTKR2015014035-appb-I000046
Figure PCTKR2015014035-appb-I000046
Figure PCTKR2015014035-appb-I000047
Figure PCTKR2015014035-appb-I000047
2. 유기 전계 발광 소자2. Organic electroluminescent device
한편, 본 발명의 다른 측면은 상기한 본 발명에 따른 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자(유기 EL 소자)에 관한 것이다.On the other hand, another aspect of the present invention relates to an organic electroluminescent device (organic EL device) comprising the compound represented by the formula (1) according to the present invention.
보다 구체적으로, 본 발명에 따른 유기 전계 발광 소자는 양극(anode), 음극(cathode) 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함한다. 이때, 상기 화합물은 단독으로 사용되거나, 2종 이상이 혼합되어 사용될 수 있다.More specifically, the organic electroluminescent device according to the present invention includes an anode, a cathode, and one or more organic material layers interposed between the anode and the cathode, and at least one of the one or more organic material layers. Includes a compound represented by the formula (1). In this case, the compound may be used alone, or two or more kinds thereof may be mixed and used.
상기 1층 이상의 유기물층은 정공주입층, 정공수송층, 발광보조층, 발광층, 전자수송층 및 전자주입층 중 어느 하나 이상일 수 있고, 이 중에서 적어도 하나의 유기물층은 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 구체적으로 상기 화학식 1로 표시되는 화합물을 포함하는 유기물층은 발광층, 전자수송층, 정공수송층인 것이 바람직하다.The one or more organic material layers may be any one or more of a hole injection layer, a hole transport layer, a light emitting auxiliary layer, a light emitting layer, an electron transport layer and an electron injection layer, wherein at least one organic material layer may include a compound represented by Formula 1 have. Specifically, the organic material layer including the compound represented by Formula 1 is preferably a light emitting layer, an electron transport layer, a hole transport layer.
본 발명의 유기 전계 발광 소자의 발광층은 호스트 재료를 포함할 수 있는데, 이때 호스트 재료로서 상기 화학식 1의 화합물을 포함할 수 있다. 또한 본 발명의 유기 전계 발광 소자의 발광층은 상기 화학식 1의 화합물 이외의 화합물을 호스트로 포함할 수 있다.The light emitting layer of the organic electroluminescent device of the present invention may include a host material, and may include the compound of Formula 1 as the host material. In addition, the light emitting layer of the organic electroluminescent device of the present invention may include a compound other than the compound of Formula 1 as a host.
이러한 본 발명의 유기 전계 발광 소자의 구조는 특별히 한정되지 않으나, 기판, 양극, 정공주입층, 정공수송층, 발광보조층, 발광층, 전자수송층 및 음극이 순차적으로 적층된 구조일 수 있다. 이때, 상기 정공주입층, 정공수송층, 발광보조층, 발광층, 전자수송층 및 전자주입층 중 하나 이상은 상기 화학식 1로 표시되는 화합물을 포함할 수 있고, 바람직하게는 정공수송층, 전자저지층, 발광보조층이 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 한편 상기 전자수송층 위에는 전자주입층이 추가로 적층될 수 있다.The structure of the organic EL device of the present invention is not particularly limited, but may be a structure in which a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting auxiliary layer, a light emitting layer, an electron transport layer, and a cathode are sequentially stacked. In this case, at least one of the hole injection layer, the hole transport layer, the light emitting auxiliary layer, the light emitting layer, the electron transport layer and the electron injection layer may include a compound represented by the formula (1), preferably a hole transport layer, electron blocking layer, light emission The auxiliary layer may include a compound represented by Chemical Formula 1. Meanwhile, an electron injection layer may be further stacked on the electron transport layer.
본 발명의 유기 전계 발광 소자의 구조는 전극과 유기물층 계면에 절연층 또는 접착층이 삽입된 구조일 수 있다.The organic electroluminescent device of the present invention may have a structure in which an insulating layer or an adhesive layer is inserted between an electrode and an organic material layer interface.
본 발명의 유기 전계 발광 소자는 상기 유기물층 중 1층 이상이 상기 화학식 1로 표시되는 화합물을 포함하는 것을 제외하고는, 당업계에 공지된 재료 및 방법으로 유기물층 및 전극을 형성하여 제조할 수 있다.The organic electroluminescent device of the present invention can be manufactured by forming an organic material layer and an electrode by materials and methods known in the art, except that at least one layer of the organic material layer includes the compound represented by Chemical Formula 1.
상기 유기물층은 진공 증착법이나 용액 도포법에 의하여 형성될 수 있다. 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있으나, 이에 한정되지는 않는다.The organic material layer may be formed by a vacuum deposition method or a solution coating method. Examples of the solution coating method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.
본 발명의 유기 전계 발광 소자 제조 시 사용되는 기판은 특별히 한정되지 않으나, 실리콘 웨이퍼, 석영, 유리판, 금속판, 플라스틱 필름 및 시트 등을 사용할 수 있다.The substrate used in the manufacture of the organic EL device of the present invention is not particularly limited, but silicon wafers, quartz, glass plates, metal plates, plastic films, sheets, and the like may be used.
또, 양극 물질로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 또는 폴리아닐린과 같은 전도성 고분자; 및 카본블랙 등을 들 수 있으나, 이에 한정되지는 않는다.In addition, examples of the anode material include metals such as vanadium, chromium, copper, zinc and gold or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO); Combinations of oxides with metals such as ZnO: Al or SnO 2: Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole or polyaniline; And carbon black, but are not limited thereto.
또, 음극 물질로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금; 및 LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등을 들 수 있으나, 이에 한정되지는 않는다.The negative electrode material may be a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, or lead or an alloy thereof; And multilayer structure materials such as LiF / Al or LiO 2 / Al, and the like, but are not limited thereto.
또한, 정공 주입층, 정공 수송층, 전자 주입층 및 전자 수송층은 특별히 한정되는 것은 아니며, 당업계에 알려진 통상의 물질을 사용할 수 있다.In addition, the hole injection layer, the hole transport layer, the electron injection layer and the electron transport layer is not particularly limited, it is possible to use conventional materials known in the art.
이하 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to Examples. However, the following examples are merely to illustrate the invention, the present invention is not limited by the following examples.
[[ 준비예Preparation 1] One]
IA-IA- 1와1 and IA-3의 합성 Synthesis of IA-3
<단계 1> 2'-(2-<Step 1> 2 '-(2- 클로로Chloro -1H-인돌-3-일)-[1,1'-비페닐]-2--1H-indol-3-yl)-[1,1'-biphenyl] -2- 아민의Amine 합성 synthesis
Figure PCTKR2015014035-appb-I000048
Figure PCTKR2015014035-appb-I000048
질소 기류 하에서 3-브로모-2-클로로-1H-인돌 (11.5 g, 50.0 mmol), 2'-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)-[1,1'-비페닐]-2-아민(14.7g, 50.0 mmol), K2CO3 (13.8 g, 100.0 mmol) 및 1,4-디옥산/H2O (120 ml/40 ml)를 혼합한 다음, Pd(PPh3)4 (2.88 g, 5 mol%)를 넣고 120℃에서 12시간 동안 교반하였다.3-bromo-2-chloro-1H-indole (11.5 g, 50.0 mmol), 2 '-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane- under nitrogen stream 2-yl)-[1,1'-biphenyl] -2-amine (14.7 g, 50.0 mmol), K 2 CO 3 (13.8 g, 100.0 mmol) and 1,4-dioxane / H 2 O (120 ml / 40 ml) then Pd (PPh 3 ) 4 (2.88 g, 5 mol%) was added and stirred at 120 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피로 정제하여 2'-(2-클로로-1H-인돌-3-일)-[1,1'-비페닐]-2-아민 (11.9 g, 수율 75%)을 얻었다.After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography to obtain 2 '-(2-chloro-1H-indol-3-yl)-[1,1'-biphenyl] -2-amine (11.9 g, yield 75%). )
1H-NMR: δ 6.25 (s, 1H), 6.68 (t, 1H), 6.88 (t, 1H), 7.13 (m, 3H), 7.48 (m, 5H), 7.84 (d, 2H), 11.9 (s, 1H) 1 H-NMR: δ 6.25 (s, 1H), 6.68 (t, 1H), 6.88 (t, 1H), 7.13 (m, 3H), 7.48 (m, 5H), 7.84 (d, 2H), 11.9 ( s, 1 H)
<단계 2> 9,10-<Step 2> 9,10- 디하이드로디벤조Dihydrodibenzo [4,5:6,7] [4,5: 6,7] 아제피노Aspino [2,3-b] [2,3-b] 인돌의Indole 합성 synthesis
Figure PCTKR2015014035-appb-I000049
Figure PCTKR2015014035-appb-I000049
2'-(2-클로로-1H-인돌-3-일)-[1,1'-비페닐]-2-아민 (12.75 g, 40.0 mmol) 및 Pd2(dba)3 (0.86 g, 1 mmol), P(t-Bu)3 (0.80 g, 4.0 mmol), 소듐 tert-부톡사이드 (5.76 g, 60.0 mmol) 을 150 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 9,10-디하이드로디벤조[4,5:6,7]아제피노[2,3-b]인돌 (7 g, 수율 62 %)을 얻었다. 2 '-(2-chloro-1H-indol-3-yl)-[1,1'-biphenyl] -2-amine (12.75 g, 40.0 mmol) and Pd 2 (dba) 3 (0.86 g, 1 mmol ), P (t-Bu) 3 (0.80 g, 4.0 mmol) and sodium tert-butoxide (5.76 g, 60.0 mmol) were added to 150 ml toluene and stirred at 110 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent of the filtered organic layer was removed, and then purified by column chromatography, 9,10-dihydrodibenzo [4,5: 6,7] azino [2,3-b] indole (7 g, yield 62). %) Was obtained.
1H-NMR: δ 4.0 (s, 1H), 6.68 (d, 1H), 7.12 (m, 3H), 7.48 (m, 5H), 7.86 (d, 2H), 11.9 (s, 1H) 1 H-NMR: δ 4.0 (s, 1H), 6.68 (d, 1H), 7.12 (m, 3H), 7.48 (m, 5H), 7.86 (d, 2H), 11.9 (s, 1H)
<단계 3> IA-1와 IA-3의 합성Step 3 Synthesis of IA-1 and IA-3
Figure PCTKR2015014035-appb-I000050
Figure PCTKR2015014035-appb-I000050
질소 기류 하에서 9,10-디하이드로디벤조[4,5:6,7]아제피노[2,3-b]인돌 (8.47 g, 30.0 mmol)과 아이오도벤젠(6.12 g, 30.0 mmol), Cu 파우더 (0.45 g, 15.0 mmol), K2CO3 (12.4 g, 90.0 mmol), 나이트로벤젠 (200 ml)를 혼합하고 250℃에서 12시간 동안 교반하였다. 9,10-dihydrodibenzo [4,5: 6,7] azetino [2,3-b] indole (8.47 g, 30.0 mmol), iodobenzene (6.12 g, 30.0 mmol), Cu under a nitrogen stream Powder (0.45 g, 15.0 mmol), K 2 CO 3 (12.4 g, 90.0 mmol), nitrobenzene (200 ml) were mixed and stirred at 250 ° C. for 12 h.
반응 종결 후 나이트로벤젠을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼크로마토그래피로 정제하여 IA-1 (4.62 g, 수율 43%)과 IA-3 (4.62 g, 수율 43%)을 얻었다. After completion of the reaction, nitrobenzene was removed, the organic layer was separated with methylene chloride, and water was removed using MgSO 4 . The solvent was removed from the organic layer to which water was removed, and then purified by column chromatography to obtain IA-1 (4.62 g, yield 43%) and IA-3 (4.62 g, yield 43%).
IA-1_1H-NMR: δ 4.01 (s, 1H), 6.68 (d, 1H), 6.88 (t, 1H), 7.15 (t, 1H), 7.46 (m, 10H), 7.73 (d, 1H), 7.84 (d, 2H), 8.15 (d, 1H)IA-1_ 1 H-NMR: δ 4.01 (s, 1H), 6.68 (d, 1H), 6.88 (t, 1H), 7.15 (t, 1H), 7.46 (m, 10H), 7.73 (d, 1H) , 7.84 (d, 2H), 8.15 (d, 1H)
IA-3_1H-NMR: δ 6.62 (d, 3H), 6.85 (t, 2H), 7.17 (m, 5H), 7.52 (t, 5H), 7.86 (d, 2H), 11.9 (s, 1H)IA-3_ 1 H-NMR: δ 6.62 (d, 3H), 6.85 (t, 2H), 7.17 (m, 5H), 7.52 (t, 5H), 7.86 (d, 2H), 11.9 (s, 1H)
[[ 준비예Preparation 2] 2]
IA-2와 IA-4의 합성Synthesis of IA-2 and IA-4
<단계 1> 2'-(1H-인돌-2-일)-[1,1'-비페닐]-<Step 1> 2 '-(1H-indol-2-yl)-[1,1'-biphenyl]- 아민의Amine 합성 synthesis
Figure PCTKR2015014035-appb-I000051
Figure PCTKR2015014035-appb-I000051
질소 기류 하에서 2-브로모-1H-인돌 (9.80 g, 50.0 mmol), 2'-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)-[1,1'-비페닐]-2-아민 (14.7 g, 50.0 mmol), K2CO3 (13.8 g, 100.0 mmol) 및 1,4-디옥산/H2O (120 ml/40 ml)를 혼합한 다음, Pd(PPh3)4 (2.88 g, 5 mol%)를 넣고 120℃에서 12시간 동안 교반하였다. 2-bromo-1H-indole (9.80 g, 50.0 mmol), 2 '-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) under nitrogen stream -[1,1'-biphenyl] -2-amine (14.7 g, 50.0 mmol), K 2 C0 3 (13.8 g, 100.0 mmol) and 1,4-dioxane / H 2 O (120 ml / 40 ml ) Was mixed and Pd (PPh 3 ) 4 (2.88 g, 5 mol%) was added thereto, followed by stirring at 120 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피로 정제하여 2'-(1H-인돌-2-일)-[1,1'-비페닐]-2-아민 (10.5 g, 수율 74%)을 얻었다.After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography to obtain 2 '-(1H-indol-2-yl)-[1,1'-biphenyl] -2-amine (10.5 g, yield 74%).
1H-NMR: δ 6.28 (s, 1H), 6.84 (m, 5H), 7.17 (t, 1H), 7.52 (m, 4H), 7.68 (d, 1H), 7.86 (d, 2H), 11.2 (s, 1H) 1 H-NMR: δ 6.28 (s, 1H), 6.84 (m, 5H), 7.17 (t, 1H), 7.52 (m, 4H), 7.68 (d, 1H), 7.86 (d, 2H), 11.2 ( s, 1 H)
<단계 2> 2'-(3-<Step 2> 2 '-(3- 아이오도Iodo -1H-인돌-2-일)-[1,1'-비페닐}-2--1H-indol-2-yl)-[1,1'-biphenyl} -2- 아민의Amine 합성 synthesis
Figure PCTKR2015014035-appb-I000052
Figure PCTKR2015014035-appb-I000052
2'-(1H-인돌-2-일)-[1,1'-비페닐]-2-아민 (5.68 g, 20.0 mmol)와 KOH(2.81 g, 50.0 mmol)를 80ml DMF에 녹인 후 상온에서 20분 동안 교반하였다. DMF에 녹인 I2 (5.07 g, 20.0 mmol)를 첨가한 후 1시간 동안 교반하였다.2 '-(1H-indol-2-yl)-[1,1'-biphenyl] -2-amine (5.68 g, 20.0 mmol) and KOH (2.81 g, 50.0 mmol) were dissolved in 80 ml DMF at room temperature. Stir for 20 minutes. I 2 (5.07 g, 20.0 mmol) dissolved in DMF was added and stirred for 1 hour.
반응 종결 후 100ml의 얼음물을 넣고 고체를 추출한다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 2'-(3-아이오도-1H-인돌-2-일)-[1,1'-비페닐]-2-아민 (7.63 g, 수율 93 %)을 얻었다. After completion of the reaction, 100 ml of ice water was added and the solids were extracted. After removing the solvent of the filtered organic layer, using column chromatography, the target compound 2 '-(3-iodo-1H-indol-2-yl)-[1,1'-biphenyl] -2-amine (7.63 g, yield 93%).
1H-NMR: δ 6.25 (s, 1H), 6.71 (d, 1H), 6.93 (m, 3H), 7.15 (t, 1H), 7.53 (t, 3H), 7.65 (d, 1H), 7.92 (m, 3H), 11.2 (s, 1H) 1 H-NMR: δ 6.25 (s, 1H), 6.71 (d, 1H), 6.93 (m, 3H), 7.15 (t, 1H), 7.53 (t, 3H), 7.65 (d, 1H), 7.92 ( m, 3H), 11.2 (s, 1H)
<단계 3> 9,14-<Step 3> 9,14- 디하이드로디벤조[4,5:6,7]아제피노Dihydrodibenzo [4,5: 6,7] azino [3,2-b][3,2-b] 인돌의Indole 합성 synthesis
Figure PCTKR2015014035-appb-I000053
Figure PCTKR2015014035-appb-I000053
2'-(3-아이오도-1H-인돌-2-일)-[1,1'-비페닐]-2-아민 (16.4 g, 40.0 mmol) 및 Pd2(dba)3 (0.86 g, 1 mmol), P(t-Bu)3 (0.80 g, 4.0 mmol), 소듐 tert-부톡사이드 (5.76 g, 60.0 mmol) 을 150 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다.2 '-(3-iodo-1H-indol-2-yl)-[1,1'-biphenyl] -2-amine (16.4 g, 40.0 mmol) and Pd 2 (dba) 3 (0.86 g, 1 mmol), P (t-Bu) 3 (0.80 g, 4.0 mmol) and sodium tert-butoxide (5.76 g, 60.0 mmol) were added to 150 ml toluene and stirred at 110 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 9,14-디하이드로디벤조[4,5:6,7]아제피노[3,2-b]인돌 (6.55 g, 수율 58 %)을 얻었다. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent of the filtered organic layer was removed, and then purified by column chromatography, 9,14-dihydrodibenzo [4,5: 6,7] azino [3,2-b] indole (6.55 g, yield 58). %) Was obtained.
1H-NMR: δ 4.1 (s, 1H), 6.53 (t, 1H), 6.72 (d, 1H), 6.88 (t, 1H), 7.02 (t, 1H), 7.18 (d, 1H), 7.48 (m, 4H), 7.68 (d, 1H), 7.86 (d, 2H), 11.2 (s, 1H) 1 H-NMR: δ 4.1 (s, 1H), 6.53 (t, 1H), 6.72 (d, 1H), 6.88 (t, 1H), 7.02 (t, 1H), 7.18 (d, 1H), 7.48 ( m, 4H), 7.68 (d, 1H), 7.86 (d, 2H), 11.2 (s, 1H)
<단계 4> IA-<Step 4> IA- 3와3 and IA-4의 합성 Synthesis of IA-4
Figure PCTKR2015014035-appb-I000054
Figure PCTKR2015014035-appb-I000054
질소 기류 하에서 9,14-디하이드로디벤조[4,5:6,7]아제피노[3,2-b]인돌 (16.9 g, 60.0 mmol)과 아이오도벤젠(6.12 g, 30.0 mmol), Cu 파우더 (0.45 g, 15.0 mmol), K2CO3 (12.4 g, 90.0 mmol), 나이트로벤젠 (200 ml)를 혼합하고 250℃에서 12시간 동안 교반하였다.9,14-dihydrodibenzo [4,5: 6,7] azetino [3,2-b] indole (16.9 g, 60.0 mmol) and iodobenzene (6.12 g, 30.0 mmol), Cu under a nitrogen stream Powder (0.45 g, 15.0 mmol), K 2 CO 3 (12.4 g, 90.0 mmol), nitrobenzene (200 ml) were mixed and stirred at 250 ° C. for 12 h.
반응 종결 후 나이트로벤젠을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼크로마토그래피로 정제하여 IA-2 (9.46 g, 수율 44%)과 IA-4 (9.46 g, 수율 44%)을 얻었다. After completion of the reaction, nitrobenzene was removed, the organic layer was separated with methylene chloride, and water was removed using MgSO 4 . The solvent was removed from the organic layer to which water was removed, and then purified by column chromatography to obtain IA-2 (9.46 g, yield 44%) and IA-4 (9.46 g, yield 44%).
IA-2_1H-NMR: δ 4.08 (s, 1H), 6.67 (d, 1H), 6.85 (t, 1H), 7.27 (m, 3H), 7.52 (m, 9H), 7.86 (d, 2H), 7.92 (d, 2H)IA-2_ 1 H-NMR: δ 4.08 (s, 1H), 6.67 (d, 1H), 6.85 (t, 1H), 7.27 (m, 3H), 7.52 (m, 9H), 7.86 (d, 2H) , 7.92 (d, 2 H)
IA-4_1H-NMR: δ 6.64 (m, 4H), 6.84 (t, 2H), 6.97 (t, 1H), 7.18 (t, 3H), 7.52 (m, 4H), 7.65 (d, 1H), 7.86 (d, 2H), 11.32 (s, 1H)IA-4_ 1 H-NMR: δ 6.64 (m, 4H), 6.84 (t, 2H), 6.97 (t, 1H), 7.18 (t, 3H), 7.52 (m, 4H), 7.65 (d, 1H) , 7.86 (d, 2H), 11.32 (s, 1H)
[[ 준비예Preparation 3] 3]
IA-5의 합성Synthesis of IA-5
<단계 1> 2'-(2-<Step 1> 2 '-(2- 클로로Chloro -1H-인돌-3-일)-[1,1'-비페닐]-2-올의 합성Synthesis of -1H-indol-3-yl)-[1,1'-biphenyl] -2-ol
Figure PCTKR2015014035-appb-I000055
Figure PCTKR2015014035-appb-I000055
질소 기류 하에서 3-브로모-2-클로로-1H-인돌 (11.5 g, 50.0 mmol), 2'-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)-[1,1'-비페닐]-2-아민(14.8g, 50.0 mmol), K2CO3 (13.8g, 100.0 mmol) 및 1,4-디옥산/H2O (120 ml/40 ml)를 혼합한 다음, Pd(PPh3)4 (2.88g, 5 mol%)를 넣고 120℃에서 12시간 동안 교반하였다. 3-bromo-2-chloro-1H-indole (11.5 g, 50.0 mmol), 2 '-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane- under nitrogen stream 2-yl)-[1,1'-biphenyl] -2-amine (14.8 g, 50.0 mmol), K 2 CO 3 (13.8 g, 100.0 mmol) and 1,4-dioxane / H 2 O (120 ml / 40 ml) then Pd (PPh 3 ) 4 (2.88 g, 5 mol%) was added thereto and stirred at 120 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피로 정제하여 2'-(2-클로로-1H-인돌-3-일)-[1,1'-비페닐]-2-올 (11.5 g, 수율 72%)을 얻었다.After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography to obtain 2 '-(2-chloro-1H-indol-3-yl)-[1,1'-biphenyl] -2-ol (11.5 g, 72% yield). )
1H-NMR: δ 5.32 (s, 1H), 7.04 (m, 4H), 7.23 (t, 1H), 7.53 (m, 5H), 7.86 (d, 2H), 11.87 (s, 1H) 1 H-NMR: δ 5.32 (s, 1H), 7.04 (m, 4H), 7.23 (t, 1H), 7.53 (m, 5H), 7.86 (d, 2H), 11.87 (s, 1H)
<단계 2> IA-5의 합성Step 2 Synthesis of IA-5
Figure PCTKR2015014035-appb-I000056
Figure PCTKR2015014035-appb-I000056
2'-(2-클로로-1H-인돌-3-일)-[1,1'-비페닐]-2-올 (12.8g, 40.0 mmol) 및 Pd2(dba)3 (0.86 g, 1 mmol), P(t-Bu)3 (0.80 g, 4.0 mmol), 소듐 tert-부톡사이드 (5.76 g, 60.0 mmol) 을 150 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다.2 '-(2-chloro-lH-indol-3-yl)-[1,1'-biphenyl] -2-ol (12.8 g, 40.0 mmol) and Pd 2 (dba) 3 (0.86 g, 1 mmol) ), P (t-Bu) 3 (0.80 g, 4.0 mmol) and sodium tert-butoxide (5.76 g, 60.0 mmol) were added to 150 ml toluene and stirred at 110 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 IA-5 (10.4 g, 수율 92 %)을 얻었다. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give the title compound IA-5 (10.4 g, 92% yield).
1H-NMR: δ 7.04 (m, 4H), 7.25 (t, 1H), 7.54 (m, 5H), 7.86 (d, 2H), 11.92 (s, 1H) 1 H-NMR: δ 7.04 (m, 4H), 7.25 (t, 1H), 7.54 (m, 5H), 7.86 (d, 2H), 11.92 (s, 1H)
[[ 준비예Preparation 4] 4]
IA-6의 합성Synthesis of IA-6
<단계 1> 2'-(2-<Step 1> 2 '-(2- 클로로Chloro -1H-인돌-3-일)-[1,1'-비페닐]-2--1H-indol-3-yl)-[1,1'-biphenyl] -2- 티올의Thiol 합성 synthesis
Figure PCTKR2015014035-appb-I000057
Figure PCTKR2015014035-appb-I000057
질소 기류 하에서 3-브로모-2-클로로-1H-인돌 (11.5g, 50.0 mmol), 2'-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)-[1,1'-비페닐]-2-티올 (15.6g, 50.0 mmol), K2CO3 (13.8g, 100.0 mmol) 및 1,4-디옥산/H2O (120 ml/40 ml)를 혼합한 다음, Pd(PPh3)4 (2.88 g, 5 mol%)를 넣고 120℃에서 12시간 동안 교반하였다. 3-bromo-2-chloro-1H-indole (11.5 g, 50.0 mmol), 2 '-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane- under nitrogen stream 2-yl)-[1,1'-biphenyl] -2-thiol (15.6 g, 50.0 mmol), K 2 CO 3 (13.8 g, 100.0 mmol) and 1,4-dioxane / H 2 O (120 ml / 40 ml) then Pd (PPh 3 ) 4 (2.88 g, 5 mol%) was added and stirred at 120 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피로 정제하여 2'-(2-클로로-1H-인돌-3-일)-[1,1'-비페닐]-2-티올 (13.1 g, 수율 78%)을 얻었다.After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography to obtain 2 '-(2-chloro-1H-indol-3-yl)-[1,1'-biphenyl] -2-thiol (13.1 g, yield 78%). )
1H-NMR: δ 3.38 (s, 1H), 7.06 (t, 2H), 7.27 (t, 2H), 7.52 (m, 6H), 7.86 (d, 2H), 11.8 (s, 1H) 1 H-NMR: δ 3.38 (s, 1H), 7.06 (t, 2H), 7.27 (t, 2H), 7.52 (m, 6H), 7.86 (d, 2H), 11.8 (s, 1H)
<단계 2> IA-6의 합성Step 2 Synthesis of IA-6
Figure PCTKR2015014035-appb-I000058
Figure PCTKR2015014035-appb-I000058
2'-(2-클로로-1H-인돌-3-일)-[1,1'-비페닐]-2-티올 (13.4 g, 40.0 mmol) 및 Pd2(dba)3 (0.86 g, 1 mmol), P(t-Bu)3 (0.80 g, 4.0 mmol), 소듐 tert-부톡사이드 (5.76 g, 60.0 mmol) 을 150 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다.2 '-(2-chloro-1H-indol-3-yl)-[1,1'-biphenyl] -2-thiol (13.4 g, 40.0 mmol) and Pd 2 (dba) 3 (0.86 g, 1 mmol ), P (t-Bu) 3 (0.80 g, 4.0 mmol) and sodium tert-butoxide (5.76 g, 60.0 mmol) were added to 150 ml toluene and stirred at 110 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 IA-6 (11.3 g, 수율 95 %)을 얻었다. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give the title compound IA-6 (11.3 g, yield 95%).
1H-NMR: δ 7.06 (t, 2H), 7.27 (t, 2H), 7.52 (m, 6H), 7.86 (d, 2H), 11.87 (s, 1H) 1 H-NMR: δ 7.06 (t, 2H), 7.27 (t, 2H), 7.52 (m, 6H), 7.86 (d, 2H), 11.87 (s, 1H)
[[ 준비예Preparation 5] 5]
IA-7의 합성Synthesis of IA-7
<단계 1> 2'-(<Step 1> 2 '-( benzofuranbenzofuran -2-일)-[1,1'-비페닐]-2--2-yl)-[1,1'-biphenyl] -2- 아민의Amine 합성 synthesis
Figure PCTKR2015014035-appb-I000059
Figure PCTKR2015014035-appb-I000059
질소 기류 하에서 2-브로모벤조퓨란 (9.85 g, 50.0 mmol), 2'-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)-[1,1'-비페닐]-2-아민 (14.7g, 50.0 mmol), K2CO3 (13.8 g, 100.0 mmol) 및 1,4-디옥산/H2O (120 ml/40 ml)를 혼합한 다음, Pd(PPh3)4 (2.88 g, 5 mol%)를 넣고 120℃에서 12시간 동안 교반하였다.2-bromobenzofuran (9.85 g, 50.0 mmol) under nitrogen stream, 2 '-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[ 1,1'-biphenyl] -2-amine (14.7 g, 50.0 mmol), K 2 CO 3 (13.8 g, 100.0 mmol) and 1,4-dioxane / H 2 O (120 ml / 40 ml) After mixing, Pd (PPh 3 ) 4 (2.88 g, 5 mol%) was added and stirred at 120 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피로 정제하여 2'-(벤조퓨란-2-일)-[1,1'-비페닐]-2-아민 (10.8 g, 수율 76%)을 얻었다.After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography to obtain 2 '-(benzofuran-2-yl)-[1,1'-biphenyl] -2-amine (10.8 g, yield 76%).
1H-NMR: δ 6.25 (s, 1H), 6.67 (d, 1H), 6.85 (t, 1H), 7.15 (m, 2H), 7.42 (m, 5H), 7.67 (d, 1H), 7.88 (d, 3H) 1 H-NMR: δ 6.25 (s, 1H), 6.67 (d, 1H), 6.85 (t, 1H), 7.15 (m, 2H), 7.42 (m, 5H), 7.67 (d, 1H), 7.88 ( d, 3H)
<단계 2> 2'-(3-<Step 2> 2 '-(3- 아이오도벤조퓨란Iodobenzofuran -2-일)-[1,1'-비페닐]-2--2-yl)-[1,1'-biphenyl] -2- 아민의Amine 합성 synthesis
Figure PCTKR2015014035-appb-I000060
Figure PCTKR2015014035-appb-I000060
2'-(벤조퓨란-2-일)-[1,1'-비페닐]-2-아민 (5.70 g, 20.0 mmol)와 KOH(2.81 g, 50.0 mmol)를 80ml DMF에 녹인 후 상온에서 20분 동안 교반하였다. DMF에 녹인 I2 (5.07 g, 20.0 mmol)를 첨가한 후 1시간 동안 교반하였다.2 '-(benzofuran-2-yl)-[1,1'-biphenyl] -2-amine (5.70 g, 20.0 mmol) and KOH (2.81 g, 50.0 mmol) were dissolved in 80 ml DMF and then cooled to 20 at room temperature. Stir for minutes. I 2 (5.07 g, 20.0 mmol) dissolved in DMF was added and stirred for 1 hour.
반응 종결 후 얼음물을 넣고 고체를 추출한다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 2'-(3-아이오도벤조퓨란-2-일)-[1,1'-비페닐]-2-아민 (7.73 g, 수율 94 %)을 얻었다. After completion of the reaction, ice water is added and the solid is extracted. After removing the solvent of the filtered organic layer using column chromatography to give the target compound 2 '-(3-iodobenzofuran-2-yl)-[1,1'-biphenyl] -2-amine (7.73 g, Yield 94%).
1H-NMR: δ 6.24 (s, 1H), 6.66 (d, 1H), 6.85 (t, 1H), 7.14 (t, 1H), 7.45 (m, 5H), 7.64 (d, 1H), 7.87 (d, 3H) 1 H-NMR: δ 6.24 (s, 1H), 6.66 (d, 1H), 6.85 (t, 1H), 7.14 (t, 1H), 7.45 (m, 5H), 7.64 (d, 1H), 7.87 ( d, 3H)
<단계 3> IA-7의 합성Step 3 Synthesis of IA-7
Figure PCTKR2015014035-appb-I000061
Figure PCTKR2015014035-appb-I000061
2'-(3-아이오도벤조퓨란-2-일)-[1,1'-비페닐]-2-아민 (16.45 g, 40.0 mmol) 및 Pd2(dba)3 (0.86 g, 1 mmol), P(t-Bu)3 (0.80 g, 4.0 mmol), 소듐 tert-부톡사이드 (5.76 g, 60.0 mmol) 을 150 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다.2 '-(3-iodobenzofuran-2-yl)-[1,1'-biphenyl] -2-amine (16.45 g, 40.0 mmol) and Pd 2 (dba) 3 (0.86 g, 1 mmol) , P (t-Bu) 3 (0.80 g, 4.0 mmol) and sodium tert-butoxide (5.76 g, 60.0 mmol) were added to 150 ml toluene and stirred at 110 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 IA-7 (7.25 g, 수율 64 %)을 얻었다. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the organic layer was filtered and purified by column chromatography to give the title compound IA-7 (7.25 g, 64% yield).
1H-NMR: δ 4.03 (s, 1H), 6.67 (d, 1H), 6.85 (d, 1H), 7.14 (d, 1H), 7.45 (m, 5H), 7.64 (d, 1H), 7.87 (d, 3H) 1 H-NMR: δ 4.03 (s, 1H), 6.67 (d, 1H), 6.85 (d, 1H), 7.14 (d, 1H), 7.45 (m, 5H), 7.64 (d, 1H), 7.87 ( d, 3H)
[[ 준비예Preparation 6] 6]
IA-8의 합성Synthesis of IA-8
<단계 1> 2'-(<Step 1> 2 '-( 벤조[b]티오펜Benzo [b] thiophene -2-일)-[1,1'-비페닐]-2--2-yl)-[1,1'-biphenyl] -2- 아민의Amine 합성 synthesis
Figure PCTKR2015014035-appb-I000062
Figure PCTKR2015014035-appb-I000062
질소 기류 하에서 2-브로모벤조[b]티오펜 (10.6 g, 50.0 mmol), 2'-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)-[1,1'-비페닐]-2-아민 (14.7 g, 50.0 mmol), K2CO3 (13.8 g, 100.0 mmol) 및 1,4-디옥산/H2O (120 ml/40 ml)를 혼합한 다음, Pd(PPh3)4 (2.88 g, 5 mol%)를 넣고 120℃에서 12시간 동안 교반하였다.2-bromobenzo [b] thiophene (10.6 g, 50.0 mmol), 2 '-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- under nitrogen stream Yl)-[1,1'-biphenyl] -2-amine (14.7 g, 50.0 mmol), K 2 CO 3 (13.8 g, 100.0 mmol) and 1,4-dioxane / H 2 O (120 ml / 40 ml) was mixed, and then Pd (PPh 3 ) 4 (2.88 g, 5 mol%) was added thereto and stirred at 120 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피로 정제하여 2'-(벤조[b]티오펜-2-일)-[1,1'-비페닐]-2-아민 (11.6 g, 수율 77%)을 얻었다.After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography to obtain 2 '-(benzo [b] thiophen-2-yl)-[1,1'-biphenyl] -2-amine (11.6 g, yield 77%). Got.
1H-NMR: δ 6.25 (s, 1H), 6.65 (d, 1H), 6.86 (t, 1H), 7.14 (t, 1H), 7.49 (m, 5H), 7.68 (s, 1H), 7.83 (d, 3H), 7.96 (d, 1H) 1 H-NMR: δ 6.25 (s, 1H), 6.65 (d, 1H), 6.86 (t, 1H), 7.14 (t, 1H), 7.49 (m, 5H), 7.68 (s, 1H), 7.83 ( d, 3H), 7.96 (d, 1H)
<단계 2> 2'-(3-<Step 2> 2 '-(3- 아이오도벤조[b]티오펜Iodobenzo [b] thiophene -2-일)-[1,1'-비페닐]-2--2-yl)-[1,1'-biphenyl] -2- 아민의Amine 합성 synthesis
Figure PCTKR2015014035-appb-I000063
Figure PCTKR2015014035-appb-I000063
2'-(벤조[b]티오펜-2-일)-[1,1'-비페닐]-2-아민 (6.03 g, 20.0 mmol)와 KOH(2.81 g, 50.0 mmol)를 80ml DMF에 녹인 후 상온에서 20분 동안 교반하였다. DMF에 녹인 I2 (5.07 g, 20.0 mmol)를 첨가한 후 1시간 동안 교반하였다.2 '-(benzo [b] thiophen-2-yl)-[1,1'-biphenyl] -2-amine (6.03 g, 20.0 mmol) and KOH (2.81 g, 50.0 mmol) dissolved in 80 ml DMF After stirring at room temperature for 20 minutes. I 2 (5.07 g, 20.0 mmol) dissolved in DMF was added and stirred for 1 hour.
반응 종결 후 얼음물을 넣고 고체를 추출한다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 2'-(3-아이오도벤조[b]티오펜-2-일)-[1,1'-비페닐]-2-아민 (8.20 g, 수율 96 %)을 얻었다. After completion of the reaction, ice water is added and the solid is extracted. After removing the solvent of the filtered organic layer, using column chromatography, the target compound 2 '-(3-iodobenzo [b] thiophen-2-yl)-[1,1'-biphenyl] -2-amine (8.20 g, yield 96%) was obtained.
1H-NMR: δ 6.25 (s, 1H), 6.66 (d, 1H), 6.85 (s, 1H), 7.14 (t, 1H), 7.49 (m, 5H), 7.86 (d, 2H), 8.03 (d, 2H) 1 H-NMR: δ 6.25 (s, 1H), 6.66 (d, 1H), 6.85 (s, 1H), 7.14 (t, 1H), 7.49 (m, 5H), 7.86 (d, 2H), 8.03 ( d, 2H)
<단계 3> IA-8의 합성Step 3 Synthesis of IA-8
Figure PCTKR2015014035-appb-I000064
Figure PCTKR2015014035-appb-I000064
2'-(3-아이오도벤조퓨란-2-일)-[1,1'-비페닐]-2-아민 (17.1 g, 40.0 mmol) 및 Pd2(dba)3 (0.86 g, 1 mmol), P(t-Bu)3 (0.80 g, 4.0 mmol), 소듐 tert-부톡사이드 (5.76 g, 60.0 mmol) 을 150 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다.2 '-(3-iodobenzofuran-2-yl)-[1,1'-biphenyl] -2-amine (17.1 g, 40.0 mmol) and Pd 2 (dba) 3 (0.86 g, 1 mmol) , P (t-Bu) 3 (0.80 g, 4.0 mmol) and sodium tert-butoxide (5.76 g, 60.0 mmol) were added to 150 ml toluene and stirred at 110 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 IA-8 (7.90 g, 수율 66 %)을 얻었다. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give the title compound IA-8 (7.90 g, 66% yield).
1H-NMR: δ 3.98 (s, 1H), 6.67 (d, 1H), 6.85 (t, 1H), 7.14 (t, 1H), 7.51 (m, 5H), 7.84 (d, 2H), 8.03 (d, 2H) 1 H-NMR: δ 3.98 (s, 1H), 6.67 (d, 1H), 6.85 (t, 1H), 7.14 (t, 1H), 7.51 (m, 5H), 7.84 (d, 2H), 8.03 ( d, 2H)
[[ 준비예Preparation 7] 7]
IA-9의 합성Synthesis of IA-9
<단계 1> 2'-(<Step 1> 2 '-( 벤조퓨란Benzofuran -2-일)-[1,1'-비페닐]-2--2-yl)-[1,1'-biphenyl] -2- 아민의Amine 합성 synthesis
Figure PCTKR2015014035-appb-I000065
Figure PCTKR2015014035-appb-I000065
질소 기류 하에서 3-브로모-2-클로로벤조퓨란 (11.6 g, 50.0 mmol), 2'-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)-[1,1'-비페닐]-2-아민 (14.7g, 50.0 mmol), K2CO3 (13.8 g, 100.0 mmol) 및 1,4-디옥산/H2O (120 ml/40 ml)를 혼합한 다음, Pd(PPh3)4 (2.88 g, 5 mol%)를 넣고 120℃에서 12시간 동안 교반하였다. 3-bromo-2-chlorobenzofuran (11.6 g, 50.0 mmol), 2 '-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2- under nitrogen stream Il)-[1,1'-biphenyl] -2-amine (14.7 g, 50.0 mmol), K 2 CO 3 (13.8 g, 100.0 mmol) and 1,4-dioxane / H 2 O (120 ml / 40 ml) was mixed, and then Pd (PPh 3 ) 4 (2.88 g, 5 mol%) was added thereto and stirred at 120 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피로 정제하여 2'-(2-클로로벤조퓨란-3-일)-[1,1'-비페닐]-2-아민 (11.8 g, 수율 74%)을 얻었다.After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer and purified by column chromatography to obtain 2 '-(2-chlorobenzofuran-3-yl)-[1,1'-biphenyl] -2-amine (11.8 g, yield 74%). Got it.
1H-NMR: δ 6.25 (s, 1H), 6.65 (d, 1H), 6.86 (t, 1H), 7.14 (t, 1H), 7.42 (m, 5H), 7.64 (d, 1H), 7.87 (d, 3H) 1 H-NMR: δ 6.25 (s, 1H), 6.65 (d, 1H), 6.86 (t, 1H), 7.14 (t, 1H), 7.42 (m, 5H), 7.64 (d, 1H), 7.87 ( d, 3H)
<단계 2> IA-<Step 2> IA- 9 의9 of 합성 synthesis
Figure PCTKR2015014035-appb-I000066
Figure PCTKR2015014035-appb-I000066
2'-(2-클로로벤조퓨란-3-일)-[1,1'-비페닐]-2-아민 (12.8 g, 40.0 mmol) 및 Pd2(dba)3 (0.86 g, 1 mmol), P(t-Bu)3 (0.80 g, 4.0 mmol), 소듐 tert-부톡사이드 (5.76 g, 60.0 mmol)을 150 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다.2 '-(2-chlorobenzofuran-3-yl)-[1,1'-biphenyl] -2-amine (12.8 g, 40.0 mmol) and Pd 2 (dba) 3 (0.86 g, 1 mmol), P (t-Bu) 3 (0.80 g, 4.0 mmol) and sodium tert-butoxide (5.76 g, 60.0 mmol) were added to 150 ml toluene and stirred at 110 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 IA-9 (7.59 g, 수율 67 %)을 얻었다. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give the title compound IA-9 (7.59 g, yield 67%).
1H-NMR: δ 4.02 (s, 1H), 6.66 (d, 1H), 6.85 (t, 1H), 7.14 (t, 1H), 7.45 (t, 5H), 7.64 (d, 1H), 7.88 (d, 3H) 1 H-NMR: δ 4.02 (s, 1H), 6.66 (d, 1H), 6.85 (t, 1H), 7.14 (t, 1H), 7.45 (t, 5H), 7.64 (d, 1H), 7.88 ( d, 3H)
[[ 준비예Preparation 8] 8]
IA-8의 합성Synthesis of IA-8
<단계 1> 2'-(2-<Step 1> 2 '-(2- 클로로벤조[b]티오펜Chlorobenzo [b] thiophene -3-일)-[1,1'-비페닐]-2--3-yl)-[1,1'-biphenyl] -2- 아민의Amine 합성 synthesis
Figure PCTKR2015014035-appb-I000067
Figure PCTKR2015014035-appb-I000067
질소 기류 하에서 3-브로모-2-클로로벤조[b]티오펜 (12.4 g, 50.0 mmol), 2'-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)-[1,1'-비페닐]-2-아민 (14.7 g, 50.0 mmol), K2CO3 (13.8 g, 100.0 mmol) 및 1,4-디옥산/H2O (120 ml/40 ml)를 혼합한 다음, Pd(PPh3)4 (2.88 g, 5 mol%)를 넣고 120℃에서 12시간 동안 교반하였다.3-bromo-2-chlorobenzo [b] thiophene (12.4 g, 50.0 mmol), 2 '-(4,4,5,5-tetramethyl-1,3,2-dioxaboro under nitrogen stream Lan-2-yl)-[1,1'-biphenyl] -2-amine (14.7 g, 50.0 mmol), K 2 CO 3 (13.8 g, 100.0 mmol) and 1,4-dioxane / H 2 O (120 ml / 40 ml) is mixed and then Pd (PPh 3 ) 4 (2.88 g, 5 mol%) was added and stirred at 120 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피로 정제하여 2'-(2-클로로벤조[b]티오펜-3-일)-[1,1'-비페닐]-2-아민 (12.1 g, 수율 72%)을 얻었다.After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the obtained organic layer, and then purified by column chromatography to obtain 2 '-(2-chlorobenzo [b] thiophen-3-yl)-[1,1'-biphenyl] -2-amine (12.1 g, yield). 72%).
1H-NMR: δ 6.25 (s, 1H), 6.66 (d, 1H), 6.85 (t, 1H), 7.14 (t, 1H), 7.52 (m, 5H), 7.86 (d, 2H), 7.97 (d, 1H), 8.43 (d, 1H) 1 H-NMR: δ 6.25 (s, 1H), 6.66 (d, 1H), 6.85 (t, 1H), 7.14 (t, 1H), 7.52 (m, 5H), 7.86 (d, 2H), 7.97 ( d, 1H), 8.43 (d, 1H)
<단계 2> IA-<Step 2> IA- 10 의10 of 합성 synthesis
Figure PCTKR2015014035-appb-I000068
Figure PCTKR2015014035-appb-I000068
2'-(2-클로로벤조[b]티오펜-3-일)-[1,1'-비페닐]-2-아민 (13.4g, 40.0 mmol) 및 Pd2(dba)3 (0.86 g, 1 mmol), P(t-Bu)3 (0.80 g, 4.0 mmol), 소듐 tert-부톡사이드 (5.76 g, 60.0 mmol) 을 150 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다.2 '-(2-chlorobenzo [b] thiophen-3-yl)-[1,1'-biphenyl] -2-amine (13.4 g, 40.0 mmol) and Pd 2 (dba) 3 (0.86 g, 1 mmol), P (t-Bu) 3 (0.80 g, 4.0 mmol) and sodium tert-butoxide (5.76 g, 60.0 mmol) were added to 150 ml toluene and stirred at 110 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 IA-10 (8.14 g, 수율 78 %)을 얻었다. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give the title compound IA-10 (8.14 g, yield 78%).
1H-NMR: δ 3.98 (s, 1H), 6.67 (d, 1H), 6.85 (t, 1H), 7.14 (t, 1H), 7.49 (m, 5H), 7.86 (d, 2H), 7.97 (d, 1H), 8.43 (d, 1H) 1 H-NMR: δ 3.98 (s, 1H), 6.67 (d, 1H), 6.85 (t, 1H), 7.14 (t, 1H), 7.49 (m, 5H), 7.86 (d, 2H), 7.97 ( d, 1H), 8.43 (d, 1H)
[[ 준비예Preparation 9] 9]
IA-11의 합성Synthesis of IA-11
<단계 1> 2'-(1H-인돌-2-일)-[1,1'-비페닐]-2-올의 합성<Step 1> Synthesis of 2 '-(1H-indol-2-yl)-[1,1'-biphenyl] -2-ol
Figure PCTKR2015014035-appb-I000069
Figure PCTKR2015014035-appb-I000069
질소 기류 하에서 2-브로모-1H-인돌 (9.80 g, 50.0 mmol), 2'-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)-[1,1'-비페닐]-2-올 (14.8 g, 50.0 mmol), K2CO3 (13.8 g, 100.0 mmol) 및 1,4-디옥산/H2O (120 ml/40 ml)를 혼합한 다음, Pd(PPh3)4 (2.88 g, 5 mol%)를 넣고 120℃에서 12시간 동안 교반하였다.2-bromo-1H-indole (9.80 g, 50.0 mmol), 2 '-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) under nitrogen stream -[1,1'-biphenyl] -2-ol (14.8 g, 50.0 mmol), K 2 CO 3 (13.8 g, 100.0 mmol) and 1,4-dioxane / H 2 O (120 ml / 40 ml ) And then Pd (PPh 3 ) 4 (2.88 g, 5 mol%) was added and stirred at 120 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피로 정제하여 2'-(1H-인돌-2-일)-[1,1'-비페닐]-2-올 (10.4 g, 수율 73%)을 얻었다.After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography to obtain 2 '-(1H-indol-2-yl)-[1,1'-biphenyl] -2-ol (10.4 g, 73% yield).
1H-NMR: δ 5.34 (s, 1H), 6.75 (s, 1H), 7.03 (m, 4H), 7.22 (t, 1H), 7.55 (m, 5H), 7.86 (d, 2H) 1 H-NMR: δ 5.34 (s, 1H), 6.75 (s, 1H), 7.03 (m, 4H), 7.22 (t, 1H), 7.55 (m, 5H), 7.86 (d, 2H)
<단계 2> 2'-(3-<Step 2> 2 '-(3- 아이오도Iodo -1H-인돌-2-일)-[1,1'-비페닐]-2-올의 합성Synthesis of -1H-indol-2-yl)-[1,1'-biphenyl] -2-ol
Figure PCTKR2015014035-appb-I000070
Figure PCTKR2015014035-appb-I000070
2'-(1H-인돌-2-일)-[1,1'-비페닐]-2-올 (5.70 g, 20.0 mmol)와 KOH(2.81 g, 50.0 mmol)를 80ml DMF에 녹인 후 상온에서 20분 동안 교반하였다. DMF에 녹인 I2 (5.07 g, 20.0 mmol)를 첨가한 후 1시간 동안 교반하였다. 2 '-(1H-indol-2-yl)-[1,1'-biphenyl] -2-ol (5.70 g, 20.0 mmol) and KOH (2.81 g, 50.0 mmol) were dissolved in 80 ml DMF at room temperature. Stir for 20 minutes. I 2 (5.07 g, 20.0 mmol) dissolved in DMF was added and stirred for 1 hour.
반응 종결 후 얼음물을 넣고 고체를 추출한다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 2'-(3-아이오도-1H-인돌-2-일)-[1,1'-비페닐]-2-올 (7.57 g, 수율 92 %)을 얻었다. After completion of the reaction, ice water is added and the solid is extracted. After removing the solvent of the filtered organic layer using column chromatography to give the target compound 2 '-(3-iodo-1H-indol-2-yl)-[1,1'-biphenyl] -2-ol (7.57 g, yield 92%).
1H-NMR: δ 5.33 (s, 1H), 7.03 (m, 4H), 7.23 (t, 1H), 7.45 (t, 2H), 7.66 (d, 2H), 7.92 (d, 3H), 11.2 (s, 1H) 1 H-NMR: δ 5.33 (s, 1H), 7.03 (m, 4H), 7.23 (t, 1H), 7.45 (t, 2H), 7.66 (d, 2H), 7.92 (d, 3H), 11.2 ( s, 1 H)
<단계 3> IA-11의 합성Step 3 Synthesis of IA-11
Figure PCTKR2015014035-appb-I000071
Figure PCTKR2015014035-appb-I000071
2'-(3-아이오도-1H-인돌-2-일)-[1,1'-비페닐]-2-올 (16.4 g, 40.0 mmol) 및 Pd2(dba)3 (0.86 g, 1 mmol), P(t-Bu)3 (0.80 g, 4.0 mmol), 소듐 tert-부톡사이드 (5.76 g, 60.0 mmol) 을 150 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다.2 '-(3-iodo-1H-indol-2-yl)-[1,1'-biphenyl] -2-ol (16.4 g, 40.0 mmol) and Pd 2 (dba) 3 (0.86 g, 1 mmol), P (t-Bu) 3 (0.80 g, 4.0 mmol) and sodium tert-butoxide (5.76 g, 60.0 mmol) were added to 150 ml toluene and stirred at 110 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 IA-11 (7.14 g, 수율 63 %)을 얻었다. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the organic layer was filtered and purified by column chromatography to give the title compound IA-11 (7.14 g, 63% yield).
1H-NMR: δ 7.03 (m, 4H), 7.23 (t, 1H), 7.45 (t, 2H), 7.65 (d, 2H), 7.88 (d, 3H), 11.2 (s, 1H) 1 H-NMR: δ 7.03 (m, 4H), 7.23 (t, 1H), 7.45 (t, 2H), 7.65 (d, 2H), 7.88 (d, 3H), 11.2 (s, 1H)
[[ 준비예Preparation 10] 10]
IA-12의 합성Synthesis of IA-12
<단계 1> 2'-(1H-인돌-2-일)-[1,1'-비페닐]-2-<Step 1> 2 '-(1H-indol-2-yl)-[1,1'-biphenyl] -2- 티올의Thiol 합성 synthesis
Figure PCTKR2015014035-appb-I000072
Figure PCTKR2015014035-appb-I000072
질소 기류 하에서 2-브로모-1H-인돌 (9.80 g, 50.0 mmol), 2'-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)-[1,1'-비페닐]-2-티올 (19.5 g, 50.0 mmol), K2CO3 (13.8 g, 100.0 mmol) 및 1,4-디옥산/H2O (120 ml/40 ml)를 혼합한 다음, Pd(PPh3)4 (2.88 g, 5 mol%)를 넣고 120℃에서 12시간 동안 교반하였다. 2-bromo-1H-indole (9.80 g, 50.0 mmol), 2 '-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) under nitrogen stream -[1,1'-biphenyl] -2-thiol (19.5 g, 50.0 mmol), K 2 CO 3 (13.8 g, 100.0 mmol) and 1,4-dioxane / H 2 O (120 ml / 40 ml ) And then Pd (PPh 3 ) 4 (2.88 g, 5 mol%) was added and stirred at 120 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피로 정제하여 2'-(1H-인돌-2-일)-[1,1'-비페닐]-2-티올 (11.3 g, 수율 75%)을 얻었다.After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. The solvent was removed from the organic layer and purified by column chromatography to obtain 2 '-(1H-indol-2-yl)-[1,1'-biphenyl] -2-thiol (11.3 g, yield 75%).
1H-NMR: δ 3.38 (s, 1H), 6.75 (d, 1H), 6.93 (t, 2H), 7.27 (t, 2H), 7.53 (m, 6H), 7.86 (d, 2H), 11.31 (s, 1H) 1 H-NMR: δ 3.38 (s, 1H), 6.75 (d, 1H), 6.93 (t, 2H), 7.27 (t, 2H), 7.53 (m, 6H), 7.86 (d, 2H), 11.31 ( s, 1 H)
<단계 2> 2'-(3-<Step 2> 2 '-(3- 아이오도Iodo -1H-인돌-2-일)-[1,1'-비페닐]-2--1H-indol-2-yl)-[1,1'-biphenyl] -2- 티올의Thiol 합성 synthesis
Figure PCTKR2015014035-appb-I000073
Figure PCTKR2015014035-appb-I000073
2'-(1H-인돌-2-일)-[1,1'-비페닐]-2-티올 (6.02 g, 20.0 mmol)와 KOH(2.81 g, 50.0 mmol)를 80ml DMF에 녹인 후 상온에서 20분 동안 교반하였다. DMF에 녹인 I2 (5.07 g, 20.0 mmol)를 첨가한 후 1시간 동안 교반하였다. 2 '-(1H-indol-2-yl)-[1,1'-biphenyl] -2-thiol (6.02 g, 20.0 mmol) and KOH (2.81 g, 50.0 mmol) were dissolved in 80 ml DMF at room temperature. Stir for 20 minutes. I 2 (5.07 g, 20.0 mmol) dissolved in DMF was added and stirred for 1 hour.
반응 종결 후 얼음물을 넣고 고체를 추출한다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 2'-(3-아이오도-1H-인돌-2-일)-[1,1'-비페닐]-2-티올 (8.03 g, 수율 94 %)을 얻었다. After completion of the reaction, ice water is added and the solid is extracted. The solvent of the filtered organic layer was removed, and then column chromatography was performed to obtain 2 '-(3-iodo-1H-indol-2-yl)-[1,1'-biphenyl] -2-thiol (8.03). g, yield 94%).
1H-NMR: δ 3.38 (s, 1H), 6.95 (t, 2H), 7.27 (t, 2H), 7.46 (m, 3H), 7.65 (d, 2H), 7.92 (d, 3H), 11.2 (s, 1H) 1 H-NMR: δ 3.38 (s, 1H), 6.95 (t, 2H), 7.27 (t, 2H), 7.46 (m, 3H), 7.65 (d, 2H), 7.92 (d, 3H), 11.2 ( s, 1 H)
<단계 3> IA-12의 합성Step 3 Synthesis of IA-12
Figure PCTKR2015014035-appb-I000074
Figure PCTKR2015014035-appb-I000074
2'-(3-아이오도-1H-인돌-2-일)-[1,1'-비페닐]-2-티올 (17.1 g, 40.0 mmol) 및 Pd2(dba)3 (0.86 g, 1 mmol), P(t-Bu)3 (0.80 g, 4.0 mmol), 소듐 tert-부톡사이드 (5.76 g, 60.0 mmol) 을 150 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다.2 '-(3-iodo-1H-indol-2-yl)-[1,1'-biphenyl] -2-thiol (17.1 g, 40.0 mmol) and Pd 2 (dba) 3 (0.86 g, 1 mmol), P (t-Bu) 3 (0.80 g, 4.0 mmol) and sodium tert-butoxide (5.76 g, 60.0 mmol) were added to 150 ml toluene and stirred at 110 ° C. for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 IA-12 (7.42 g, 수율 62 %)을 얻었다. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give the title compound IA-12 (7.42 g, yield 62%).
1H-NMR: δ 6.95 (t, 2H), 7.27 (t, 2H), 7.46 (m, 3H), 7.65 (d, 2H), 7.89 (d, 3H), 11.4 (s, 1H) 1 H-NMR: δ 6.95 (t, 2H), 7.27 (t, 2H), 7.46 (m, 3H), 7.65 (d, 2H), 7.89 (d, 3H), 11.4 (s, 1H)
[[ 합성예Synthesis Example 1] One]
A-14의 합성Synthesis of A-14
Figure PCTKR2015014035-appb-I000075
Figure PCTKR2015014035-appb-I000075
IA-1 (3.58 g, 10.00 mmol), 2-클로로-4,6-디페닐-1,3,5-트리아진 (2.68 g, 10.00 mmol), Pd2(dba)3 (0.46 g, 0.5 mmol), P(t-Bu)3 (0.40 g, 2.0 mmol), 소듐 tert-부톡사이드 (2.88 g, 30.0 mmol) 을 50 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-14 (4.95 g, 수율 84 %)을 얻었다.IA-1 (3.58 g, 10.00 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (2.68 g, 10.00 mmol), Pd 2 (dba) 3 (0.46 g, 0.5 mmol ), P (t-Bu) 3 (0.40 g, 2.0 mmol) and sodium tert-butoxide (2.88 g, 30.0 mmol) were added to 50 ml toluene and stirred at 110 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give the title compound A-14 (4.95 g, 84% yield).
MS [M+1]+ 590MS [M + 1] + 590
[[ 합성예Synthesis Example 2] 2]
A-16의 합성Synthesis of A-16
Figure PCTKR2015014035-appb-I000076
Figure PCTKR2015014035-appb-I000076
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 4-클로로-2,6-디페닐피리미딘 (2.67 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 방법을 수행하여 목적 화합물 A-16 (4.82 g, 수율 82 %)을 얻었다. Synthesis Example 1 except that 4-chloro-2,6-diphenylpyrimidine (2.67 g, 10.00 mmol) was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. The same method was followed to obtain the target compound A-16 (4.82 g, yield 82%).
MS [M+1]+ 589MS [M + 1] + 589
[[ 합성예Synthesis Example 3] 3]
A-17의 합성Synthesis of A-17
Figure PCTKR2015014035-appb-I000077
Figure PCTKR2015014035-appb-I000077
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-(3-클로로페닐)-4,6-디페닐-1,3,5-트리아진 (3.44 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 방법을 수행하여 목적 화합물 A-17 (5.65 g, 수율 85 %)을 얻었다. 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (3.44 g, 10.00 mmol instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound A-17 (5.65 g, Yield 85%) was obtained in the same manner as in Synthesis example 1 except that was used.
MS [M+1]+ 666MS [M + 1] + 666
[[ 합성예Synthesis Example 4] 4]
A-19의 합성Synthesis of A-19
Figure PCTKR2015014035-appb-I000078
Figure PCTKR2015014035-appb-I000078
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 4-(3-클로로페닐)-2,6-디페닐피리미딘 (3.43 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 방법을 수행하여 목적 화합물 A-19 (5.31 g, 수율 80 %)을 얻었다. Except for using 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (3.43 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine Was prepared in the same manner as in Synthesis example 1 to obtain the title compound A-19 (5.31 g, yield 80%).
MS [M+1]+ 665MS [M + 1] + 665
[[ 합성예Synthesis Example 5] 5]
A-26의 합성Synthesis of A-26
Figure PCTKR2015014035-appb-I000079
Figure PCTKR2015014035-appb-I000079
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4-브로모페닐)-[1,1'-비페닐]-4-아민 (4.76 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 방법을 수행하여 목적 화합물 A-26 (5.65 g, 수율 75%)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4-bromophenyl)-[1 instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound A-26 (5.65 g, yield 75%) was obtained by the same method as Synthesis Example 1, except that 1, -biphenyl] -4-amine (4.76 g, 10.00 mmol) was used.
MS [M+1]+ 754MS [M + 1] + 754
[[ 합성예Synthesis Example 6] 6]
A-41의 합성Synthesis of A-41
Figure PCTKR2015014035-appb-I000080
Figure PCTKR2015014035-appb-I000080
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-페닐퀴나졸린 (2.85 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 방법을 수행하여 목적 화합물 A-41 (4.38 g, 수율 78 %)을 얻었다. Same method as in Synthesis Example 1, except using 2-bromo-4-phenylquinazolin (2.85 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine This carried out the title compound A-41 (4.38 g, yield 78%).
MS [M+1]+ 563MS [M + 1] + 563
[[ 합성예Synthesis Example 7] 7]
A-53의 합성Synthesis of A-53
Figure PCTKR2015014035-appb-I000081
Figure PCTKR2015014035-appb-I000081
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 8-(4-브로모페닐)퀴놀린 (2.84 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 방법을 수행하여 목적 화합물 A-53 (4.26 g, 수율 76 %)을 얻었다. Same method as in Synthesis Example 1, except using 8- (4-bromophenyl) quinoline (2.84 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine This carried out the title compound A-53 (4.26 g, yield 76%).
MS [M+1]+ 562MS [M + 1] + 562
[[ 합성예Synthesis Example 8] 8]
A-59의 합성Synthesis of A-59
Figure PCTKR2015014035-appb-I000082
Figure PCTKR2015014035-appb-I000082
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-(4-(나프탈렌-1-일)페닐)퀴나졸린 (4.11 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 방법을 수행하여 목적 화합물 A-59 (5.51 g, 수율 80 %)을 얻었다. Use 2-bromo-4- (4- (naphthalen-1-yl) phenyl) quinazolin (4.11 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound A-59 (5.51 g, yield 80%) was obtained in the same manner as in Synthesis example 1 except for the following.
MS [M+1]+ 689MS [M + 1] + 689
[[ 합성예Synthesis Example 9] 9]
A-64의 합성Synthesis of A-64
Figure PCTKR2015014035-appb-I000083
Figure PCTKR2015014035-appb-I000083
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4'-브로모-[1,1'-비페닐]-4-일)-9,9-디메틸-9H-플루오렌-2-아민 (5.93 g, 10.00mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 방법을 수행하여 목적 화합물 A-64 (6.78 g, 수율 78 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4'-bromo- [1, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The same procedure as in Synthesis Example 1 was carried out except that 1'-biphenyl] -4-yl) -9,9-dimethyl-9H-fluoren-2-amine (5.93 g, 10.00 mmol) was used. Compound A-64 (6.78 g, yield 78%) was obtained.
MS [M+1]+ 871MS [M + 1] + 871
[[ 합성예Synthesis Example 10] 10]
B-14의 합성Synthesis of B-14
Figure PCTKR2015014035-appb-I000084
Figure PCTKR2015014035-appb-I000084
IA-2 (3.58 g, 10.00 mmol), 2-클로로-4,6-디페닐-1,3,5-트리아진 (2.68 g, 10.00 mmol), Pd2(dba)3 (0.46 g, 0.5 mmol), P(t-Bu)3 (0.40 g, 2.0 mmol), 소듐 tert-부톡사이드 (2.88 g, 30.0 mmol) 을 50 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 B-14 (5.07 g, 수율 86 %)을 얻었다. IA-2 (3.58 g, 10.00 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (2.68 g, 10.00 mmol), Pd 2 (dba) 3 (0.46 g, 0.5 mmol ), P (t-Bu) 3 (0.40 g, 2.0 mmol) and sodium tert-butoxide (2.88 g, 30.0 mmol) were added to 50 ml toluene and stirred at 110 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give the title compound B-14 (5.07 g, yield 86%).
MS [M+1]+ 590MS [M + 1] + 590
[[ 합성예Synthesis Example 11] 11]
B-16의 합성Synthesis of B-16
Figure PCTKR2015014035-appb-I000085
Figure PCTKR2015014035-appb-I000085
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 4-클로로-2,6-디페닐피리미딘 (2.67 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 10과 동일한 방법을 수행하여 목적 화합물 B-16 (5.07 g, 수율 84 %)을 얻었다. Synthesis Example 10, except that 4-chloro-2,6-diphenylpyrimidine (2.67 g, 10.00 mmol) was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. The same method was followed to obtain the target compound B-16 (5.07 g, yield 84%).
MS [M+1]+ 589MS [M + 1] + 589
[[ 합성예Synthesis Example 12] 12]
B-17의 합성Synthesis of B-17
Figure PCTKR2015014035-appb-I000086
Figure PCTKR2015014035-appb-I000086
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-(3-클로로페닐)-4,6-디페닐-1,3,5-트리아진 (3.44 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 10과 동일한 방법을 수행하여 목적 화합물 B-17 (5.79 g, 수율 87 %)을 얻었다. 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (3.44 g, 10.00 mmol instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound B-17 (5.79 g, yield 87%) was obtained in the same manner as in Synthesis example 10 except for using a).
MS [M+1]+ 666MS [M + 1] + 666
[[ 합성예Synthesis Example 13] 13]
B-19의 합성Synthesis of B-19
Figure PCTKR2015014035-appb-I000087
Figure PCTKR2015014035-appb-I000087
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 4-(3-클로로페닐)-2,6-디페닐피리미딘 (3.43 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 10과 동일한 방법을 수행하여 목적 화합물 B-19 (5.45 g, 수율 82 %)을 얻었다. Except for using 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (3.43 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine Was prepared in the same manner as in Synthesis Example 10 to obtain the title compound B-19 (5.45 g, yield 82%).
MS [M+1]+ 665MS [M + 1] + 665
[[ 합성예Synthesis Example 14] 14]
B-26의 합성Synthesis of B-26
Figure PCTKR2015014035-appb-I000088
Figure PCTKR2015014035-appb-I000088
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4-브로모페닐)-[1,1'-비페닐]-4-아민 (4.76 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 10과 동일한 방법을 수행하여 목적 화합물 B-26 (5.80 g, 수율 77 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4-bromophenyl)-[1 instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound B-26 (5.80 g, yield 77%) was obtained by the same method as Synthesis Example 10, except using, 1'-biphenyl] -4-amine (4.76 g, 10.00 mmol).
MS [M+1]+ 754MS [M + 1] + 754
[[ 합성예Synthesis Example 15] 15]
B-41의 합성Synthesis of B-41
Figure PCTKR2015014035-appb-I000089
Figure PCTKR2015014035-appb-I000089
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-페닐퀴나졸린 (2.85 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 10과 동일한 방법을 수행하여 목적 화합물 B-41 (4.50 g, 수율 80 %)을 얻었다. The same method as in Synthesis Example 10 except for using 2-bromo-4-phenylquinazolin (2.85 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. The obtained compound B-41 (4.50 g, yield 80%) was obtained.
MS [M+1]+ 563MS [M + 1] + 563
[[ 합성예Synthesis Example 16] 16]
B-53의 합성Synthesis of B-53
Figure PCTKR2015014035-appb-I000090
Figure PCTKR2015014035-appb-I000090
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 8-(4-브로모페닐)퀴놀린 (2.84 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 10과 동일한 방법을 수행하여 목적 화합물 B-53 (4.38 g, 수율 78 %)을 얻었다. Same method as in Synthesis Example 10, except that 8- (4-bromophenyl) quinoline (2.84 g, 10.00 mmol) was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine This carried out the title compound B-53 (4.38 g, yield 78%).
MS [M+1]+ 562MS [M + 1] + 562
[[ 합성예Synthesis Example 17] 17]
B-59의 합성Synthesis of B-59
Figure PCTKR2015014035-appb-I000091
Figure PCTKR2015014035-appb-I000091
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-(4-(나프탈렌-1-일)페닐)퀴나졸린 (4.11 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 10과 동일한 방법을 수행하여 목적 화합물 B-59 (5.64 g, 수율 82 %)을 얻었다. Use 2-bromo-4- (4- (naphthalen-1-yl) phenyl) quinazolin (4.11 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound B-59 (5.64 g, Yield 82%) was obtained in the same manner as in Synthesis Example 10 except for the following procedure.
MS [M+1]+ 689MS [M + 1] + 689
[[ 합성예Synthesis Example 18] 18]
B-64의 합성Synthesis of B-64
Figure PCTKR2015014035-appb-I000092
Figure PCTKR2015014035-appb-I000092
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4'-브로모-[1,1'-비페닐]-4-일)-9,9-디메틸-9H-플루오렌-2-아민 (5.93 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 10과 동일한 방법을 수행하여 목적 화합물 B-64 (6.96 g, 수율 80 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4'-bromo- [1, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The same procedure as in Synthesis Example 10 was carried out except that 1'-biphenyl] -4-yl) -9,9-dimethyl-9H-fluoren-2-amine (5.93 g, 10.00 mmol) was used. Compound B-64 (6.96 g, yield 80%) was obtained.
MS [M+1]+ 871MS [M + 1] + 871
[[ 합성예Synthesis Example 19] 19]
C-14의 합성Synthesis of C-14
Figure PCTKR2015014035-appb-I000093
Figure PCTKR2015014035-appb-I000093
IA-3 (3.58 g, 10.00 mmol), 2-클로로-4,6-디페닐-1,3,5-트리아진 (2.68 g, 10.00 mmol), Pd2(dba)3 (0.46 g, 0.5 mmol), P(t-Bu)3 (0.40 g, 2.0 mmol), 소듐 tert-부톡사이드 (2.88 g, 30.0 mmol) 을 50 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 C-14 (4.59g, 수율 78 %)을 얻었다. IA-3 (3.58 g, 10.00 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (2.68 g, 10.00 mmol), Pd 2 (dba) 3 (0.46 g, 0.5 mmol ), P (t-Bu) 3 (0.40 g, 2.0 mmol) and sodium tert-butoxide (2.88 g, 30.0 mmol) were added to 50 ml toluene and stirred at 110 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the organic layer was filtered and purified by column chromatography to give the title compound C-14 (4.59g, 78% yield).
MS [M+1]+ 590MS [M + 1] + 590
[[ 합성예Synthesis Example 20] 20]
C-16의 합성Synthesis of C-16
Figure PCTKR2015014035-appb-I000094
Figure PCTKR2015014035-appb-I000094
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 4-클로로-2,6-디페닐피리미딘 (2.67 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 19과 동일한 방법을 수행하여 목적 화합물 C-16 (4.41 g, 수율 75 %)을 얻었다. Synthesis Example 19, except that 4-chloro-2,6-diphenylpyrimidine (2.67 g, 10.00 mmol) was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. The same method was followed to obtain the target compound C-16 (4.41 g, yield 75%).
MS [M+1]+ 589MS [M + 1] + 589
[[ 합성예Synthesis Example 21] 21]
C-17의 합성Synthesis of C-17
Figure PCTKR2015014035-appb-I000095
Figure PCTKR2015014035-appb-I000095
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-(3-클로로페닐)-4,6-디페닐-1,3,5-트리아진 (3.44 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 19과 동일한 방법을 수행하여 목적 화합물 C-17 (5.32 g, 수율 80 %)을 얻었다. 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (3.44 g, 10.00 mmol instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound C-17 (5.32 g, Yield 80%) was obtained in the same manner as in Synthesis example 19 except for using).
MS [M+1]+ 666MS [M + 1] + 666
[[ 합성예Synthesis Example 22] 22]
C-19의 합성Synthesis of C-19
Figure PCTKR2015014035-appb-I000096
Figure PCTKR2015014035-appb-I000096
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 4-(3-클로로페닐)-2,6-디페닐피리미딘 (3.43 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 19과 동일한 방법을 수행하여 목적 화합물 C-19 (4.85 g, 수율 73 %)을 얻었다. Except for using 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (3.43 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine Was prepared in the same manner as in Synthesis Example 19 to obtain the title compound C-19 (4.85 g, yield 73%).
MS [M+1]+ 679MS [M + 1] + 679
[[ 합성예Synthesis Example 23] 23]
C-26의 합성Synthesis of C-26
Figure PCTKR2015014035-appb-I000097
Figure PCTKR2015014035-appb-I000097
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4-브로모페닐)-[1,1'-비페닐]-4-아민 (4.76 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 19과 동일한 방법을 수행하여 목적 화합물 C-26 (5.12 g, 수율 68 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4-bromophenyl)-[1 instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound C-26 (5.12 g, 68% yield) was obtained by the same method as Synthesis Example 19 except for using, 1'-biphenyl] -4-amine (4.76 g, 10.00 mmol).
MS [M+1]+ 665MS [M + 1] + 665
[[ 합성예Synthesis Example 24] 24]
C-41의 합성Synthesis of C-41
Figure PCTKR2015014035-appb-I000098
Figure PCTKR2015014035-appb-I000098
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-페닐퀴나졸린 (2.85 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 19과 동일한 방법을 수행하여 목적 화합물 C-41 (3.93 g, 수율 70 %)을 얻었다. The same method as in Synthesis Example 19, except that 2-bromo-4-phenylquinazolin (2.85 g, 10.00 mmol) was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. The desired compound C-41 (3.93 g, yield 70%) was obtained.
MS [M+1]+ 754MS [M + 1] + 754
[[ 합성예Synthesis Example 25] 25]
C-53의 합성Synthesis of C-53
Figure PCTKR2015014035-appb-I000099
Figure PCTKR2015014035-appb-I000099
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 8-(4-브로모페닐)퀴놀린 (2.84 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 19과 동일한 방법을 수행하여 목적 화합물 C-53 (3.65 g, 수율 65 %)을 얻었다. Same method as in Synthesis Example 19, except using 8- (4-bromophenyl) quinoline (2.84 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine This carried out the title compound C-53 (3.65 g, yield 65%).
MS [M+1]+ 602MS [M + 1] + 602
[[ 합성예Synthesis Example 26] 26]
C-59의 합성Synthesis of C-59
Figure PCTKR2015014035-appb-I000100
Figure PCTKR2015014035-appb-I000100
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-(4-(나프탈렌-1-일)페닐)퀴나졸린 (4.11 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 19과 동일한 방법을 수행하여 목적 화합물 C-59 (4.94 g, 수율 72 %)을 얻었다. Use 2-bromo-4- (4- (naphthalen-1-yl) phenyl) quinazolin (4.11 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound C-59 (4.94 g, Yield 72%) was obtained in the same manner as in Synthesis example 19 except for the following.
MS [M+1]+ 563MS [M + 1] + 563
[[ 합성예Synthesis Example 27] 27]
C-64의 합성Synthesis of C-64
Figure PCTKR2015014035-appb-I000101
Figure PCTKR2015014035-appb-I000101
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4'-브로모-[1,1'-비페닐]-4-일)-9,9-디메틸-9H-플루오렌-2-아민 (5.93 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 19과 동일한 방법을 수행하여 목적 화합물 C-64 (6.17 g, 수율 71 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4'-bromo- [1, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The same procedure as in Synthesis Example 19 was carried out except that 1'-biphenyl] -4-yl) -9,9-dimethyl-9H-fluoren-2-amine (5.93 g, 10.00 mmol) was used. Compound C-64 (6.17 g, yield 71%) was obtained.
MS [M+1]+ 562MS [M + 1] + 562
[[ 합성예Synthesis Example 28] 28]
D-14의 합성Synthesis of D-14
Figure PCTKR2015014035-appb-I000102
Figure PCTKR2015014035-appb-I000102
IA-4 (3.58 g, 10.00 mmol), 2-클로로-4,6-디페닐-1,3,5-트리아진 (2.68 g, 10.00 mmol), Pd2(dba)3 (0.46 g, 0.5 mmol), P(t-Bu)3 (0.40 g, 2.0 mmol), 소듐 tert-부톡사이드 (2.88 g, 30.0 mmol)을 50 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 D-14 (4.83 g, 수율 82 %)을 얻었다. IA-4 (3.58 g, 10.00 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (2.68 g, 10.00 mmol), Pd 2 (dba) 3 (0.46 g, 0.5 mmol ), P (t-Bu) 3 (0.40 g, 2.0 mmol) and sodium tert-butoxide (2.88 g, 30.0 mmol) were added to 50 ml toluene and stirred at 110 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give the title compound D-14 (4.83 g, yield 82%).
MS [M+1]+ 590MS [M + 1] + 590
[[ 합성예Synthesis Example 29] 29]
D-16의 합성Synthesis of D-16
Figure PCTKR2015014035-appb-I000103
Figure PCTKR2015014035-appb-I000103
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 4-클로로-2,6-디페닐피리미딘 (2.67 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 28과 동일한 방법을 수행하여 목적 화합물 D-16 (4.65 g, 수율 79 %)을 얻었다. Synthesis Example 28, except that 4-chloro-2,6-diphenylpyrimidine (2.67 g, 10.00 mmol) was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The same method was followed to obtain the target compound D-16 (4.65 g, yield 79%).
MS [M+1]+ 589MS [M + 1] + 589
[[ 합성예Synthesis Example 30] 30]
D-17의 합성Synthesis of D-17
Figure PCTKR2015014035-appb-I000104
Figure PCTKR2015014035-appb-I000104
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-(3-클로로페닐)-4,6-디페닐-1,3,5-트리아진 (3.44 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 28과 동일한 방법을 수행하여 목적 화합물 D-17 (5.59 g, 수율 84 %)을 얻었다. 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (3.44 g, 10.00 mmol instead of 2-chloro-4,6-diphenyl-1,3,5-triazine Except for using), the same method as in Synthesis Example 28 was carried out to obtain the target compound D-17 (5.59 g, yield 84%).
MS [M+1]+ 666MS [M + 1] + 666
[[ 합성예Synthesis Example 31] 31]
D-19의 합성Synthesis of D-19
Figure PCTKR2015014035-appb-I000105
Figure PCTKR2015014035-appb-I000105
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 4-(3-클로로페닐)-2,6-디페닐피리미딘 (3.43 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 28과 동일한 방법을 수행하여 목적 화합물 D-19 (5.65 g, 수율 85 %)을 얻었다. Except for using 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (3.43 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine Was prepared in the same manner as in Synthesis Example 28 to obtain the title compound D-19 (5.65 g, 85% yield).
MS [M+1]+ 665MS [M + 1] + 665
[[ 합성예Synthesis Example 32] 32]
D-26의 합성Synthesis of D-26
Figure PCTKR2015014035-appb-I000106
Figure PCTKR2015014035-appb-I000106
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4-브로모페닐)-[1,1'-비페닐]-4-아민 (4.76 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 28과 동일한 방법을 수행하여 목적 화합물 D-26 (5.72 g, 수율 76 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4-bromophenyl)-[1 instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound D-26 (5.72 g, yield 76%) was obtained by the same method as Synthesis Example 28 except for using, 1'-biphenyl] -4-amine (4.76 g, 10.00 mmol).
MS [M+1]+ 754MS [M + 1] + 754
[[ 합성예Synthesis Example 33] 33]
D-41의 합성Synthesis of D-41
Figure PCTKR2015014035-appb-I000107
Figure PCTKR2015014035-appb-I000107
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-페닐퀴나졸린 (2.85 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 28과 동일한 방법을 수행하여 목적 화합물 D-41 (4.50 g, 수율 80 %)을 얻었다. The same method as in Synthesis 28, except that 2-bromo-4-phenylquinazolin (2.85 g, 10.00 mmol) was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. The desired compound D-41 (4.50 g, yield 80%) was obtained.
MS [M+1]+ 563MS [M + 1] + 563
[[ 합성예Synthesis Example 34] 34]
D-53의 합성Synthesis of D-53
Figure PCTKR2015014035-appb-I000108
Figure PCTKR2015014035-appb-I000108
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 8-(4-브로모페닐)퀴놀린 (2.84 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 28과 동일한 방법을 수행하여 목적 화합물 D-53 (4.21 g, 수율 75 %)을 얻었다. Same method as in Synthesis Example 28, except using 8- (4-bromophenyl) quinoline (2.84 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine This carried out the title compound D-53 (4.21 g, yield 75%).
MS [M+1]+ 562MS [M + 1] + 562
[[ 합성예Synthesis Example 35] 35]
D-59의 합성Synthesis of D-59
Figure PCTKR2015014035-appb-I000109
Figure PCTKR2015014035-appb-I000109
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-(4-(나프탈렌-1-일)페닐)퀴나졸린 (4.11 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 28과 동일한 방법을 수행하여 목적 화합물 D-59 (5.64 g, 수율 82 %)을 얻었다. Use 2-bromo-4- (4- (naphthalen-1-yl) phenyl) quinazolin (4.11 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound D-59 (5.64 g, Yield 82%) was obtained in the same manner as in Synthesis Example 28 except for the following procedure.
MS [M+1]+ 689MS [M + 1] + 689
[[ 합성예Synthesis Example 36] 36]
D-64의 합성Synthesis of D-64
Figure PCTKR2015014035-appb-I000110
Figure PCTKR2015014035-appb-I000110
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4'-브로모-[1,1'-비페닐]-4-일)-9,9-디메틸-9H-플루오렌-2-아민 (5.93 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 28과 동일한 방법을 수행하여 목적 화합물 D-64 (6.26 g, 수율 72 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4'-bromo- [1, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The same procedure as in Synthesis Example 28 was carried out except that 1'-biphenyl] -4-yl) -9,9-dimethyl-9H-fluoren-2-amine (5.93 g, 10.00 mmol) was used. Compound D-64 (6.26 g, yield 72%) was obtained.
MS [M+1]+ 871MS [M + 1] + 871
[[ 합성예Synthesis Example 37] 37]
E-14의 합성Synthesis of E-14
Figure PCTKR2015014035-appb-I000111
Figure PCTKR2015014035-appb-I000111
IA-5 (2.83 g, 10.00 mmol), 2-클로로-4,6-디페닐-1,3,5-트리아진 (2.68 g, 10.00 mmol), Pd2(dba)3 (0.46 g, 0.5 mmol), P(t-Bu)3 (0.40 g, 2.0 mmol), 소듐 tert-부톡사이드 (2.88 g, 30.0 mmol) 을 50 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 E-14 (3.60 g, 수율 70 %)을 얻었다. IA-5 (2.83 g, 10.00 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (2.68 g, 10.00 mmol), Pd 2 (dba) 3 (0.46 g, 0.5 mmol ), P (t-Bu) 3 (0.40 g, 2.0 mmol) and sodium tert-butoxide (2.88 g, 30.0 mmol) were added to 50 ml toluene and stirred at 110 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give the title compound E-14 (3.60 g, 70% yield).
MS [M+1]+ 515MS [M + 1] + 515
[[ 합성예Synthesis Example 38] 38]
E-17의 합성Synthesis of E-17
Figure PCTKR2015014035-appb-I000112
Figure PCTKR2015014035-appb-I000112
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-(3-클로로페닐)-4,6-디페닐-1,3,5-트리아진 (3.44 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 37과 동일한 방법을 수행하여 목적 화합물 E-17 (4.48 g, 수율 76 %)을 얻었다. 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (3.44 g, 10.00 mmol instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound E-17 (4.48 g, 76% yield) was obtained in the same manner as in Synthesis example 37 except for using a).
MS [M+1]+ 591MS [M + 1] + 591
[[ 합성예Synthesis Example 39] 39]
E-26의 합성Synthesis of E-26
Figure PCTKR2015014035-appb-I000113
Figure PCTKR2015014035-appb-I000113
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4-브로모페닐)-[1,1'-비페닐]-4-아민 (4.76 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 37과 동일한 방법을 수행하여 목적 화합물 E-26 (4.95 g, 수율 73 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4-bromophenyl)-[1 instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound E-26 (4.95 g, 73% yield) was obtained by the same method as Synthesis Example 37, except that 1, -biphenyl] -4-amine (4.76 g, 10.00 mmol) was used.
MS [M+1]+ 679MS [M + 1] + 679
[[ 합성예Synthesis Example 40] 40]
E-41의 합성Synthesis of E-41
Figure PCTKR2015014035-appb-I000114
Figure PCTKR2015014035-appb-I000114
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-페닐퀴나졸린 (2.85 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 37과 동일한 방법을 수행하여 목적 화합물 E-41 (3.31 g, 수율 68 %)을 얻었다. Same method as in Synthesis Example 37, except for using 2-bromo-4-phenylquinazolin (2.85 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine This carried out the title compound E-41 (3.31 g, yield 68%).
MS [M+1]+ 488MS [M + 1] + 488
[[ 합성예Synthesis Example 41] 41]
E-53의 합성Synthesis of E-53
Figure PCTKR2015014035-appb-I000115
Figure PCTKR2015014035-appb-I000115
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 8-(4-브로모페닐)퀴놀린 (2.84 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 37과 동일한 방법을 수행하여 목적 화합물 E-53 (3.64 g, 수율 75 %)을 얻었다. The same method as in Synthesis Example 37 except for using 8- (4-bromophenyl) quinoline (2.84 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. The obtained compound E-53 (3.64 g, yield 75%) was obtained.
MS [M+1]+ 487MS [M + 1] + 487
[[ 합성예Synthesis Example 42] 42]
E-64의 합성Synthesis of E-64
Figure PCTKR2015014035-appb-I000116
Figure PCTKR2015014035-appb-I000116
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4'-브로모-[1,1'-비페닐]-4-일)-9,9-디메틸-9H-플루오렌-2-아민 (5.93 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 37과 동일한 방법을 수행하여 목적 화합물 E-64 (5.72 g, 수율 72 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4'-bromo- [1, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The same procedure as in Synthesis Example 37 was carried out except that 1'-biphenyl] -4-yl) -9,9-dimethyl-9H-fluoren-2-amine (5.93 g, 10.00 mmol) was used. Compound E-64 (5.72 g, Yield 72%) was obtained.
MS [M+1]+ 795MS [M + 1] + 795
[[ 합성예Synthesis Example 43] 43]
F-14의 합성Synthesis of F-14
Figure PCTKR2015014035-appb-I000117
Figure PCTKR2015014035-appb-I000117
IA-6 (2.99 g, 10.00 mmol), 2-클로로-4,6-디페닐-1,3,5-트리아진 (2.68 g, 10.00 mmol), Pd2(dba)3 (0.46 g, 0.5 mmol), P(t-Bu)3 (0.40 g, 2.0 mmol), 소듐 tert-부톡사이드 (2.88 g, 30.0 mmol) 을 50 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 F-14 (3.82 g, 수율 72 %)을 얻었다. IA-6 (2.99 g, 10.00 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (2.68 g, 10.00 mmol), Pd 2 (dba) 3 (0.46 g, 0.5 mmol ), P (t-Bu) 3 (0.40 g, 2.0 mmol) and sodium tert-butoxide (2.88 g, 30.0 mmol) were added to 50 ml toluene and stirred at 110 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer to obtain the target compound F-14 (3.82 g, yield 72%) by column chromatography.
MS [M+1]+ 531MS [M + 1] + 531
[[ 합성예Synthesis Example 44] 44]
F-17의 합성Synthesis of F-17
Figure PCTKR2015014035-appb-I000118
Figure PCTKR2015014035-appb-I000118
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-(3-클로로페닐)-4,6-디페닐-1,3,5-트리아진 (3.44 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 43과 동일한 방법을 수행하여 목적 화합물 F-17 (4.79 g, 수율 79 %)을 얻었다. 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (3.44 g, 10.00 mmol instead of 2-chloro-4,6-diphenyl-1,3,5-triazine Except for using), the same method as in Synthesis Example 43 was carried out to obtain the target compound F-17 (4.79 g, yield 79%).
MS [M+1]+ 607MS [M + 1] + 607
[[ 합성예Synthesis Example 45] 45]
F-26의 합성Synthesis of F-26
Figure PCTKR2015014035-appb-I000119
Figure PCTKR2015014035-appb-I000119
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4-브로모페닐)-[1,1'-비페닐]-4-아민 (4.76 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 43과 동일한 방법을 수행하여 목적 화합물 F-26 (4.86 g, 수율 70 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4-bromophenyl)-[1 instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound F-26 (4.86 g, yield 70%) was obtained in the same manner as in Synthesis Example 43, except that 1, -biphenyl] -4-amine (4.76 g, 10.00 mmol) was used.
MS [M+1]+ 695MS [M + 1] + 695
[[ 합성예Synthesis Example 46] 46]
F-41의 합성Synthesis of F-41
Figure PCTKR2015014035-appb-I000120
Figure PCTKR2015014035-appb-I000120
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-페닐퀴나졸린 (2.85 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 43과 동일한 방법을 수행하여 목적 화합물 F-41 (3.27 g, 수율 65 %)을 얻었다. The same method as in Synthesis 43, except that 2-bromo-4-phenylquinazolin (2.85 g, 10.00 mmol) is used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. This carried out the title compound F-41 (3.27 g, yield 65%).
MS [M+1]+ 504MS [M + 1] + 504
[[ 합성예Synthesis Example 47] 47]
F-53의 합성Synthesis of F-53
Figure PCTKR2015014035-appb-I000121
Figure PCTKR2015014035-appb-I000121
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 8-(4-브로모페닐)퀴놀린 (2.84 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 43과 동일한 방법을 수행하여 목적 화합물 F-53 (3.41 g, 수율 68 %)을 얻었다. Same method as in Synthesis Example 43, except using 8- (4-bromophenyl) quinoline (2.84 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine This carried out the title compound F-53 (3.41 g, yield 68%).
MS [M+1]+ 503MS [M + 1] + 503
[[ 합성예Synthesis Example 48] 48]
F-64의 합성Synthesis of F-64
Figure PCTKR2015014035-appb-I000122
Figure PCTKR2015014035-appb-I000122
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4'-브로모-[1,1'-비페닐]-4-일)-9,9-디메틸-9H-플루오렌-2-아민 (5.93 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 43과 동일한 방법을 수행하여 목적 화합물 F-64 (5.92 g, 수율 73 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4'-bromo- [1, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The same procedure as in Synthesis Example 43 was carried out except that 1'-biphenyl] -4-yl) -9,9-dimethyl-9H-fluoren-2-amine (5.93 g, 10.00 mmol) was used. Compound F-64 (5.92 g, yield 73%) was obtained.
MS [M+1]+ 812MS [M + 1] + 812
[[ 합성예Synthesis Example 49] 49]
G-14의 합성Synthesis of G-14
Figure PCTKR2015014035-appb-I000123
Figure PCTKR2015014035-appb-I000123
IA-7 (2.83 g, 10.00 mmol), 2-클로로-4,6-디페닐-1,3,5-트리아진 (2.68 g, 10.00 mmol), Pd2(dba)3 (0.46 g, 0.5 mmol), P(t-Bu)3 (0.40 g, 2.0 mmol), 소듐 tert-부톡사이드 (2.88 g, 30.0 mmol) 을 50 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 G-14 (3.85 g, 수율 75 %)을 얻었다. IA-7 (2.83 g, 10.00 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (2.68 g, 10.00 mmol), Pd 2 (dba) 3 (0.46 g, 0.5 mmol ), P (t-Bu) 3 (0.40 g, 2.0 mmol) and sodium tert-butoxide (2.88 g, 30.0 mmol) were added to 50 ml toluene and stirred at 110 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give the title compound G-14 (3.85 g, yield 75%).
MS [M+1]+ 515MS [M + 1] + 515
[[ 합성예Synthesis Example 50] 50]
G-17의 합성Synthesis of G-17
Figure PCTKR2015014035-appb-I000124
Figure PCTKR2015014035-appb-I000124
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-(3-클로로페닐)-4,6-디페닐-1,3,5-트리아진 (3.44 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 49과 동일한 방법을 수행하여 목적 화합물 G-17 (4.90 g, 수율 83 %)을 얻었다. 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (3.44 g, 10.00 mmol instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound G-17 (4.90 g, Yield 83%) was obtained in the same manner as in Synthesis Example 49 except for using a).
MS [M+1]+ 591MS [M + 1] + 591
[[ 합성예Synthesis Example 51] 51]
G-26의 합성Synthesis of G-26
Figure PCTKR2015014035-appb-I000125
Figure PCTKR2015014035-appb-I000125
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4-브로모페닐)-[1,1'-비페닐]-4-아민(4.76 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 49과 동일한 방법을 수행하여 목적 화합물 G-26 (5.22 g, 수율 77 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4-bromophenyl)-[1 instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound G-26 (5.22 g, yield 77%) was obtained by the same method as Synthesis Example 49 except for using, 1'-biphenyl] -4-amine (4.76 g, 10.00 mmol).
MS [M+1]+ 679MS [M + 1] + 679
[[ 합성예Synthesis Example 52] 52]
G-41의 합성Synthesis of G-41
Figure PCTKR2015014035-appb-I000126
Figure PCTKR2015014035-appb-I000126
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-페닐퀴나졸린 (2.85 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 49과 동일한 방법을 수행하여 목적 화합물 G-41 (3.51 g, 수율 72 %)을 얻었다. Same procedure as in Synthesis 49 except for using 2-bromo-4-phenylquinazoline (2.85 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The desired compound G-41 (3.51 g, yield 72%) was obtained.
MS [M+1]+ 488MS [M + 1] + 488
[[ 합성예Synthesis Example 53] 53]
G-53의 합성Synthesis of G-53
Figure PCTKR2015014035-appb-I000127
Figure PCTKR2015014035-appb-I000127
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 8-(4-브로모페닐)퀴놀린 (2.84 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 49과 동일한 방법을 수행하여 목적 화합물 G-53 (3.79 g, 수율 78 %)을 얻었다. Same method as in Synthesis 49, except that 8- (4-bromophenyl) quinoline (2.84 g, 10.00 mmol) was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine This carried out the title compound G-53 (3.79 g, yield 78%).
MS [M+1]+ 487MS [M + 1] + 487
[[ 합성예Synthesis Example 54] 54]
G-64의 합성Synthesis of G-64
Figure PCTKR2015014035-appb-I000128
Figure PCTKR2015014035-appb-I000128
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4'-브로모-[1,1'-비페닐]-4-일)-9,9-디메틸-9H-플루오렌-2-아민 (5.93 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 49과 동일한 방법을 수행하여 목적 화합물 G-64 (5.64 g, 수율 71 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4'-bromo- [1, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The same procedure as in Synthesis Example 49 was carried out except that 1'-biphenyl] -4-yl) -9,9-dimethyl-9H-fluoren-2-amine (5.93 g, 10.00 mmol) was used. Compound G-64 (5.64 g, yield 71%) was obtained.
MS [M+1]+ 795MS [M + 1] + 795
[[ 합성예Synthesis Example 55] 55]
H-14의 합성Synthesis of H-14
Figure PCTKR2015014035-appb-I000129
Figure PCTKR2015014035-appb-I000129
IA-8 (2.99 g, 10.00 mmol), 2-클로로-4,6-디페닐-1,3,5-트리아진 (2.68 g, 10.00 mmol), Pd2(dba)3 (0.46 g, 0.5 mmol), P(t-Bu)3 (0.40 g, 2.0 mmol), 소듐 tert-부톡사이드 (2.88 g, 30.0 mmol) 을 50 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 H-14 (3.92 g, 수율 74 %)을 얻었다. IA-8 (2.99 g, 10.00 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (2.68 g, 10.00 mmol), Pd 2 (dba) 3 (0.46 g, 0.5 mmol ), P (t-Bu) 3 (0.40 g, 2.0 mmol) and sodium tert-butoxide (2.88 g, 30.0 mmol) were added to 50 ml toluene and stirred at 110 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give the title compound H-14 (3.92 g, 74% yield).
MS [M+1]+ 531MS [M + 1] + 531
[[ 합성예Synthesis Example 56] 56]
H-17의 합성Synthesis of H-17
Figure PCTKR2015014035-appb-I000130
Figure PCTKR2015014035-appb-I000130
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-(3-클로로페닐)-4,6-디페닐-1,3,5-트리아진 (3.44 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 55과 동일한 방법을 수행하여 목적 화합물 H-17 (4.97 g, 수율 82 %)을 얻었다. 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (3.44 g, 10.00 mmol instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound H-17 (4.97 g, 82% yield) was obtained in the same manner as in Synthesis Example 55 except for using).
MS [M+1]+ 607MS [M + 1] + 607
[[ 합성예Synthesis Example 57] 57]
H-26의 합성Synthesis of H-26
Figure PCTKR2015014035-appb-I000131
Figure PCTKR2015014035-appb-I000131
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4-브로모페닐)-[1,1'-비페닐]-4-아민 (4.76 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 55과 동일한 방법을 수행하여 목적 화합물 H-26 (5.07 g, 수율 73 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4-bromophenyl)-[1 instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound H-26 (5.07 g, 73% yield) was obtained by the same method as Synthesis Example 55 except for using, l'-biphenyl] -4-amine (4.76 g, 10.00 mmol).
MS [M+1]+ 695MS [M + 1] + 695
[[ 합성예Synthesis Example 58] 58]
H-41의 합성Synthesis of H-41
Figure PCTKR2015014035-appb-I000132
Figure PCTKR2015014035-appb-I000132
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-페닐퀴나졸린 (2.85 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 55과 동일한 방법을 수행하여 목적 화합물 H-41 (3.42 g, 수율 68 %)을 얻었다. The same method as in Synthesis Example 55 except for using 2-bromo-4-phenylquinazolin (2.85 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. The desired compound H-41 (3.42 g, yield 68%) was obtained.
MS [M+1]+ 504MS [M + 1] + 504
[[ 합성예Synthesis Example 59] 59]
H-53의 합성Synthesis of H-53
Figure PCTKR2015014035-appb-I000133
Figure PCTKR2015014035-appb-I000133
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 8-(4-브로모페닐)퀴놀린 (2.84 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 55과 동일한 방법을 수행하여 목적 화합물 H-53 (3.76 g, 수율 75 %)을 얻었다. Same method as in Synthesis Example 55 except for using 8- (4-bromophenyl) quinoline (2.84 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine This carried out the title compound H-53 (3.76 g, yield 75%).
MS [M+1]+ 503MS [M + 1] + 503
[[ 합성예Synthesis Example 60] 60]
H-64의 합성Synthesis of H-64
Figure PCTKR2015014035-appb-I000134
Figure PCTKR2015014035-appb-I000134
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4'-브로모-[1,1'-비페닐]-4-일)-9,9-디메틸-9H-플루오렌-2-아민 (5.93 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 55과 동일한 방법을 수행하여 목적 화합물 H-64 (5.43 g, 수율 67 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4'-bromo- [1, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The same procedure as in Synthesis Example 55 was carried out except that 1'-biphenyl] -4-yl) -9,9-dimethyl-9H-fluoren-2-amine (5.93 g, 10.00 mmol) was used. Compound H-64 (5.43 g, yield 67%) was obtained.
MS [M+1]+ 812MS [M + 1] + 812
[[ 합성예Synthesis Example 61] 61]
I-14의 합성Synthesis of I-14
Figure PCTKR2015014035-appb-I000135
Figure PCTKR2015014035-appb-I000135
IA-9 (2.83 g, 10.00 mmol), 2-클로로-4,6-디페닐-1,3,5-트리아진 (2.68 g, 10.00 mmol), Pd2(dba)3 (0.46 g, 0.5 mmol), P(t-Bu)3 (0.40 g, 2.0 mmol), 소듐 tert-부톡사이드 (2.88 g, 30.0 mmol) 을 50 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 I-14 (3.75 g, 수율 73 %)을 얻었다. IA-9 (2.83 g, 10.00 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (2.68 g, 10.00 mmol), Pd 2 (dba) 3 (0.46 g, 0.5 mmol ), P (t-Bu) 3 (0.40 g, 2.0 mmol) and sodium tert-butoxide (2.88 g, 30.0 mmol) were added to 50 ml toluene and stirred at 110 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the organic layer was filtered and purified by column chromatography to give the title compound I-14 (3.75 g, 73% yield).
MS [M+1]+ 515MS [M + 1] + 515
[[ 합성예Synthesis Example 62] 62]
I-17의 합성Synthesis of I-17
Figure PCTKR2015014035-appb-I000136
Figure PCTKR2015014035-appb-I000136
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-(3-클로로페닐)-4,6-디페닐-1,3,5-트리아진 (3.44 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 61과 동일한 방법을 수행하여 목적 화합물 I-17 (4.54 g, 수율 77 %)을 얻었다. 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (3.44 g, 10.00 mmol instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound I-17 (4.54 g, Yield 77%) was obtained in the same manner as in Synthesis Example 61 except for using a).
MS [M+1]+ 591MS [M + 1] + 591
[[ 합성예Synthesis Example 63] 63]
I-26의 합성Synthesis of I-26
Figure PCTKR2015014035-appb-I000137
Figure PCTKR2015014035-appb-I000137
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4-브로모페닐)-[1,1'-비페닐]-4-아민 (4.76 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 61과 동일한 방법을 수행하여 목적 화합물 I-26 (5.02 g, 수율 74 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4-bromophenyl)-[1 instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound I-26 (5.02 g, yield 74%) was obtained by the same method as Synthesis Example 61 except for using 1'-biphenyl] -4-amine (4.76 g, 10.00 mmol).
MS [M+1]+ 679MS [M + 1] + 679
[[ 합성예Synthesis Example 64] 64]
I-41의 합성Synthesis of I-41
Figure PCTKR2015014035-appb-I000138
Figure PCTKR2015014035-appb-I000138
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-페닐퀴나졸린 (2.85 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 61과 동일한 방법을 수행하여 목적 화합물 I-41 (3.26 g, 수율 67 %)을 얻었다. Same method as in Synthesis Example 61, except that 2-bromo-4-phenylquinazolin (2.85 g, 10.00 mmol) was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. The desired compound I-41 (3.26 g, yield 67%) was obtained.
MS [M+1]+ 488MS [M + 1] + 488
[[ 합성예Synthesis Example 65] 65]
I-53의 합성Synthesis of I-53
Figure PCTKR2015014035-appb-I000139
Figure PCTKR2015014035-appb-I000139
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 8-(4-브로모페닐)퀴놀린 (2.84 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 61과 동일한 방법을 수행하여 목적 화합물 I-53 (3.26 g, 수율 67 %)을 얻었다. Same procedure as in Synthesis Example 61, except using 8- (4-bromophenyl) quinoline (2.84 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The obtained compound I-53 (3.26 g, yield 67%) was obtained.
MS [M+1]+ 487MS [M + 1] + 487
[[ 합성예Synthesis Example 66] 66]
I-64의 합성Synthesis of I-64
Figure PCTKR2015014035-appb-I000140
Figure PCTKR2015014035-appb-I000140
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4'-브로모-[1,1'-비페닐]-4-일)-9,9-디메틸-9H-플루오렌-2-아민 (5.93 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 61과 동일한 방법을 수행하여 목적 화합물 I-64 (5.56 g, 수율 70 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4'-bromo- [1, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The same procedure as in Synthesis Example 61 was carried out except that 1'-biphenyl] -4-yl) -9,9-dimethyl-9H-fluoren-2-amine (5.93 g, 10.00 mmol) was used. Compound I-64 (5.56 g, yield 70%) was obtained.
MS [M+1]+ 795MS [M + 1] + 795
[[ 합성예Synthesis Example 67] 67]
J-14의 합성Synthesis of J-14
Figure PCTKR2015014035-appb-I000141
Figure PCTKR2015014035-appb-I000141
IA-10 (2.99 g, 10.00 mmol), 2-클로로-4,6-디페닐-1,3,5-트리아진 (2.68 g, 10.00 mmol), Pd2(dba)3 (0.46 g, 0.5 mmol), P(t-Bu)3 (0.40 g, 2.0 mmol), 소듐 tert-부톡사이드 (2.88 g, 30.0 mmol) 을 50 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 J-14 (3.60 g, 수율 68 %)을 얻었다. IA-10 (2.99 g, 10.00 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (2.68 g, 10.00 mmol), Pd 2 (dba) 3 (0.46 g, 0.5 mmol ), P (t-Bu) 3 (0.40 g, 2.0 mmol) and sodium tert-butoxide (2.88 g, 30.0 mmol) were added to 50 ml toluene and stirred at 110 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give the title compound J-14 (3.60 g, yield 68%).
MS [M+1]+ 531MS [M + 1] + 531
[[ 합성예Synthesis Example 68] 68]
J-17의 합성Synthesis of J-17
Figure PCTKR2015014035-appb-I000142
Figure PCTKR2015014035-appb-I000142
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-(3-클로로페닐)-4,6-디페닐-1,3,5-트리아진 (3.44 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 67과 동일한 방법을 수행하여 목적 화합물 J-17 (4.55 g, 수율 75 %)을 얻었다. 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (3.44 g, 10.00 mmol instead of 2-chloro-4,6-diphenyl-1,3,5-triazine Except for using), the same method as in Synthesis Example 67 was performed to obtain the target compound J-17 (4.55 g, yield 75%).
MS [M+1]+ 607MS [M + 1] + 607
[[ 합성예Synthesis Example 69] 69]
J-26의 합성Synthesis of J-26
Figure PCTKR2015014035-appb-I000143
Figure PCTKR2015014035-appb-I000143
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4-브로모페닐)-[1,1'-비페닐]-4-아민 (4.76 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 67과 동일한 방법을 수행하여 목적 화합물 J-26 (4.51 g, 수율 65 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4-bromophenyl)-[1 instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound J-26 (4.51 g, 65% yield) was obtained in the same manner as in Synthesis Example 67, except that 1, -biphenyl] -4-amine (4.76 g, 10.00 mmol) was used.
MS [M+1]+ 695MS [M + 1] + 695
[[ 합성예Synthesis Example 70] 70]
J-41의 합성Synthesis of J-41
Figure PCTKR2015014035-appb-I000144
Figure PCTKR2015014035-appb-I000144
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-페닐퀴나졸린 (2.85 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 67과 동일한 방법을 수행하여 목적 화합물 J-41 (3.17 g, 수율 63 %)을 얻었다. The same method as in Synthesis Example 67 except for using 2-bromo-4-phenylquinazolin (2.85 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. This carried out the title compound J-41 (3.17 g, yield 63%).
MS [M+1]+ 504MS [M + 1] + 504
[[ 합성예Synthesis Example 71] 71]
J-53의 합성Synthesis of J-53
Figure PCTKR2015014035-appb-I000145
Figure PCTKR2015014035-appb-I000145
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 8-(4-브로모페닐)퀴놀린 (2.84 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 67과 동일한 방법을 수행하여 목적 화합물 J-53 (3.51 g, 수율 70 %)을 얻었다. Same method as in Synthesis Example 67, except using 8- (4-bromophenyl) quinoline (2.84 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The obtained compound J-53 (3.51 g, yield 70%) was obtained.
MS [M+1]+ 503MS [M + 1] + 503
[[ 합성예Synthesis Example 72] 72]
J-64의 합성Synthesis of J-64
Figure PCTKR2015014035-appb-I000146
Figure PCTKR2015014035-appb-I000146
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4'-브로모-[1,1'-비페닐]-4-일)-9,9-디메틸-9H-플루오렌-2-아민 (5.93 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 67과 동일한 방법을 수행하여 목적 화합물 J-64 (5.92 g, 수율 73 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4'-bromo- [1, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The same procedure as in Synthesis Example 67 was carried out except that 1'-biphenyl] -4-yl) -9,9-dimethyl-9H-fluoren-2-amine (5.93 g, 10.00 mmol) was used. Compound J-64 (5.92 g, yield 73%) was obtained.
MS [M+1]+ 812MS [M + 1] + 812
[[ 합성예Synthesis Example 73] 73]
K-14의 합성Synthesis of K-14
Figure PCTKR2015014035-appb-I000147
Figure PCTKR2015014035-appb-I000147
IA-11 (2.83 g, 10.00 mmol), 2-클로로-4,6-디페닐-1,3,5-트리아진 (2.68 g, 10.00 mmol), Pd2(dba)3 (0.46 g, 0.5 mmol), P(t-Bu)3 (0.40 g, 2.0 mmol), 소듐 tert-부톡사이드 (2.88 g, 30.0 mmol) 을 50 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 K-14 (4.05 g, 수율 79 %)을 얻었다. IA-11 (2.83 g, 10.00 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (2.68 g, 10.00 mmol), Pd 2 (dba) 3 (0.46 g, 0.5 mmol ), P (t-Bu) 3 (0.40 g, 2.0 mmol) and sodium tert-butoxide (2.88 g, 30.0 mmol) were added to 50 ml toluene and stirred at 110 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer using column chromatography to give the title compound K-14 (4.05 g, yield 79%).
MS [M+1]+ 515MS [M + 1] + 515
[[ 합성예Synthesis Example 74] 74]
K-17의 합성Synthesis of K-17
Figure PCTKR2015014035-appb-I000148
Figure PCTKR2015014035-appb-I000148
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-(3-클로로페닐)-4,6-디페닐-1,3,5-트리아진 (3.44 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 73과 동일한 방법을 수행하여 목적 화합물 K-17 (4.84 g, 수율 82 %)을 얻었다. 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (3.44 g, 10.00 mmol instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound K-17 (4.84 g, 82% yield) was obtained in the same manner as in Synthesis Example 73 except for using).
MS [M+1]+ 591MS [M + 1] + 591
[[ 합성예Synthesis Example 75] 75]
K-26의 합성Synthesis of K-26
Figure PCTKR2015014035-appb-I000149
Figure PCTKR2015014035-appb-I000149
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4-브로모페닐)-[1,1'-비페닐]-4-아민 (4.76 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 73과 동일한 방법을 수행하여 목적 화합물 K-26 (5.36 g, 수율 79 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4-bromophenyl)-[1 instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound K-26 (5.36 g, 79% yield) was obtained in the same manner as in Synthesis Example 73, except that 1, -biphenyl] -4-amine (4.76 g, 10.00 mmol) was used.
MS [M+1]+ 679MS [M + 1] + 679
[[ 합성예Synthesis Example 76] 76]
K-41의 합성Synthesis of K-41
Figure PCTKR2015014035-appb-I000150
Figure PCTKR2015014035-appb-I000150
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-페닐퀴나졸린 (2.85 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 73과 동일한 방법을 수행하여 목적 화합물 K-41 (3.65 g, 수율 75 %)을 얻었다. The same method as in Synthesis 73, except that 2-bromo-4-phenylquinazolin (2.85 g, 10.00 mmol) was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. The desired compound K-41 (3.65 g, yield 75%) was obtained.
MS [M+1]+ 488MS [M + 1] + 488
[[ 합성예Synthesis Example 77] 77]
K-53의 합성Synthesis of K-53
Figure PCTKR2015014035-appb-I000151
Figure PCTKR2015014035-appb-I000151
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 8-(4-브로모페닐)퀴놀린 (2.84 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 73과 동일한 방법을 수행하여 목적 화합물 K-53 (4.03 g, 수율 83 %)을 얻었다. Same method as in Synthesis 73, except that 8- (4-bromophenyl) quinoline (2.84 g, 10.00 mmol) was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The desired compound K-53 (4.03 g, yield 83%) was obtained.
MS [M+1]+ 487MS [M + 1] + 487
[[ 합성예Synthesis Example 78] 78]
K-64의 합성Synthesis of K-64
Figure PCTKR2015014035-appb-I000152
Figure PCTKR2015014035-appb-I000152
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4'-브로모-[1,1'-비페닐]-4-일)-9,9-디메틸-9H-플루오렌-2-아민 (5.93 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 73과 동일한 방법을 수행하여 목적 화합물 K-64 (6.04 g, 수율 76 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4'-bromo- [1, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The same procedure as in Synthesis Example 73 was carried out except that 1'-biphenyl] -4-yl) -9,9-dimethyl-9H-fluoren-2-amine (5.93 g, 10.00 mmol) was used. Compound K-64 (6.04 g, yield 76%) was obtained.
MS [M+1]+ 795MS [M + 1] + 795
[[ 합성예Synthesis Example 79] 79]
L-14의 합성Synthesis of L-14
Figure PCTKR2015014035-appb-I000153
Figure PCTKR2015014035-appb-I000153
IA-12 (2.99 g, 10.00 mmol), 2-클로로-4,6-디페닐-1,3,5-트리아진 (2.68 g, 10.00 mmol), Pd2(dba)3 (0.46 g, 0.5 mmol), P(t-Bu)3 (0.40 g, 2.0 mmol), 소듐 tert-부톡사이드 (2.88 g, 30.0 mmol) 을 50 ml 톨루엔에 넣고 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 여과된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 L-14 (3.97 g, 수율 75 %)을 얻었다. IA-12 (2.99 g, 10.00 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (2.68 g, 10.00 mmol), Pd 2 (dba) 3 (0.46 g, 0.5 mmol ), P (t-Bu) 3 (0.40 g, 2.0 mmol) and sodium tert-butoxide (2.88 g, 30.0 mmol) were added to 50 ml toluene and stirred at 110 ° C. for 12 hours. After completion of the reaction, the mixture was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent of the filtered organic layer to obtain the target compound L-14 (3.97 g, yield 75%) by column chromatography.
MS [M+1]+ 531MS [M + 1] + 531
[[ 합성예Synthesis Example 80] 80]
L-17의 합성Synthesis of L-17
Figure PCTKR2015014035-appb-I000154
Figure PCTKR2015014035-appb-I000154
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-(3-클로로페닐)-4,6-디페닐-1,3,5-트리아진 (3.44 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 79과 동일한 방법을 수행하여 목적 화합물 L-17 (5.15 g, 수율 85 %)을 얻었다. 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (3.44 g, 10.00 mmol instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound L-17 (5.15 g, Yield 85%) was obtained in the same manner as in Synthesis Example 79 except for using a).
MS [M+1]+ 607MS [M + 1] + 607
[[ 합성예Synthesis Example 81] 81]
L-26의 합성Synthesis of L-26
Figure PCTKR2015014035-appb-I000155
Figure PCTKR2015014035-appb-I000155
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4-브로모페닐)-[1,1'-비페닐]-4-아민 (4.76 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 79과 동일한 방법을 수행하여 목적 화합물 L-26 (5.69 g, 수율 82 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4-bromophenyl)-[1 instead of 2-chloro-4,6-diphenyl-1,3,5-triazine A target compound L-26 (5.69 g, 82% yield) was obtained in the same manner as in Synthesis Example 79, except that 1, -biphenyl] -4-amine (4.76 g, 10.00 mmol) was used.
MS [M+1]+ 695MS [M + 1] + 695
[[ 합성예Synthesis Example 82] 82]
L-41의 합성Synthesis of L-41
Figure PCTKR2015014035-appb-I000156
Figure PCTKR2015014035-appb-I000156
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 2-브로모-4-페닐퀴나졸린 (2.85 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 79과 동일한 방법을 수행하여 목적 화합물 L-41 (3.67 g, 수율 73 %)을 얻었다. The same method as in Synthesis Example 79 except for using 2-bromo-4-phenylquinazolin (2.85 g, 10.00 mmol) instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. The desired compound L-41 (3.67 g, yield 73%) was obtained.
MS [M+1]+ 504MS [M + 1] + 504
[[ 합성예Synthesis Example 83] 83]
L-53의 합성Synthesis of L-53
Figure PCTKR2015014035-appb-I000157
Figure PCTKR2015014035-appb-I000157
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 8-(4-브로모페닐)퀴놀린 (2.84 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 79과 동일한 방법을 수행하여 목적 화합물 L-53 (3.97 g, 수율 79 %)을 얻었다. The same method as in Synthesis 79, except that 8- (4-bromophenyl) quinoline (2.84 g, 10.00 mmol) was used instead of 2-chloro-4,6-diphenyl-1,3,5-triazine. The target compound L-53 (3.97 g, yield 79%) was obtained.
MS [M+1]+ 503MS [M + 1] + 503
[[ 합성예Synthesis Example 84] 84]
L-64의 합성Synthesis of L-64
Figure PCTKR2015014035-appb-I000158
Figure PCTKR2015014035-appb-I000158
2-클로로-4,6-디페닐-1,3,5-트리아진 대신 N-([1,1'-비페닐]-4-일)-N-(4'-브로모-[1,1'-비페닐]-4-일)-9,9-디메틸-9H-플루오렌-2-아민 (5.93 g, 10.00 mmol)을 사용하는 것을 제외하고는 합성예 79과 동일한 방법을 수행하여 목적 화합물 L-64 (5.67 g, 수율 70 %)을 얻었다. N-([1,1'-biphenyl] -4-yl) -N- (4'-bromo- [1, instead of 2-chloro-4,6-diphenyl-1,3,5-triazine The same procedure as in Synthesis Example 79 was carried out except that 1'-biphenyl] -4-yl) -9,9-dimethyl-9H-fluoren-2-amine (5.93 g, 10.00 mmol) was used. Compound L-64 (5.67 g, yield 70%) was obtained.
MS [M+1]+ 812MS [M + 1] + 812
[[ 실시예Example 1~32] 1-32]
녹색 유기 EL 소자의 제작Fabrication of Green Organic EL Devices
합성예 1~80에서 합성한 화합물 A-14 ~ L-17를 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 녹색 유기 EL 소자를 제작하였다.Compounds A-14 to L-17 synthesized in Synthesis Examples 1 to 80 were subjected to high purity sublimation purification by a conventionally known method, and then a green organic EL device was manufactured according to the following procedure.
먼저, ITO (Indium tin oxide)가 1500Å 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium tin oxide) having a thickness of 1500 Å was washed with distilled water ultrasonic waves. After washing the distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, etc. is dried and transferred to a UV OZONE cleaner (Power sonic 405, Hwasin Tech). The substrate was transferred to.
이렇게 준비된 ITO 투명 전극 위에 m-MTDATA (60 nm)/TCTA (80 nm)/ A-14 ~ L-17의 각각의 화합물 + 10 % Ir(ppy)3 (30nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 EL 소자를 제작하였다. M-MTDATA (60 nm) / TCTA (80 nm) / A-14 to L-17 each compound + 10% Ir (ppy) 3 (30nm) / BCP (10 nm) / Alq on the thus prepared ITO transparent electrode An organic EL device was fabricated by stacking 3 (30 nm) / LiF (1 nm) / Al (200 nm) in this order.
m-MTDATA, TCTA, Ir(ppy)3, CBP 및 BCP의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, Ir (ppy) 3 , CBP and BCP are as follows.
Figure PCTKR2015014035-appb-I000159
Figure PCTKR2015014035-appb-I000159
[[ 비교예Comparative example 1] One]
녹색 유기 EL 소자의 제작Fabrication of Green Organic EL Devices
발광층 형성시 발광 호스트 물질로서 화합물 A-14 대신 CBP를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 녹색 유기 EL 소자를 제작하였다.A green organic EL device was manufactured in the same manner as in Example 1, except that CBP was used instead of Compound A-14 as a light emitting host material when forming the emission layer.
[[ 평가예Evaluation example 1] One]
실시예 1 ~ 32 및 비교예 1에서 제작한 각각의 녹색 유기 EL 소자에 대하여 전류밀도 (10) mA/㎠에서의 구동전압, 전류효율 및 발광 피크를 측정하고, 그 결과를 하기 표 1에 나타내었다.For each of the green organic EL devices produced in Examples 1 to 32 and Comparative Example 1, the driving voltage, current efficiency, and emission peak at current density (10) mA / cm 2 were measured, and the results are shown in Table 1 below. It was.
샘플Sample 호스트Host 구동전압(V)Driving voltage (V) EL 피크(nm)EL peak (nm) 전류효율(cd/A)Current efficiency (cd / A)
실시예 1Example 1 A-14A-14 6.786.78 517517 40.240.2
실시예 2Example 2 A-16A-16 6.836.83 518518 41.541.5
실시예 3Example 3 A-17A-17 6.796.79 517517 40.640.6
실시예 4Example 4 A-19A-19 6.846.84 516516 42.342.3
실시예 5Example 5 B-14B-14 6.826.82 518518 40.440.4
실시예 6Example 6 B-16B-16 6.776.77 518518 41.341.3
실시예 7Example 7 B-17B-17 6.656.65 517517 42.942.9
실시예 8Example 8 B-19B-19 6.856.85 518518 41.841.8
실시예 9Example 9 C-14C-14 6.786.78 517517 40.340.3
실시예 10Example 10 C-16C-16 6.756.75 517517 41.641.6
실시예 11Example 11 C-17C-17 6.856.85 518518 40.740.7
실시예 12Example 12 C-19C-19 6.896.89 518518 40.840.8
실시예 13Example 13 D-14D-14 6.746.74 516516 41.341.3
실시예 14Example 14 D-16D-16 6.826.82 518518 41.941.9
실시예 15Example 15 D-17D-17 6.836.83 517517 45.245.2
실시예 16Example 16 D-19D-19 6.746.74 518518 41.941.9
실시예 17Example 17 E-14E-14 6.796.79 518518 42.342.3
실시예 18Example 18 E-17E-17 6.696.69 517517 41.741.7
실시예 19Example 19 F-14F-14 6.686.68 516516 42.742.7
실시예 20Example 20 F-17F-17 6.846.84 518518 40.840.8
실시예 21Example 21 G-14G-14 6.756.75 517517 41.341.3
실시예 22Example 22 G-17G-17 6.796.79 517517 42.242.2
실시예 23Example 23 H-14H-14 6.676.67 518518 40.640.6
실시예 24Example 24 H-17H-17 6.736.73 517517 41.241.2
실시예 25Example 25 I-14I-14 6.826.82 518518 40.740.7
실시예 26Example 26 I-17I-17 6.856.85 517517 41.341.3
실시예 27Example 27 J-14J-14 6.726.72 518518 41.941.9
실시예 28Example 28 J-17J-17 6.836.83 516516 42.842.8
실시예 29Example 29 K-14K-14 6.726.72 517517 41.041.0
실시예 30Example 30 K-17K-17 6.886.88 516516 42.942.9
실시예 31Example 31 L-14L-14 6.826.82 516516 43.543.5
실시예 32Example 32 L-17L-17 6.786.78 517517 42.542.5
비교예 1Comparative Example 1 CBPCBP 6.936.93 516516 38.238.2
상기 표1에 나타낸 바와 같이, 본 발명에 따른 화합물 (A-14 ~ L-17)을 녹색 유기 EL 소자의 발광층으로 사용하였을 경우(실시예 1-32) 종래 CBP를 사용한 녹색 유기 EL 소자(비교예1)와 비교해 볼 때 효율 및 구동전압 면에서 보다 우수한 성능을 나타내는 것을 알 수 있다.As shown in Table 1, when the compounds (A-14 to L-17) according to the present invention were used as the light emitting layer of the green organic EL device (Examples 1-32), the green organic EL device using the conventional CBP (compared to Compared with Example 1, it can be seen that it shows better performance in terms of efficiency and driving voltage.
[[ 실시예Example 33~60] 33 ~ 60]
적색 유기 EL 소자의 제작Fabrication of Red Organic EL Devices
합성예에서 합성한 화합물을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 적색 유기 전계 발광 소자를 제작하였다.The compound synthesized in the synthesis example was subjected to high purity sublimation purification by a conventionally known method, and then a red organic EL device was manufactured according to the following procedure.
먼저, ITO (Indium tin oxide)가 1500Å 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium tin oxide) having a thickness of 1500 Å was washed with distilled water ultrasonic waves. After washing the distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, etc. is dried and transferred to a UV OZONE cleaner (Power sonic 405, Hwasin Tech). The substrate was transferred to.
이렇게 준비된 ITO 투명 전극 위에 m-MTDATA (60 nm)/TCTA (80 nm)/ A-41 ~ L-53 의 화합물 + 10 % (piq)2Ir(acac) (30nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제작하였다.M-MTDATA (60 nm) / TCTA (80 nm) / A-41 to L-53 + 10% (piq) 2 Ir (acac) (30nm) / BCP (10 nm) / An organic electroluminescent device was manufactured by laminating in order of Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm).
[[ 비교예Comparative example 2] 2]
적색 유기 EL 소자의 제작Fabrication of Red Organic EL Devices
발광층 형성시 발광 호스트 물질로서 상기 합성예 6의 화합물 대신 CBP를 사용하는 것을 제외하고는 상기 실시예 33와 동일한 과정으로 적색 유기 전계 발광 소자를 제작하였다.A red organic electroluminescent device was manufactured in the same manner as in Example 33, except that CBP was used instead of the compound of Synthesis Example 6 as a light emitting host material when forming the emission layer.
상기 실시예 33 ~ 60 및 비교예 2에서 사용된 m-MTDATA, (piq)2Ir(acac), CBP 및 BCP의 구조는 하기와 같다.The structures of m-MTDATA, (piq) 2 Ir (acac), CBP, and BCP used in Examples 33 to 60 and Comparative Example 2 are as follows.
Figure PCTKR2015014035-appb-I000160
Figure PCTKR2015014035-appb-I000160
[[ 평가예Evaluation example 2] 2]
실시예 33 ~ 60 및 비교예 2에서 제작한 각각의 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압 및 전류효율을 측정하고, 그 결과를 하기 표 2에 나타내었다.For each organic electroluminescent device manufactured in Examples 33 to 60 and Comparative Example 2, the driving voltage and the current efficiency at a current density of 10 mA / cm 2 were measured, and the results are shown in Table 2 below.
샘플Sample 호스트Host 구동전압(V)Driving voltage (V) 전류효율(cd/A)Current efficiency (cd / A)
실시예 33Example 33 A-41A-41 4.894.89 13.313.3
실시예 34 Example 34 A-53A-53 4.924.92 12.912.9
실시예 35Example 35 A-59A-59 4.874.87 12.712.7
실시예 36Example 36 B-41B-41 4.934.93 13.213.2
실시예 37Example 37 B-53B-53 4.884.88 12.812.8
실시예 38Example 38 B-59B-59 4.874.87 13.413.4
실시예 39Example 39 C-41C-41 4.834.83 12.612.6
실시예 40Example 40 C-53C-53 4.844.84 12.912.9
실시예 41Example 41 C-59C-59 4.924.92 13.613.6
실시예 42Example 42 D-41D-41 4.874.87 13.213.2
실시예 43Example 43 D-53D-53 4.934.93 12.912.9
실시예 44Example 44 D-59D-59 4.924.92 13.613.6
실시예 45Example 45 E-41E-41 4.984.98 12.812.8
실시예 46Example 46 E-53E-53 4.894.89 13.213.2
실시예 47Example 47 F-41F-41 4.834.83 12.012.0
실시예 48Example 48 F-53F-53 4.824.82 13.213.2
실시예 49Example 49 G-41G-41 4.934.93 12.712.7
실시예 50Example 50 G-53G-53 4.874.87 12.912.9
실시예 51Example 51 G-41G-41 4.934.93 13.413.4
실시예 52Example 52 G-53G-53 4.874.87 12.912.9
실시예 53Example 53 I-41I-41 4.894.89 13.813.8
실시예 54Example 54 I-53I-53 4.924.92 12.412.4
실시예 55Example 55 J-41J-41 4.834.83 13.013.0
실시예 56Example 56 J-53J-53 4.884.88 12.212.2
실시예 57Example 57 K-41K-41 4.894.89 13.913.9
실시예 58Example 58 K-53K-53 4.934.93 12.512.5
실시예 59Example 59 L-41L-41 4.924.92 13.613.6
실시예 60Example 60 L-53L-53 4.854.85 12.312.3
비교예 2Comparative Example 2 CBPCBP 5.255.25 8.28.2
상기 표2에 나타낸 바와 같이, 본 발명에 따른 화합물을 적색 유기 전계 발광 소자의 발광층의 재료로 사용하였을 경우(실시예 33-60) 종래 CBP를 발광층의 재료로 사용한 적색 유기 전계 발광 소자(비교예2)와 비교해 볼 때 효율 및 구동전압 면에서 우수한 성능을 나타내는 것을 알 수 있다.As shown in Table 2 above, when the compound according to the present invention was used as a material of the light emitting layer of the red organic electroluminescent device (Examples 33-60), a red organic electroluminescent device using a conventional CBP as a material of the light emitting layer (Comparative Example) Compared with 2), it shows excellent performance in terms of efficiency and driving voltage.
[[ 실시예Example 61] 61]
유기 EL 소자의 제작Fabrication of Organic EL Devices
ITO (Indium tin oxide)가 1500 Å 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후, UV OZONE 세정기(Power sonic 405, 화신테크)로 이송시킨 다음, UV를 이용하여 상기 기판을 5 분간 세정한 후 진공 층착기로 기판을 이송하였다.A glass substrate coated with ITO (Indium tin oxide) to a thickness of 1500 Å was washed with distilled water ultrasonically. After washing with distilled water, ultrasonic washing with a solvent such as isopropyl alcohol, acetone, methanol, and drying was carried out, and then transferred to a UV OZONE cleaner (Power sonic 405, Hwasin Tech), and the substrate was cleaned for 5 minutes using UV. The substrate was then transferred to a vacuum depositor.
상기와 같이 준비된 ITO 투명 전극 위에 m-MTDATA(60nm)/합성예 5에서 합성된 화합물 A-26 (80nm)/DS-H522 + 5% DS-501(30nm)/BCP(10nm)/Alq3(30 nm)/LiF(1nm)/Al(200nm) 순서로 유기 EL 소자를 제조하였다.  M-MTDATA (60nm) / Compound A-26 (80nm) / DS-H522 + 5% DS-501 (30nm) / BCP (10nm) / Alq3 (30) synthesized in Example 5 on the prepared ITO transparent electrode An organic EL device was manufactured in the order of nm) / LiF (1 nm) / Al (200 nm).
소자 제작에 사용된 DS-H522 및 DS-501은 ㈜두산 전자 BG의 제품이며, m-MTDATA, TCTA, CBP, Ir(ppy)3, 및 BCP의 구조는 하기와 같다.DS-H522 and DS-501 used in device fabrication are products of Doosan Electronics BG, and the structures of m-MTDATA, TCTA, CBP, Ir (ppy) 3 , and BCP are as follows.
Figure PCTKR2015014035-appb-I000161
Figure PCTKR2015014035-appb-I000161
[[ 실시예Example 62 ~ 84] 62 to 84]
유기 EL 소자의 제작Fabrication of Organic EL Devices
실시예 61에서 정공 수송층 형성시 정공 수송층 물질로 사용된 화합물 A-26 대신 A-64 ~ L-64 를 사용하는 것을 제외하고는, 실시예 61과 동일하게 수행하여 유기 EL 소자를 제조하였다.An organic EL device was manufactured in the same manner as in Example 61, except that A-64 to L-64 were used instead of the compound A-26 used as the hole transport layer material in forming the hole transport layer in Example 61.
[[ 비교예Comparative example 3] 3]
유기 EL 소자의 제작Fabrication of Organic EL Devices
실시예 61에서 정공 수송층 형성시 정공 수송층 물질로 사용된 화합물 A-26 대신 NPB를 정공수송층 물질로 사용한 것을 제외하고는, 상기 실시예 61과 동일한 방법으로 유기 EL 소자를 제조하였다. 사용된 NPB의 구조는 하기와 같다.An organic EL device was manufactured in the same manner as in Example 61, except that NPB was used as the hole transport layer material instead of Compound A-26 used as the hole transport layer material when forming the hole transport layer in Example 61. The structure of the NPB used is as follows.
Figure PCTKR2015014035-appb-I000162
Figure PCTKR2015014035-appb-I000162
[[ 평가예Evaluation example 3] 3]
실시예 61 ~ 39, 및 비교예 1에서 각각 제조된 유기 EL 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압 및 전류효율를 측정하였고, 그 결과를 하기 표 1에 나타내었다.The driving voltage and current efficiency at the current density of 10 mA / cm 2 were measured for the organic EL devices manufactured in Examples 61 to 39 and Comparative Example 1, respectively, and the results are shown in Table 1 below.
샘플Sample 정공수송층Hole transport layer 구동 전압(V)Drive voltage (V) 전류효율(cd/A)Current efficiency (cd / A)
실시예 61Example 61 A-26A-26 4.84.8 20.820.8
실시예 62Example 62 A-64A-64 4.94.9 20.320.3
실시예 63Example 63 B-26B-26 4.74.7 20.420.4
실시예 64Example 64 B-64B-64 4.84.8 20.420.4
실시예 65Example 65 C-26C-26 4.84.8 20.420.4
실시예 66Example 66 C-64C-64 4.74.7 20.220.2
실시예 67Example 67 D-26D-26 4.74.7 21.321.3
실시예 68 Example 68 D-64D-64 4.64.6 21.521.5
실시예 69Example 69 E-26E-26 4.84.8 21.221.2
실시예 70Example 70 E-64E-64 4.94.9 22.322.3
실시예 71Example 71 F-26F-26 4.94.9 21.121.1
실시예 72Example 72 F-64F-64 4.84.8 20.420.4
실시예 73Example 73 G-26G-26 4.84.8 20.920.9
실시예 74Example 74 G-64G-64 4.74.7 22.122.1
실시예 75Example 75 H-26H-26 5.05.0 20.820.8
실시예 76Example 76 H-64H-64 5.15.1 21.421.4
실시예 77Example 77 I-26I-26 4.84.8 21.621.6
실시예 78Example 78 I-64I-64 4.94.9 21.721.7
실시예 79Example 79 J-26J-26 4.74.7 22.322.3
실시예 80Example 80 J-64J-64 4.74.7 20.720.7
실시예 81Example 81 K-26K-26 5.15.1 20.920.9
실시예 82Example 82 K-64K-64 5.05.0 20.420.4
실시예 83Example 83 L-26L-26 4.74.7 21.421.4
실시예 84Example 84 L-64L-64 4.74.7 21.221.2
비교예 3Comparative Example 3 NPBNPB 5.25.2 18.118.1
상기 표 3에 나타낸 바와 같이, 본 발명에 따른 화합물(A-26 ~ L-64)을 정공수송층으로 사용한 유기 EL 소자(실시예 61 내지 84에서 각각 제조된 유기 EL 소자)는, 종래 NPB를 사용한 유기 EL 소자(비교예 3의 유기 EL 소자)에 비해 전류효율 및 구동전압 면에서 보다 우수한 성능을 나타내는 것을 알 수 있었다.As shown in Table 3, the organic EL device (the organic EL device manufactured in each of Examples 61 to 84) using the compounds (A-26 to L-64) according to the present invention as the hole transport layer was conventionally used NPB. Compared with the organic EL device (organic EL device of Comparative Example 3), it was found that the device exhibited better performance in terms of current efficiency and driving voltage.

Claims (17)

  1. 하기 화학식 1로 표시되는 화합물:Compound represented by the following formula (1):
    [화학식 1][Formula 1]
    Figure PCTKR2015014035-appb-I000163
    Figure PCTKR2015014035-appb-I000163
    상기 화학식 1에서,In Chemical Formula 1,
    R1과 R2은 서로 결합하여 하기 화학식 2와 축합 환을 형성하고,R 1 and R 2 are bonded to each other to form a condensed ring with the formula (2),
    [화학식 2][Formula 2]
    Figure PCTKR2015014035-appb-I000164
    Figure PCTKR2015014035-appb-I000164
    상기 화학식 2에서,In Chemical Formula 2,
    점선은 축합이 이루어지는 부분이고,The dotted line is the part where condensation takes place
    X1 및 X2는 각각 독립적으로 O, S, Se, N(Ar1), C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로 구성된 군으로부터 선택되고;X 1 and X 2 are each independently selected from the group consisting of O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 );
    Y1 내지 Y12은 각각 독립적으로 N 또는 C(R3)에서 선택되고;Y 1 to Y 12 are each independently selected from N or C (R 3 );
    R3은 서로 동일하거나 상이하며, 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 각각의 R3는 서로 결합하여 축합 방향족환 또는 축합 헤테로방향족환을 형성할 수 있으며;R 3 is the same as or different from each other, and each independently hydrogen, deuterium, halogen, cyano group, nitro group, C 1 -C 40 alkyl group, C 2 -C 40 alkenyl group, C 2 -C 40 alkynyl group, C 3 -C 40 cycloalkyl group, nuclear atom 3 to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, nuclear atom 5 to 60 heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 arylphosphine group, C 6 ~ C 60 mono or diaryl phosphinyl group and C 6 ~ C 60 arylamine group selected from each of the adjacent R 3 is bonded to each other condensed aromatic Can form a ring or a condensed heteroaromatic ring;
    Ar1 내지 Ar5는 C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고;Ar 1 to Ar 5 is C 1 ~ C 40 Alkyl group, C 2 ~ C 40 Alkenyl group, C 2 ~ C 40 Alkynyl group, C 3 ~ C 40 Cycloalkyl group, 3 to 40 heterocycloheteronuclear Alkyl group, C 6 ~ C 60 aryl group, 5 to 60 heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 3 ~ C 40 alkylsilyl Group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 mono or A diaryl phosphinyl group and a C 6 -C 60 arylamine group;
    R3, Ar1 내지 Ar5의 알킬기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴아민기는 각각 독립적으로, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상으로 치환될 수 있으며, 복수개의 치환기로 치환될 경우 이들은 서로 동일하거나 상이할 수 있다.R 3 , Ar 1 to Ar 5 alkyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group, arylsilyl group, alkyl boron group, aryl boron group, aryl A phosphine group, a mono or diaryl phosphinyl group and an arylamine group are each independently a C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 A cycloalkyl group, a nuclear atom having 3 to 40 heterocycloalkyl groups, a C 6 to C 60 aryl group, a nuclear atom having 5 to 60 heteroaryl groups, a C 1 to C 40 alkyloxy group, a C 6 to C 60 group Aryloxy group, C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 an aryl phosphine group, C 6 ~ C 60 mono or diaryl phosphine blood group and a C 6 ~ C 60 aryl group, and the amine may be substituted with at least one member selected from the group consisting of, optionally substituted with a plurality of substituents Wu they may be the same or different from each other.
  2. 제 1항에 있어서, The method of claim 1,
    상기 화합물이 하기 화학식 3 및 화학식 4로 표시되는 화합물인 것을 특징으로 하는 화합물:Compounds, characterized in that the compound represented by the formula (3) and formula (4):
    [화학식 3][Formula 3]
    Figure PCTKR2015014035-appb-I000165
    Figure PCTKR2015014035-appb-I000165
    [화학식 4][Formula 4]
    Figure PCTKR2015014035-appb-I000166
    Figure PCTKR2015014035-appb-I000166
    상기 화학식 3 및 화학식 4에 있어서, In Chemical Formulas 3 and 4,
    X1, X2 및 Y1 내지 Y12는 제1항에 정의된 바와 같다.X 1 , X 2 and Y 1 to Y 12 are as defined in claim 1.
  3. 제 1항 또는 제 2항에 있어서, The method according to claim 1 or 2,
    X1 및 X2 중 적어도 하나는 N(Ar1)인 것을 특징으로 하는 화합물.At least one of X 1 and X 2 is N (Ar 1 ).
  4. 제 1항 또는 제 2항에 있어서, The method according to claim 1 or 2,
    Y1 내지 Y12은 각각 독립적으로 N 또는 C(R3)에서 선택되고, 이들 모두 C(R3)이거나 이들 중 하나가 N인 것을 특징으로 하는 화합물.Y 1 to Y 12 are each independently selected from N or C (R 3 ), all of which are C (R 3 ) or one of them is N.
  5. 제 1항에 있어서, The method of claim 1,
    상기 화합물이 하기 화학식 1-1 내지 화학식 1-18로 표시되는 화합물인 것을 특징으로 하는 화합물:Compounds, characterized in that the compound is represented by the formula 1-1 to formula 1-18:
    Figure PCTKR2015014035-appb-I000167
    Figure PCTKR2015014035-appb-I000167
    상기 화학식 1-1 내지 1-18 에서, In Chemical Formulas 1-1 to 1-18,
    Y1 내지 Y12 및 Ar1 내지 Ar5는 제1항에 정의된 바와 같다.Y 1 to Y 12 and Ar 1 to Ar 5 are as defined in claim 1 .
  6. 제 1항에 있어서, The method of claim 1,
    축합을 형성하는 것을 제외한 R3, Ar1 내지 Ar5 중 적어도 하나는 C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되는 것을 특징으로 하는 화합물.At least one of R 3 and Ar 1 to Ar 5 except forming a condensation is an alkyl group of C 1 to C 40 , an aryl group of C 6 to C 60 , a heteroaryl group of 5 to 60 nuclear atoms, and C 6 to C A compound characterized in that it is selected from the group consisting of 60 arylamine groups.
  7. 제 6항에 있어서, The method of claim 6,
    상기 R3, Ar1 내지 Ar5 의 알킬기, 아릴기, 헤테로아릴기 및 아릴아민기는 각각 독립적으로, 중수소, 할로겐, 시아노기, C1~C40의 알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상으로 치환될 수 있으며, 복수개의 치환기로 치환될 경우 이들은 서로 동일하거나 상이할 수 있는 것을 특징으로 하는 화합물.The alkyl group, aryl group, heteroaryl group and arylamine group of R 3 , Ar 1 to Ar 5 are each independently deuterium, halogen, cyano group, C 1 ~ C 40 alkyl group, C 6 ~ C 60 aryl group, It may be substituted with one or more selected from the group consisting of 5 to 60 heteroaryl groups, C 6 ~ C 60 arylamine groups, and when substituted with a plurality of substituents, they may be the same or different from each other Compound made into.
  8. 제 1항에 있어서, The method of claim 1,
    축합을 형성하는 것을 제외한 R3, Ar1 내지 Ar5 중 적어도 하나는 하기 화학식 5로 표시되는 치환체, 또는 페닐기에서 선택되는 것을 특징으로 하는 화합물:At least one of R 3 , Ar 1 to Ar 5 , except for forming a condensation, is selected from a substituent represented by the following formula (5), or a phenyl group:
    [화학식 5][Formula 5]
    Figure PCTKR2015014035-appb-I000168
    Figure PCTKR2015014035-appb-I000168
    상기 화학식 5에서,In Chemical Formula 5,
    *는 상기 화학식 1에 결합되는 부분을 의미하고;* Means a moiety bonded to Formula 1;
    L1은 단일결합이거나, 또는 C6~C18의 아릴렌기 및 핵원자수 5 내지 18개의 헤테로아릴렌기로 이루어진 군에서 선택되고, L 1 is selected from the group consisting of or a single bond, or C 6 ~ C 18 arylene group and a 5 to 18 nuclear atoms of the heteroarylene group,
    Z1 내지 Z5는 각각 독립적으로 N 또는 C(R11)이며, 다만 Z1 내지 Z5중 적어도 하나는 N이고, R11이 복수 개인 경우, 이들은 서로 동일하거나 상이하며;Z 1 to Z 5 are each independently N or C (R 11 ), provided that at least one of Z 1 to Z 5 is N and when there are a plurality of R 11 , they are the same or different from each other;
    R11은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40개의 헤테로아릴기, C6~C 40의 아릴옥시기 C1~C40의 알킬옥시기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C40의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 모노 또는 디아릴포스피닐기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택되거나, 또는 인접하는 기와 결합하여 축합 고리를 형성할 수 있으며;R 11 is hydrogen, deuterium, halogen, cyano group, nitro group, C 1 -C 40 alkyl group, C 2 -C 40 alkenyl group, C 2 -C 40 alkynyl group, C 6 -C 40 aryl group, 5 to 40 heteroaryl groups, C 6 to C 40 aryloxy groups, C 1 to C 40 alkyloxy groups, C 3 to C 40 cycloalkyl groups, 3 to 40 heterocycloalkyl groups, C 6 ~ C 40 arylamine group, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 40 aryl boron group, C 6 ~ C 40 aryl phosphine group, A C 6 -C 40 mono or diarylphosphinyl group and a C 6 -C 40 arylsilyl group, or may be combined with an adjacent group to form a condensed ring;
    상기 R11의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40개의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 모노 또는 디아릴포스피닐기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 상기 치환기가 복수 개인 경우, 이들은 서로 동일하거나 상이할 수 있다.An alkyl group, an alkenyl group, an alkynyl group, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, a cycloalkyl group of R 11 , a heterocycloalkyl group, an arylamine group, an alkylsilyl group, an alkyl boron group, an aryl boron group, The arylphosphine group, mono or diarylphosphinyl group and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 Alkynyl group, C 6 ~ C 40 aryl group, 5 to 40 heteroaryl groups, C 6 ~ C 40 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 40 An arylamine group, a C 3 to C 40 cycloalkyl group, a C 3 to C 40 heterocycloalkyl group, a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 40 group aryl boron group, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 mono or diaryl phosphine blood group and a C 6 ~ C 40 aryl silyl groups at least one member selected from the group consisting of When substituted or unsubstituted with a substituent and there are a plurality of the substituents, they may be the same or different from each other.
  9. 제 8항에 있어서, The method of claim 8,
    화학식 5는 하기 화학식A-1 내지 A-15로 표시되는 치환체인 것을 특징으로 하는 화합물.Formula 5 is a compound represented by the following formula A-1 to A-15.
    Figure PCTKR2015014035-appb-I000169
    Figure PCTKR2015014035-appb-I000169
    상기 A-1 내지 A-15에서,In the above A-1 to A-15,
    L1 및 R11은 각각 상기 화학식 5에서 정의한 바와 같고,L 1 and R 11 are each as defined in Formula 5,
    n은 0 내지 4의 정수로서, 상기 n이 0인 경우, 수소가 치환기 R12로 치환되지 않는 것을 의미하고, 상기 n이 1 내지 4의 정수인 경우, R12는 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40개의 헤테로아릴기, C6~C40 60의 아릴옥시기 C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 모노 또는 디아릴포스피닐기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택되거나, 또는 인접하는 기와 결합하여 축합 고리를 형성할 수 있으며, 상기 R12가 복수 개인 경우 이들은 서로 동일하거나 상이하며;n is an integer of 0 to 4, and when n is 0, it means that hydrogen is not substituted with a substituent R 12 , and when n is an integer of 1 to 4, R 12 is deuterium, halogen, cyano group, nitro C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 cycloalkyl group, nuclear atom of 3 to 40 heterocycloalkyl group, C 6 Aryl group of ~ C 40 , heteroaryl group of 5 to 40 nuclear atoms, aryloxy group of C 6 ~ C 40 60 C 1 ~ C 40 alkyloxy group, C 6 ~ C 40 arylamine group, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C 40 group of the arylboronic, C 6 ~ mono or diaryl phosphine of C 40 aryl phosphine group, C 6 ~ C 40 P Or a arylsilyl group of C 6 to C 40 , or may be combined with an adjacent group to form a condensed ring, and when there are a plurality of R 12 , they are the same or different from each other;
    상기 R12의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40개의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 모노 또는 디아릴포스피닐기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 상기 치환기가 복수 개인 경우, 이들은 서로 동일하거나 상이할 수 있다.Alkyl group of the R 12, an alkenyl group, an alkynyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, an arylamine group, an alkylsilyl group, an alkyl boron group, an aryl boron group, The arylphosphine group, mono or diarylphosphinyl group and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 Alkynyl group, C 6 ~ C 40 aryl group, 5 to 40 heteroaryl groups, C 6 ~ C 40 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 40 An arylamine group, a C 3 to C 40 cycloalkyl group, a C 3 to C 40 heterocycloalkyl group, a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 40 group aryl boron group, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 mono or diaryl phosphine blood group and a C 6 ~ C 40 aryl silyl groups at least one member selected from the group consisting of When substituted or unsubstituted with a substituent and there are a plurality of the substituents, they may be the same or different from each other.
  10. 제 1항에 있어서, The method of claim 1,
    축합을 형성하는 것을 제외한 R3, Ar1 내지 Ar5 중 적어도 하나는 하기 화학식 6으로 표시되는 치환체인 것을 특징으로 하는 화합물:At least one of R 3 and Ar 1 to Ar 5 except for forming a condensation is a substituent represented by Formula 6 below:
    [화학식 6][Formula 6]
    Figure PCTKR2015014035-appb-I000170
    Figure PCTKR2015014035-appb-I000170
    상기 화학식 6에서,In Chemical Formula 6,
    *는 상기 화학식 1에 결합되는 부분을 의미하고;* Means a moiety bonded to Formula 1;
    L2은 단일결합이거나, 또는 C6~C18의 아릴렌기 및 핵원자수 5 내지 18개의 헤테로아릴렌기로 이루어진 군에서 선택되고, L 2 is selected from the group consisting of or a single bond, or C 6 ~ C 18 arylene group and a 5 to 18 nuclear atoms of the heteroarylene group,
    R13 및 R14는 각각 독립적으로 C1~C40의 알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40개의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되거나, 또는 R13 및 R14가 결합하여 축합 고리를 형성할 수 있으며;R 13 and R 14 are each independently a C 1 ~ C 40 alkyl group, C 6 ~ C 40 aryl group, the number of nuclear atoms of 5 to 40 heteroaryl group, and a C 6 ~ selected from the group consisting of an aryl amine of the C 60 Or R 13 and R 14 may combine to form a condensed ring;
    상기 R13 및 R14의 알킬기, 아릴기, 헤테로아릴기 및 아릴아민기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C40의 아릴기, 핵원자수 5 내지 40개의 헤테로아릴기, C6~C40의 아릴옥시기, C1~C40의 알킬옥시기, C6~C40의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C40의 아릴보론기, C6~C40의 아릴포스핀기, C6~C40의 모노 또는 디아릴포스피닐기 및 C6~C40의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 상기 치환기가 복수 개인 경우, 이들은 서로 동일하거나 상이할 수 있다.The alkyl group, aryl group, heteroaryl group and arylamine group of R 13 and R 14 are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 40 aryl group, the number of nuclear atoms of 5 to 40 heteroaryl group, C 6 ~ C 40 aryloxy group, alkyloxy group of C 1 ~ C 40 of the, C 6 ~ C 40 aryl amine group, C 3 ~ C 40 cycloalkyl group, a number of nuclear atoms of 3 to 40 heterocycloalkyl group, C 1 ~ alkyl silyl group of C 40, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C 40 aryl boron group, C 6 ~ C 40 aryl phosphine group, C 6 ~ C 40 mono or diaryl phosphine blood group and one substituent at least one selected from the group consisting of C 6 ~ with an aryl silyl group of C 40 of the When substituted or unsubstituted, and when there are a plurality of said substituents, they may be the same or different from each other.
  11. 제 1항에 있어서, The method of claim 1,
    상기 화합물이 아래의 화합물로 이루어진 군으로부터 선택되는 것을 특징으로 하는 화합물:Compounds characterized in that the compound is selected from the group consisting of:
    Figure PCTKR2015014035-appb-I000171
    Figure PCTKR2015014035-appb-I000171
    Figure PCTKR2015014035-appb-I000172
    Figure PCTKR2015014035-appb-I000172
    Figure PCTKR2015014035-appb-I000173
    Figure PCTKR2015014035-appb-I000173
    Figure PCTKR2015014035-appb-I000174
    Figure PCTKR2015014035-appb-I000174
    Figure PCTKR2015014035-appb-I000175
    Figure PCTKR2015014035-appb-I000175
    Figure PCTKR2015014035-appb-I000176
    Figure PCTKR2015014035-appb-I000176
    Figure PCTKR2015014035-appb-I000177
    Figure PCTKR2015014035-appb-I000177
    Figure PCTKR2015014035-appb-I000178
    Figure PCTKR2015014035-appb-I000178
    Figure PCTKR2015014035-appb-I000179
    Figure PCTKR2015014035-appb-I000179
    Figure PCTKR2015014035-appb-I000180
    Figure PCTKR2015014035-appb-I000180
    Figure PCTKR2015014035-appb-I000181
    Figure PCTKR2015014035-appb-I000181
    Figure PCTKR2015014035-appb-I000182
    Figure PCTKR2015014035-appb-I000182
    Figure PCTKR2015014035-appb-I000183
    Figure PCTKR2015014035-appb-I000183
    Figure PCTKR2015014035-appb-I000184
    Figure PCTKR2015014035-appb-I000184
    Figure PCTKR2015014035-appb-I000185
    Figure PCTKR2015014035-appb-I000185
    Figure PCTKR2015014035-appb-I000186
    Figure PCTKR2015014035-appb-I000186
    Figure PCTKR2015014035-appb-I000187
    Figure PCTKR2015014035-appb-I000187
    Figure PCTKR2015014035-appb-I000188
    Figure PCTKR2015014035-appb-I000188
    Figure PCTKR2015014035-appb-I000189
    Figure PCTKR2015014035-appb-I000189
    Figure PCTKR2015014035-appb-I000190
    Figure PCTKR2015014035-appb-I000190
    Figure PCTKR2015014035-appb-I000191
    Figure PCTKR2015014035-appb-I000191
    Figure PCTKR2015014035-appb-I000192
    Figure PCTKR2015014035-appb-I000192
    Figure PCTKR2015014035-appb-I000193
    Figure PCTKR2015014035-appb-I000193
    Figure PCTKR2015014035-appb-I000194
    Figure PCTKR2015014035-appb-I000194
    Figure PCTKR2015014035-appb-I000195
    Figure PCTKR2015014035-appb-I000195
    Figure PCTKR2015014035-appb-I000196
    Figure PCTKR2015014035-appb-I000196
    Figure PCTKR2015014035-appb-I000197
    Figure PCTKR2015014035-appb-I000197
    Figure PCTKR2015014035-appb-I000198
    Figure PCTKR2015014035-appb-I000198
    Figure PCTKR2015014035-appb-I000199
    Figure PCTKR2015014035-appb-I000199
    Figure PCTKR2015014035-appb-I000200
    Figure PCTKR2015014035-appb-I000200
    Figure PCTKR2015014035-appb-I000201
    Figure PCTKR2015014035-appb-I000201
    Figure PCTKR2015014035-appb-I000202
    Figure PCTKR2015014035-appb-I000202
    Figure PCTKR2015014035-appb-I000203
    Figure PCTKR2015014035-appb-I000203
    Figure PCTKR2015014035-appb-I000204
    Figure PCTKR2015014035-appb-I000204
    Figure PCTKR2015014035-appb-I000205
    Figure PCTKR2015014035-appb-I000205
    Figure PCTKR2015014035-appb-I000206
    Figure PCTKR2015014035-appb-I000206
  12. 제 1항에 있어서, The method of claim 1,
    상기 화합물에 질소-함유 헤테로환이 추가로 결합되는 것을 특징으로 하는 화합물.A compound comprising a nitrogen-containing heterocycle further bonded to the compound.
  13. 제 1항에 있어서, The method of claim 1,
    상기 화합물에 아릴아민기, 카바졸기, 터페닐기, 및 트리페닐렌기로 이루어진 군으로부터 선택되는 1종 이상의 치환체가 추가로 결합되는 것을 특징으로 하는 화합물.At least one substituent selected from the group consisting of an arylamine group, a carbazole group, a terphenyl group, and a triphenylene group is further bonded to the compound.
  14. (i) 양극, (ii) 음극, 및 (iii) 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, An organic electroluminescent device comprising (i) an anode, (ii) a cathode, and (iii) one or more layers of organic material interposed between the anode and the cathode,
    상기 1층 이상의 유기물층 중에서 적어도 하나는 제1항의 화합물을 포함하는 것을 특징으로 하는 유기 전계 발광 소자. At least one of the one or more organic material layer comprises an organic electroluminescent device, characterized in that the compound of claim 1.
  15. 제 14항에 있어서, The method of claim 14,
    상기 화합물이 발광층의 인광 호스트로 사용되는 것을 특징으로 하는 유기 전계 발광 소자.The compound is used as a phosphorescent host of the light emitting layer.
  16. 제 14항에 있어서, The method of claim 14,
    상기 화합물이 전자수송층으로 사용되는 것을 특징으로 하는 유기 전계 발광 소자.The compound is an organic electroluminescent device, characterized in that used as an electron transport layer.
  17. 제 14항에 있어서, 상기 화합물이 정공수송층으로 사용되는 것을 특징으로 하는 유기 전계 발광 소자.The organic electroluminescent device according to claim 14, wherein the compound is used as a hole transport layer.
PCT/KR2015/014035 2014-12-24 2015-12-21 Organic light emitting compound and organic electroluminescent element using same WO2016105054A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020140188477A KR102248650B1 (en) 2014-12-24 2014-12-24 Organic light-emitting compound and organic electroluminescent device using the same
KR10-2014-0188477 2014-12-24

Publications (2)

Publication Number Publication Date
WO2016105054A2 true WO2016105054A2 (en) 2016-06-30
WO2016105054A3 WO2016105054A3 (en) 2016-09-22

Family

ID=56151586

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2015/014035 WO2016105054A2 (en) 2014-12-24 2015-12-21 Organic light emitting compound and organic electroluminescent element using same

Country Status (2)

Country Link
KR (1) KR102248650B1 (en)
WO (1) WO2016105054A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017099360A1 (en) * 2015-12-08 2017-06-15 Rohm And Haas Electronic Materials Korea Ltd. Organic electroluminescent compound and organic electroluminescent device comprising the same
CN108290900A (en) * 2015-12-08 2018-07-17 罗门哈斯电子材料韩国有限公司 Organic electroluminescent compounds and Organnic electroluminescent device comprising it
CN109096125A (en) * 2017-06-20 2018-12-28 三星显示有限公司 Fused ring compound and organic light emitting apparatus including the fused ring compound
JP2020132579A (en) * 2019-02-20 2020-08-31 国立大学法人静岡大学 COMPOUND, ACTIVE MATERIAL FOR STORAGE BATTERY, n-TYPE SEMICONDUCTOR MATERIAL, HYDROGEN STORAGE MATERIAL, AND METHOD FOR PRODUCING COMPOUND

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102656920B1 (en) * 2016-12-20 2024-04-16 솔루스첨단소재 주식회사 Organic compounds and organic electro luminescence device comprising the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5804797B2 (en) 2011-06-28 2015-11-04 キヤノン株式会社 Benzotriphenylenofuran compound and organic light emitting device having the same

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017099360A1 (en) * 2015-12-08 2017-06-15 Rohm And Haas Electronic Materials Korea Ltd. Organic electroluminescent compound and organic electroluminescent device comprising the same
CN108290900A (en) * 2015-12-08 2018-07-17 罗门哈斯电子材料韩国有限公司 Organic electroluminescent compounds and Organnic electroluminescent device comprising it
CN109096125A (en) * 2017-06-20 2018-12-28 三星显示有限公司 Fused ring compound and organic light emitting apparatus including the fused ring compound
JP2019006765A (en) * 2017-06-20 2019-01-17 三星ディスプレイ株式會社Samsung Display Co.,Ltd. Condensed-ring compound, and organic light emitting element containing the same
US11706973B2 (en) 2017-06-20 2023-07-18 Samsung Display Co., Ltd. Condensed cyclic compound and organic light-emitting device including the same
JP2020132579A (en) * 2019-02-20 2020-08-31 国立大学法人静岡大学 COMPOUND, ACTIVE MATERIAL FOR STORAGE BATTERY, n-TYPE SEMICONDUCTOR MATERIAL, HYDROGEN STORAGE MATERIAL, AND METHOD FOR PRODUCING COMPOUND
JP7212220B2 (en) 2019-02-20 2023-01-25 国立大学法人静岡大学 Compound, active material for storage battery, n-type semiconductor material, hydrogen storage material, and method for producing compound

Also Published As

Publication number Publication date
KR20160077941A (en) 2016-07-04
KR102248650B1 (en) 2021-05-07
WO2016105054A3 (en) 2016-09-22

Similar Documents

Publication Publication Date Title
WO2018038401A1 (en) Organic compound and organic electroluminescence device including same
WO2017179809A1 (en) Organic light-emitting compound and organic electroluminescent element using same
WO2018093107A1 (en) Organic compound and organic electroluminescent element comprising same
WO2016089080A1 (en) Organic luminescent compound and organic electroluminescent device comprising same
WO2018110958A1 (en) Organic light-emitting compound and organic electroluminescent element using same
WO2013094999A2 (en) Organic compound, and organic electroluminescent device using same
WO2018038400A1 (en) Organic compound and organic electroluminescence device including same
WO2014142488A1 (en) Organic compound and organic electroluminescent element including same
WO2018038464A1 (en) Organic compound and organic electroluminescent device comprising same
WO2014010810A1 (en) Novel compound and electroluminescent device including same
WO2014092354A1 (en) Organic compound and organic electroluminescent element comprising same
WO2014025209A1 (en) Novel compound and organic electroluminescence device comprising same
WO2017023125A1 (en) Organic light-emitting compound and organic electroluminescent device using same
WO2016122178A2 (en) Organic light-emitting compound and organic electroluminescent element using same
WO2015111943A1 (en) Organic compound, and organic electroluminescent device containing same
WO2020027463A1 (en) Organic compound and organic electroluminescent device using same
WO2014046392A1 (en) Organic compound and electroluminescent element having same
WO2016105123A2 (en) Organic compound and organic electroluminescent device comprising same
WO2016105054A2 (en) Organic light emitting compound and organic electroluminescent element using same
WO2014027822A1 (en) Novel compound and organic electroluminescent device comprising same
WO2015111942A2 (en) Organic compound and organic electroluminescent element comprising same
WO2017111389A1 (en) Organic compound and organic electroluminescent diode including same
WO2013133575A1 (en) Novel compound and organic electroluminescence element including same
WO2020218680A1 (en) Organic compound and organic electroluminescent diode using same
WO2017105041A1 (en) Organic compound and organic electroluminescent device comprising same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15873581

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 30.08.2017)

122 Ep: pct application non-entry in european phase

Ref document number: 15873581

Country of ref document: EP

Kind code of ref document: A2